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I. Summary 
One of the major growth-promoting factors in animal development and growth is the 
epidermal growth factor receptor (Egfr). The Egfr pathway is involved in 
proliferation, cell survival, migration and differentiation and is one of the most 
commonly deregulated pathways in cancer. Medaka fish have two copies of the egfr 
gene, egfr a and b, which have so far not been analyzed for their particular function 
and redundancy.  
To understand the role of Egfr signaling in the neural stem cell zones of the retina and 
the brain, we performed a whole mount in situ hybridization screen for egfrs, selected 
ligands as well as selected downstream signal transducers. We found that both egfrs 
are broadly and overlapping expressed during development and more specifically in 
proliferative zones of the brain and the ciliary marginal zone in hatchlings. 
To determine the effect of enhanced growth signaling on the retinal stem and 
progenitor cells we created a versatile toolbox for targeted induction of Egfr-related 
oncogenes (Xmrk, myrAKT, and K-Ras12V) in cell types of interest. To this end, we 
tagged the Egfr variant Xmrk with a fluorescent protein and demonstrated its 
oncogenicity in a somitic overproliferation assay. A Cre-loxP based induction of 
oncogenes in single cells in somites and also in the retina was successfully achieved in 
transient and stable lines, and multiple lines were generated. The analysis of 
oncogenic effects on RSCs was however hampered by the loss of visible expression in 
later generations in the retina and brain.  
To analyze the specific role of Egfra in development and growth I generated a 
CRISPR/Cas9 based knockout (KO) disrupting the open reading frame by GFP-
plasmid insertion or deletion and analyzed the resulting phenotype. Egfra-KO fish 
develop and reproduce normally but have a defect in oogenesis. Oocytes derived from 
homozygous Egfra-KO females contain multiple sperm entry sites (micropyles), 
which causes polyspermy and therefore lethality. The characterization of the 
polyspermy phenotype, as well as the oogenesis defect in adult ovaries, points towards 
a role of Egfra in the communication between the granulosa cell layer and the oocyte 
to specify the micropyle. 
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By generation of genetic loss and gain of function tools for Egfra and related 
oncogenes, this work will contribute to understanding the general and the more 
specific role of Egfr signaling in growth and development of the Medaka fish. 
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II. Zusammenfassung 
Der Epidermal growth factor (Egf) Rezeptor ist ein SchlüsselfAKTor in der 
Entwicklung und dem Wachstum von Tieren. Der Egf-Rezeptor Signalweg steuert 
Zellteilung, Zellmigration, Zellüberleben und Differenzierung und ist einer der am 
häufigsten deregulierten Signalwege in Tumoren. Der Medaka Fisch hat zwei Kopien 
des Rezeptors: a und b, deren Funktion bisher nicht bekannt ist. Des Weiteren ist 
unerforscht inwieweit sich beide Rezeptoren in ihrer Funktion unterscheiden oder ob 
sie redundant agieren.  
Um die Rolle des Egf-Signalweges in den neuronalen Stammzellregionen der Retina 
und des Gehirns besser zu verstehen wurde ein In Situ Hybridisierung Screening 
durchgeführt. Hierfür wurden Sonden für die Erkennung der mRNA beider Egf-
Rezeptoren sowie ausgewählter Liganden und Signalübertragungsproteine verwendet. 
Die Untersuchung hat ergeben, dass die Gene beider Egf-Rezeptoren großflächig und 
überlappend während der Entwicklung, jedoch später auch in den Stammzellzonen 
der Retina und des Gehirns abgelesen werden. 
Um heraus zu finden ob ein erhöhtes Wachstumssignal eine Auswirkung auf das 
Verhalten retinaler Stamm- und Vorläuferzellen hat, haben wir eine Reihe von 
vielseitigen transgenen Fischlinien entwickelt, die es erlauben, Egf-Rezeptor 
verwandte Onkogene (Xmrk, myrAKT, and K-Ras12V) in einzelnen Zellen oder 
Zelltypen zu exprimieren. Hierfür haben wir eine onkogene Variante des Egf-
Rezeptors, Xmrk, mit einem fluoreszierenden Protein verbunden und die Fähigkeit 
der Rezeptorvariante, die Zellteilung anzuregen, in einem in vivo Zellteilungsassay 
bestätigt. Ein auf Cre-Lox Rekombination basierendes System ermöglichte es 
erfolgreich Onkogene in einzelnen Zellen in den Somiten und in der Retina zu 
exprimieren. Diverse induzierbare Onkogen-Fischlinien wurden generiert und 
getestet, jedoch wurde die Analyse der Onkogeneffekte auf retinale Stammzellen 
dadurch erschwert, dass in späteren Generationen der Onkogen-Linien keine 
sichtbare Expression des fluoreszierenden Onkogens mehr detektiert werden konnte. 
Die spezifische Funktion des Egf-Rezeptors a in Entwicklung und Wachstum des 
Medaka Fisches wurde untersucht, indem das Gen mit Hilfe der CRISPR/Cas9 
Zusammenfassung 
 11 
Technologie deAKTiviert wurde. Homozygote Träger beider Mutationen, eine GFP-
Plasmid Insertion sowie eine Deletion von 12 Basen, wurden auf ihren Phänotyp hin 
untersucht. Egf-Rezeptor mutante Fische sind lebensfähig und in ihrer Fortpflanzung 
nicht beeinträchtigt; die Nachkommen homozygoter Weibchen weisen jedoch einen 
spezifischen Defekt bei der Oogenese auf. Homozygote Egf-Rezeptor a mutierte 
Weibchen produzieren Eier, die mehrere Mikropyle in ihrem Chorion aufweisen, die 
die Befruchtung der Eizelle mit mehreren Spermien ermöglichen (Polyspermie) und 
daher zum Absterben der Embryonen führen. In dieser Arbeit wurde der Phänotyp 
der Polyspermie sowie der Oogenesedefekt charAKTerisiert. Die Ergebnisse deuten 
darauf hin, dass der Egf-Rezeptor a eine wichtige Rolle bei der Kommunikation 
zwischen der Eizelle und der umgebenden Granulosa-Zellschicht spielt, die für die 
Ausbildung des Mikropyle verantwortlich ist. 
Durch die Entwicklung genetischer „Gain- and Loss-of-Function“ Systeme für Egf-
Rezeptor a und verwandte Onkogene wird diese Arbeit dazu beitragen, die spezifische 
Rolle des Egf-Signalwegs in Entwicklung und Wachstum des Medaka Fisches zu 
verstehen.  
.
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1. Introduction 
One of the cardinal signaling pathways in animal development and growth is the 
epidermal growth factor receptor (Egfr) pathway. The Egfr, also known as 
ErbB1/HER-1 mediates proliferation, cell survival, migration and differentiation 
(Herbst 2004). A major challenge in studying the Egfr pathway is its diverse role in 
development and growth of multicellular organisms. The question how a single 
receptor can influence such a big range of developmental decisions is an issue that is 
studied for centuries. Other than most vertebrate, ray-finned fish (Teleostei) have two 
copies of the egfr (egfra and egfrb). The subfunctionalization or redundancy of the 
two receptors has not been studied in much detail so far. First steps to understanding 
the individual role of Egfra in fish are described in this work. Of particular interest is 
the function of Egfr signaling in the central nervous system (CNS) and more specific 
in the retina. Presented here is a toolbox that allows expressing Egfr related oncogenes 
in single clones of the freshwater Japanese Killifish Oryzias latipes, also known as 
Medaka.  
The introduction covers different aspects of biology with relation to the Egfr and sets 
the base to understand the results subdivided into three chapters: 
1. Expression of egfrs, ligand and signal transducer genes in the CNS 
2. Egfr related oncogene expression systems for inducible expression in the 
retina 
3. Egfra knock-out phenotype characterization: Defects in oocyte maturation 
1.1 Structure and function of the Egfr 
The first growth factor was identified and characterized by its ability to induce growth 
in epidermal tissues of mice and therefore called epidermal growth factor (Egf) 
(Cohen 1962). In the 1970s an Egf-binding trans-membrane glycoprotein was 
identified: the Egf-receptor (Egfr). The Egfr belongs to the ErbB family of receptor 
tyrosine kinases (RTK). Other members of this receptor family in mammals are 
ErbB2/Neu/HER-2, ErbB3/HER-3, and ErbB4/HER-4. Several biochemical studies 
demonstrated that the Egfr has an intrinsic kinase function which is specific for 
tyrosine residues (Buhrow, Cohen, and Staros 1982; Cohen et al. 1982; Ushiro and 
Introduction 
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Cohen 1980). To be activated the Egfr has to form homo- or heterodimers with other 
ErbB receptors (Tao and Maruyama 2008) or the Insulin-like growth factor receptor 
(Igrf) which is structurally very similar (Morgillo et al. 2006). 
On their extracellular site, ErbB receptors are heavily glycosylated, and the cysteine-
rich domains II and IV (see figure 1 A) can form several disulfide bonds. The other 
two extracellular domains (I and III) are responsible for binding of ligands. As other 
RTKs, ErbB receptors have a single transmembrane domain. The intracellular part (C-
terminal region) contains several autophosphorylation sites as well as a 
juxtamembrane tail (Linggi and Carpenter 2006). 
 
 
Figure 1: Schematic representation of the extracellular and intracellular domains of the 
Egfr upon ligand-binding induced activation. A. The Egfr has four domains, two ligand-binding 
domains (I and III) and two interaction domains (II and IV). Upon ligand binding, the receptor changes 
its conformation and can interact with one other receptor monomer. B. Upon dimerization of the 
extracellular interaction domains, the cytoplasmic domains phosphorylate each other on their tyrosine 
residues and become activated. The figure is redrawn from Linggi and Carpenter 2006. 
Adding to the complexity of Egfr- signaling is that various structurally related ligands 
can bind the receptors extracellular domain. The vast majority of ligands namely Egf, 
heparin-binding Egf (Hb-Egf), transforming growth factor-α (Tgf-α), amphiregulin, 
epiregulin, epigen and betacellulin bind exclusively to the ErbB1 receptor (Linggi and 
Carpenter 2006). All of these ligands are translated into transmembrane precursors 
and become activated by proteolytic cleavage mediated by membrane-anchored 
metalloproteases of the ADAM family, a process known as ectodomain shedding. The 
ectodomain is then freed to act as a receptor ligand (Blobel 2005; Schlöndorff and 
Blobel 1999).  
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Ligand binding to the receptor domains I and III causes homo- and 
heterodimerization of two receptors which in turn activates the intracellular kinase 
domain (figure 1B). The kinase domains of dimerized receptors phosphorylate each 
other at specific tyrosine residues on the cytoplasmic tail. The phosphorylated 
tyrosine residues, in turn, serve as binding sites for Src homology 2 domain (SH2) 
containing proteins. The main SH2 domain containing proteins of the Egfr signaling 
pathway are Grb2 (Lowenstein et al. 1992), Son Of Sevenless (SOS) (Buday and 
Downward 2017), Src homology 2 domain containing (SHC) proteins (Pelicci et al. 
2017; Ruff-Jamison et al. 1993) and Protein Lipase C-γ PLCγ (Margolis et al. 1990; 
Rotin et al. 1992), which in turn activate complex downstream signal transduction 
cascades (Schlessinger 2002; Yarden and Sliwkowski 2001). The output of activated 
Egfr signaling is diverse and depends on the type of ligand binding and dimer formed 
(Maria Sibilia et al. 2007).  
 
 
Figure 2 Simplif ied signal transduction pathways activated by the Egfr. The RAS/MAPK 
pathway is activated via SOS. NFkB and mTOR signaling are activated via PI3K and AKT. SRC and JAK 
both activate different STAT proteins. PLC activates PKC after interaction with autophosphorylated 
Egfr. 
The Egfr controls vital functions of cells like survival, growth, cell division, motility, 
apoptosis and differentiation and thereby fulfills a fundamental role in development. 
Introduction 
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Several downstream signaling cascades mediate the diverse cellular processes induced 
by Egfr-ligand interaction. SH2-containing proteins bind to the phosphorylated 
tyrosine residues of the activated receptor and in turn activate downstream signal 
transducers as rat sarcoma (RAS), Protein kinase B (PKB/AKT) and Signal 
Transducers and Activators of Transcription (STAT) proteins and protein kinase B 
(PKB) (figure 2). The reactions elicited by the Egfr activation are specified by the 
ligand-receptor interaction and other co-factors (K. J. Wilson et al. 2009). On top of 
the diversity of ligands and downstream effectors, additional layers of regulation of 
EGFR signaling exist, that guarantee spatial and temporal control.  
Intracellular Egfr-stimulated signal transducers are highly interlinked with other 
signaling pathways as the insulin-like growth factor (Igf) or the fibroblast growth 
factor (Fgf) pathway, which makes it difficult to dissect Egfr-specific functions. The 
study of the physiological role of the receptor was long hampered by the severity of 
the effects caused by enhanced or decreased activity of the receptor in various tissues 
of mammals (Maria Sibilia et al. 2007).  
The presence of two Egfrs in Medaka might allow uncovering new roles of Egfr 
signaling in development and growth of vertebrates since a partial redundancy might 
allow generation of loss of function models and the sub-functionalization might 
permit the dissection of different roles in complex processes. 
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1.2 General physiological role of EGFR signaling 
Egfr proteins are conserved in metazoans and have derived from a basic receptor 
ligand interaction pair as found in Caenorhabditis elegans (C.elegans) where LET-23 is 
the only receptor and LIN3 the only ligand (Aroian et al. 1990; Moghal and Sternberg 
2003).LET-23 mediates two different kinds of processes dependent on the signal 
transducer used downstream of the receptor. The receptor stimulates the Ras/MAPK 
pathway to regulate cell fate specification during organogenesis on the one hand, on 
the other myoepithelial contractions during ovulation via IP3 mediated signal 
transduction (Moghal and Sternberg 2003). Looking at this simple version of the 
pathway in C. elegans already demonstrates the various ways in which Egfr signaling 
acts in development.  
In Drosophila melanogaster only one ErbB receptor (DER) is present. In contrast to 
only one ligand in C.elegans however, five different ligands exist Spitz, Keren, Gurken, 
Agros and Vein. The downstream signaling cascade in flies is much simpler than in 
vertebrates with unbranched canonical Ras/MAPK activation being the default output 
of receptor activation. The fly Egfr receptor, DER, and its main ligands Spitz are 
broadly expressed. Nevertheless, EGFR signaling is spatially and temporally tightly 
regulated (B.-Z. Shilo 2005) to control various processes in the embryo and the 
larvae/pupae stage as cell and tissue fate during development, proliferation, and 
differentiation of cell types in wings, eyes, legs and ovaries (Schweitzer and Shilo 
1997). While the multitude of developmental programs in the fruit fly are regulated by 
the Spitz ligand, Gurken is mainly involved in oogenesis related processes (Shilo 
2003).  
In vertebrates, the Egfr controls a similar spectrum of developmental programs. Loss 
of function studies, performed mainly in mice, helped to understand the vertebrate 
Egfr pathway in more detail. Egfr mutant mice die during different stages of 
development and are growth retarded. Mice that reach post-natal stages show 
abnormalities in the bone, brain heart, skin, hair follicle, and eyes. Egfr-/- embryos 
mostly die in utero because of placental defects and lung immaturity; surviving 
embryos have severe brain defects (Miettinen et al. 1995; M Sibilia and Wagner 1995; 
Threadgill et al. 1995). Knockouts of single receptor ligands lead to comparably mild 
Introduction 
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phenotypes indicating that there is high redundancy between ligands (Cook et al. 
1997; Luetteke et al. 1994). 
In fish, not many aspects of Egfr signaling have been investigated so far. In Zebrafish 
Egfr-signaling is essential for proper heart development (Goishi et al. 2003) as well as 
for oocyte maturation (Wang and Ge 2004; Yefei and Wei 2002). Novel genome 
editing tools like CRISPR/Cas9 allow fast and easy generation of loss of function 
mutants and enable researchers to dissect Egfr function in teleost species in more 
detail. 
With the help of conditional alleles the receptor is now studied more specifically for 
its role in different tissues or processes (Lee and Threadgill 2009) for example in bone 
metabolism (X. Zhang et al. 2011), renal development (Z. Zhang et al. 2010) and skin 
innervation (Maklad et al. 2009). Although some studies are concentrating on the 
physiological functions of Egfr signaling the main focus of mammalian Egfr-related 
research is the role of the receptor in cancer and its potential as a target for anti-
cancer therapy. 
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1.3 Egfr signaling out of control 
The diversity of functions that the Egfr has in growth and development is reflected by 
the severity of effects resulting from deregulation of the pathway. Hyperactivity of 
Egfr-signaling is a common feature of many cancers by causing an unbalance between 
proliferation and differentiation of cells. Egfr itself can be found over-expressed for 
example in brain, colorectal, breast, lung, pancreatic and prostate cancers but can 
transform cells only in the presence of a ligand to stimulate an autocrine loop. Many 
cancers bear a somatic mutation that renders the receptor constitutively active for 
example by deletion of a part of the extracellular domain (Moscatello et al. 1995) or 
changes in the intracellular kinase domain. Constitutively activated Egfr signaling in 
cells that are not interrupted by induction of apoptosis will start dividing uncontrolled 
and adapt a more migratory phenotype. Tumor growth and metastasis are also often 
correlated with increased ligand and receptor levels (Überall et al. 2008). 
Various cancer models in mice, rats and fish use Egfr related oncogenes to induce 
over-proliferation and thereby tumor formation. These oncogenes are for example 
constitutively active forms of the receptor itself or hyperactive downstream signaling 
components as K-Ras, AKT or Braf. K-Ras variants are used to induce cancer in the 
pancreas (Friedlander et al. 2009), lung (Kim et al. 2005) and brain (Bachoo et al. 
2015. Oncogenic AKT is used as a trigger for brain tumors (Holland et al. 2000).  
Xmrk (Xiphophorus melanoma receptor kinase), a mutant form of the egfrb, is used to 
transform melanocytes (Schartl et al. 2010) as is a mutant for of BRAF (Dhomen et al. 
2009) and other mutant forms of Egfrs induce glioblastoma (Bachoo et al. 2002). 
1.4 Teleost as cancer models 
Teleost fish, like Zebrafish and Medaka, are used to model human diseases for 
approximately 25 years. Tumors of various tissues, which develop spontaneously or 
after induction of mutations by radiation or chemicals, resemble those of humans, 
histologically and genetically (Feitsma and Cuppen 2008). Many fish tumor models 
based on chemical treatment, xenotransplantation, knockout of genes or transgenesis 
were established (Feitsma and Cuppen 2008; H. Feng et al. 2007; Le et al. 2007). The 
generation of transgenic lines, often expressing mammalian oncogenes, overcame the 
disadvantages of tumor models based on random mutation screens: the frequency of 
Introduction 
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off-target mutations, the unpredictability of the outcome and the amount of fish 
necessary. 
An example for a transgenic tumor model is the Medaka melanoma model (Schartl et 
al. 2010) based on the expression of the potent oncogene, the Xiphophorus melanoma 
receptor kinase (Xmrk). Xmrk is a mutated variant of the egfrb proto-oncogene that is 
unique to the genus Xiphophorus (Wittbrodt et al. 1989). The oncogenic receptor 
occurred during the diversification of the genus from a duplication event (Weis and 
Schartl 1998) and is favored by sexual selection for the hyperpigmentation it causes in 
male carriers (Fernandez and Bowser 2010). If uncoupled from a repressor by hybrid 
back-crosses, expression of xmrk leads to the formation of a spontaneous, lethal 
melanoma (Ahuja and Anders 1976).  
If transgenically expressed under the pigment cell-specific microphthalmia-associated 
transcription factor (mitf) promoter in Medaka, xmrk causes malignant melanomas 
with a prevalence of 100% in homozygous carriers without any additional mutation 
(Schartl et al. 2010). The oncogenicity of this specific Egfr-variant is due to two 
activating mutations in the extracellular domain of the receptor which render it 
constitutively activated in a ligand-independent manner (Dimitrijevic et al. 1998; 
Winnemoeller, Wellbrock, and Schartl 2005). Because Egfr is upstream of various 
downstream signaling cascades, it is not surprising that in vitro and in vivo Xmrk is 
able to induce several characteristics of neoplastic transformation. Xmrk induces 
strong cell proliferation and anti-apoptotic signals, inhibition of differentiation and 
survival of melanocytes in cell culture as well as in Medaka (C Wellbrock et al. 1998; 
Claudia Wellbrock et al. 2002; Claudia Wellbrock, Fischer, and Scharti 1998). Various 
tissues of fish embryos are sensitive to cancerogenic transformation through xmrk 
expression; it is, therefore, a gene with enormous oncogenic potential (Geissinger et 
al. 2002; Winkler et al. 1994). Melanomas, as well as hepatocellular carcinomas 
stimulated by xmrk expression, share molecular signatures with respective human 
cancers and cancer cell lines (Teutschbein et al. 2010; Zheng et al. 2014). A 
tetracycline-inducible system (Tet-ON) has been used to express xmrk in the liver to 
induce hepatocellular over-proliferation. These "carcinomas" develop within a couple 
of weeks with a 100% penetrance when fish are constantly treated. The liver, however, 
regresses to normal size as soon as the treatment is stopped. The "carcinomas" are 
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thus xmrk-dependent as is the activity of downstream signal transducers Stat5 and Erk 
(Li et al. 2012). 
Oncogenic versions of the small GTPase protein Ras as the K-RASG12V are often 
mutated in the GTPase domain leading to a constant signaling GTPase. This Ras-
variants are used for cancer models to induce for example pancreatic cancers 
(Friedlander et al. 2009). K-RASV12 was also expressed in a GAL4-UAS transactivator 
system in Zebrafish to induce proliferation of endothelial cells (Alghisi et al. 2013) and 
brain tumors (Mayrhofer et al. 2016).  The clonal mouse tumor models are either 
based on the expression of an oncogene, knockout of an endogenous tumor 
suppressor gene or a combination of both in single cells. Widely adapted for 
activation of the oncogene is the excision of a floxed STOP cassette. An inducible and 
lineage-specific expression of a recombinase guarantees spatial and temporal control 
of oncogenes (Rappaport and Johnson 2014).  Several Cre-Lox based inducible clonal 
tumor models exist in mice, but so far there is no genetic fish model expressing xmrk 
or any other oncogene in a clonal manner 
1.5 CNS- and retina-specific effects of Egfr signaling and 
oncogenes 
Looking at the incidence number of cancer in different tissues and the correlation to 
enhanced Egfr signaling it becomes apparent that different cell types react differently 
to Egfr-related oncogene expression. Some cell types will develop malignant tumors 
(Schartl et al. 2010) while other tissues react with enhanced proliferation (Li et al. 
2012) and terminal differentiation (Aguirre, Rubio, and Gallo 2010) or even apoptosis 
(Rush et al. 2012). In humans, most adult cancers arise in tissues in which cells are 
regularly replaced by adult stem cells, such as skin (Blanpain and Fuchs 2006) and 
intestine (Barker et al. 2009). In other adult tissues as the CNS, more specifically the 
retina, cancers develop very rarely or never which might be due to the lack of 
proliferating cells. Subsets of cells isolated from the pigmented ciliary margin of the 
mouse retina can however clonally proliferate in vitro and differentiate into various 
retinal cell types if stimulated with Egf or Fgf (Tropepe 2000). In contrast to 
mammals, teleost fish like Zebrafish and Medaka have adult retinal stem cells (RSCs) 
that are active throughout the life of the fish and are implicated in maintenance, 
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growth, and regeneration of the eye (Amato, Arnault, and Perron 2004; P. Raymond 
et al. 2006) and could thus be responsive to the occurrence of oncogenic mutations in 
the Egfr pathway. Yet, cancers or even over-proliferation of the neural retina never 
occur as far as the literature reports, suggesting a very tight control of growth in the 
retina that cannot be disturbed easily.  
The Egfr  plays a central role in the development of the D. melanogaster eye. Its role in 
vertebrate eye development and growth has so far not been elucidated to a high 
extend. Various signaling pathways as insulin (Boucher and Hitchcock 1998), 
Hedgehog, Tgf-ß, Wnt (Meyers et al. 2012) and Fgf (Martinez-Morales et al. 2005) 
signaling play and important role in eye development and growth.   
Enhanced Egfr signaling in the neural stem cells (NSCs) of mouse brains shifts the 
balance between NCS and their progenitors towards the neural progenitor cell (NPC) 
pool reducing self-renewal of NSCs. Egfr signaling, together with Notch,  mediates the 
balance between these two cell populations (Aguirre, Rubio, and Gallo 2010). Notably, 
in this case, the over-activity of Egfr alone is not enough to stimulate tumor formation 
but rather drives the stem cell pool towards terminal differentiation. 
The result of Egfr loss in mammals is progressive, wide-ranging neurodegeneration 
due to apoptosis of neurons and glial cells (astrocytes and oligodendrocytes) 
(Kornblum et al. 1998; M Sibilia et al. 1998).  
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1.6 The retina in teleost fish 
Development and organization of the eye are highly conserved among vertebrate 
species. The events leading to the formation of the mature NR out of an epithelial 
monolayer happen in a very stereotypic manner. The retina is the most available part 
of the CNS and is therefore a traditional model to study neurogenesis and behavior of 
NSCs. The single layer of neuroepithelium develops into a laminated tissue with seven 
major cell types (six neural and one glial cell type), each of which takes a well-defined 
position in the retina (Figure 3 A and B). By this retinal cells form a highly organized 
structure of three nuclear layers divided by two plexiform layers (Livesey and Cepko 
2001). The nuclei of rod and cone photoreceptors make up the outer nuclear layer 
(ONL) in which light is photoconverted into membrane potentials. The neural 
impulses are then transmitted through a relay in the inner nuclear layer (INL) to the 
retinal ganglion cells (RGCs). In the ganglion cell layer (GCL). RGCs project the 
signals through their axons bundled in the optic nerve towards the optic tectum (OT). 
 
Figure 3: Different views on the retina and the CMZ of the Medaka hatchling. A. 
Schematic representation of the Medaka hatchling. B Eye of the Medaka fish represented to 
understand the orientation of retinal growth. Cells are added at the CMZ (green ring) around the lens 
so that the direction of growth is from the proximal embryonic retina (red) to distal. The gray square 
represents the section plane shown in C. C. Schematic drawing of the CMZ. Rx2-positive RSCs, at the 
most distal part of the CMZ, are depicted in green, highly proliferative retinal progenitor cells (RPC) are 
depicted in magenta. The CMZ and the differentiated neural retina (gray) are surrounded by a single 
cell layered retinal pigmented epithelium (RPE, brown). D. Section through a retina of a hatchling 
incubated in BrdU for three days. Stem cells, photoreceptors and Müller glia cells (MGCs) expressing 
Rx2 are stained in green. BrdU labeling the dividing RPCs are depicted in magenta. F=frontal, 
V=vental, D=dorstal, Di = distal , C=caudal, CMZ=ciliary marginal zone, RSC=retinal stem cell, RPC= 
retinal progenitor cell, GCL=ganglion cell layer, INL=inner nuclear layer, ONL=outer nuclear layer, 
RPE=retinal pigmented epithelium 
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The INL accommodates the bipolar-, horizontal-, amacrine and Müller-glia cells 
(MGCs). MGCs, being the only non-neurogenic cells, are the radial glia of the retina 
(Bernardos et al. 2007; Urlinger et al. 2000) and fulfill special functions. They span the 
whole neural retina and act to support retina homeostasis. Upon injury, MGCs can 
act as multipotent RSCs (Bernardos et al. 2007; P. A. Raymond et al. 2006) and can 
even be stimulated to re-enter cell cycle by expression of Atoh7 (Lust et al. 2016) or 
stimulation with HB-EGF (Wan, Ramachandran, and Goldman 2012).  
The actual RSCs of the adult fish retina are located in the ciliary marginal zone (CMZ) 
a ring of cells in the outermost periphery of the retina (Figure 3A, green ring). As the 
NR grows, the CMZ moves outwards, and newly formed neurons are added to the 
outer rim close to the lens. This temporal organization of the retina, leaving old 
neurons in a central position and young neurons in the periphery, makes the position 
of a neuron a direct temporal read-out. The homeobox transcription factor retina-
specific homeobox gene 2 (rx2) can be used as a bona fide marker for RSCs (Figure 
3D) (Reinhardt et al. 2015) but is also expressed in photoreceptors and MGC. As the 
RSCs divide they give rise to faster cycling RPCs that then terminally differentiate into 
neurons or MGCs and take their place in the structured retina.  
Transplantation experiments, using fish lines that express fluorescent proteins 
ubiquitously, could prove that multipotent adult stem cells located in the CMZ form 
arched-continuous stripes (ArCoS) independently in the NR and the retinal 
pigmented epithelium (RPE) (Centanin, Hoeckendorf, and Wittbrodt 2011). The RPE 
is a single epithelial layer essential for proper functioning of the retina (Ramón 
Martínez-Morales, Rodrigo, and Bovolenta 2004), grows in a coordinated fashion 
with the NR and shares the developmental origin. However, the RPE stem cell is not 
concordant with the NR stem cell even though location in the CMZ and growth 
patterns are similar (Centanin, Hoeckendorf, and Wittbrodt 2011).  
More recently it could be verified by long-term analysis of induced color-recombined 
RSCs that these cells retain their ability to divide throughout the life of the fish 
asymmetrically (Centanin et al. 2014). Using stem cell specific (Rx2 driver) or heat 
shock inducible Cre-driver lines (Rx2:: Cre-ERT2/hsp70:: Cre) and a fish ubiquitously 
expressing a floxed labeling cassette (Livet et al. 2007) recombination towards an 
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easily detectable H2B-GFP label in single stem cells let to the formation of colored 
ArCoS. The history of a clone derived from a single RSC can be analyzed by the shape 
of the ArCoS (Centanin et al. 2014; Centanin, Hoeckendorf, and Wittbrodt 2011). The 
ArCoS assay is a great tool to study the effect of genetic factors, more precise the 
expression of oncogenes, on the behavior of single RSCs and RPCs and their 
descendants.  
The vertebrate neural retina seems to be immune to the occurance or the effect of 
oncogenic mutations, given the fact that tumors originating from this tissue have not 
been described. The growing NR must thus have active mechanisms that prevent 
over-proliferation since it is of great importance for proper functioning of the eye that 
the stereotypic organization is not disturbed. The only tumor arising from the retina 
is retinoblastoma caused by a bi-allelic mutation of the Retinoblastoma (Rb) gene. 
This tumor exclusively occurs in children from immature retinoblasts with 
proliferative capacity. In mammals, the noticeable absence of retinal cancers might 
thus be due to the lack of proliferating cells in the retina. In vitro however, the 
receptor ligand Egf stimulates proliferation and differentiation of murine RSCs 
(Angénieux, Schorderet, and Arsenijevic 2006). 
 
Figure 4: ArCoS assay used to label single RSC clones used to demonstrate the 
preference for asymmetric division mode of RSCs. A. Genetic layout of the labeling cassette 
expressing the default DsRed and upon recombination in single cells express H2B-GFP as a clonal 
label. B. Schematic representation of ArCoS formed by single labeled clones spanning from the 
embryonic retina (proximal ring) to the CMZ (green ring around lens). C. Example of a whole retina with 
several ArCos. D. Section through the entire retina showing several ArCoS. E H2B-GFP labeled clone, 
containing cells of all three nuclear layers. Di=distal, D=dorsal, P=proximal, V=vental, ArCoS=arched 
continuous stripes, ONL=outer nuclear layer, INL=inner nuclear layer, GCL=ganglion cell layer. Panel 
C-E were adapted from (Centanin et al. 2014). 
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1.6.1 Egfrs and its ligands in teleost fish 
The mammalian EGFR is the only receptor of the ErbB1 class of Erb RTKs, and not 
much had been known about egfrs in fish until the beginning of the ‘00s. Except for 
the Xiphophorus xmrk gene, that was described in 1989 no other teleost Egfr had been 
isolated until 2004, even though a proto-oncogenic version of Xmrk (INV-
xmrk/egfrb) was described before (Dimitrijevic et al. 1998).  
In 2004 Gómes et al. published the isolation and characterization of another 
Xiphophorus egfr gene (egfra) and suggested a fish-specific duplication of an ancestral 
receptor gene (Gómez et al. 2004). Another local gene-duplication of egfrb in the 
Xiphophorus genus then let to the occurrence of xmrk. The expression of egfra in 
different tissues of Xiphophorus is much closer to the expression patterns of the Egfr 
in mice then is the pattern of egfrb expression. Another hint that egfra might be 
functionally more related to the mammalian Egfr is its ability to react to stimulation 
with human EGF (hEGF) which does not stimulate egfrb (Gómez et al. 2004). During 
development of Medaka, the egfrs are expressed in a dynamic pattern as could be 
shown by using a human antibody (AB) against the more conserved tyrosine kinase 
domain (Boomsma, Scott, and Walters 2001).  
The two egfrs in teleost are a result of the fish-specific genome duplication of (FSGD) 
320-350 million years ago after which many duplicates disappeared again, but some 
were retained because of neofunctionalization or subfunctionalization of the gene 
copies (Meyer and Van De Peer 2005; Postlethwait et al. 2004). Whether one or the 
other is the case for egfra and egfrb or whether they are completely redundant is not 
known so far. In contrast to the receptors, only one copy of each ligand is conserved 
in fish except for the two hb-egf genes in Zebrafish (Kassahn et al. 2009; Laisney et al. 
2010). Even though all Egfr ligands were retained in teleosts as in tetrapods, the 
sequence conservation is rather weak. The comparison between tetrapod and teleost 
egfr gene sequences revealed that highest similarities could be found in the 
intracellular tyrosine kinase domain and greatest difference in the extracellular 
domain. The ligand-binding domain displays little identity between teleost and 
tetrapods and even between different teleost's itself, suggesting the co-evolution of 
ligands and receptor ligand binding site (Laisney et al. 2010). This might also be a hint 
for a possible sub-functionalization between the two teleost egfrs. 
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Egfr transcripts are deposited in the oocyte since high expression of both receptors in 
stage 8 Medaka embryos, and only low zygotic expression could be detected. RT-PCR 
analysis of egfr transcripts revealed that egfra and egfrb are similarly expressed in 
muscles, testis, brain eye and heart and different in spleen, kidney, skin (egfra higher) 
and gills liver and ovary (egfrb higher) (Laisney et al. 2010). The same pattern could be 
observed in Xiphophorus (Gómez et al. 2004) and might be due to a tissue specific 
subfunctionalization of the receptor.  
Relevant answers about the subfunctionalization and redundancy of the two egfrs are 
to be gained by loss-of-function approaches that are feasible in times of easy genome 
editing techniques as CRISPR/Cas9. Described in this work is an egfra loss-of-
function Medaka line in which a surprising function during oogenesis of egfra is 
revealed. The course of oogenesis and the known functions of egfr in this process are 
in the following described in more detail.  
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1.7 Oogenesis and Egfr signaling 
One organ in which Egfr-signaling is known to play a significant role in different 
species is the ovary, especially during the process of oogenesis (FregosoLomas et al. 
2013; Jamnongjit, Gill, and Hammes 2005; Schweitzer and Shilo 1997; Wang and Ge 
2004; Yefei and Wei 2002).  
Most teleost fish are oviparous, meaning that they produce yolk-containing eggs 
instead of living offspring. For the generation of these eggs, three different ways are 
described: synchronous, group-synchronous and asynchronous ovarian development. 
While in Zebrafish oocytes develop in a group-synchronous way, Medaka oocyte 
maturation happens asynchronously, so that all stages of developing oocytes are 
present at all times (Wallace and Selman 1981). 
1.7.1 Oogenesis 
The differentiation of a primary oocyte into an egg is accompanied by significant 
structural and functional changes (Lubzens et al. 2010), and the process in which an 
oocyte matures can be divided into four major phases. The follicular layer, the cells 
supporting and regulating oocyte development and growth, develops along with the 
oocyte. From a single cell layer, the follicle in teleosts develops into a two cell layer in 
which the oocyte is directly surrounded by interconnected granulosa cells which in 
turn are surrounded by the theca cell layer. 
The process of oogenesis in Medaka was subdivided into ten stages based on the 
internal and external structure and morphology as seen by electron microscopy by 
Iwamatsu et al. (Iwamatsu et al. 1988) and schematically illustrated in figure 5.  
In the previtellogenic stage, oocytes of the chromatin nucleolar stage (Stage I), ranging 
in size between 20 and 60µM, can be found next to the ovarian epithelium. In stage I 
and II (perinucleolar stage) the oocytes lack a chorion and are surrounded by a single 
layer of flat follicular cells. The animal-vegetal axis of oocytes is defined in the earliest 
stages of oogenesis by the presence of the yolk nucleus, also known as the balbiani 
body (BB), on the vegetal side of the developing egg. In stage III (egg-envelop-
rudiment stage) oocytes reach a diameter of 100 µM and start developing their egg 
envelope, the chorion. In the last previtellogenic stage (stage IV) oocytes reach a size 
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between 120-150 µM and their nucleus can grow up to 90 µM in diameter (Kinoshita 
et al. 2009) 
In stage IV oocyte maturation starts, the primary oocyte leaves the diplotene stage 
(first meiotic prophase) and resumes meiosis. The maturation process and meiosis 
resumption is triggered by pulses of gonadotropic hormone and leads to changes in 
the ooplasm and the nucleus (Suwa and Yamashita 2007). Several nucleoli localize 
along the nuclear membrane and oil droplets appear in the cytoplasm of late 
previtellogenic oocytes. Along the newly formed chorion, the attaching filaments start 
to form (Kinoshita et al. 2009). 
During the vitellogenic phase, nutrients and information for the developing embryos 
are stored in the yolk. To sustain the rapid growth of the yolk and eggshell the oocyte 
has a high rate of endocytosis to take up vitellogenin (Lessman 2009). The oocyte 
nucleus (germinal vesicle) is located in the center of the primary oocyte, but upon 
receiving the maturation, trigger migrates to the animal pole of the oocyte where 
germinal vesicle breakdown (GVBD) takes place after which the first polar body 
becomes expelled (Suwa and Yamashita 2007). Oocytes grow enormously from 150 
µM in the early yolk vesicle stage (Stage V) up to 800 µM in diameter in the late yolk 
formation stage (Stage VIII). From the early to the late yolk formation stage (Stage VII 
and VIII) yolk globules appearing around the yolk vesicles fuse to each other to 
occupy most of the yolk. 
In the post-vitellogenic phase (maturation stage IX) the yolk mass makes up most of 
the oocyte and yolk vesicles (oil droplets) are pushed against the egg envelope at the 
outer part of the cytoplasm. The egg envelope is well developed and still in close 
contact with the follicular layer and the oocytes grows another 400 µM in diameter 
from 800 to 1200 µM. When the oocytes arrest again in metaphase of the second 
meiotic division (metaphase II) the oocyte has reached maturation state. 
In the ovulation stage (Stage X) oocytes ovulate into the ovarian cavity by separating 
from the follicular layer (Kinoshita et al. 2009).  
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Figure 5: Different stages of Medaka oogenesis. A. Schematic drawing of a Medaka ovary 
with different stages of oocyte development. B. Phases of the cell cycle in which the oocyte is at the 
different stages of development. The cell cycle is resumed in secondary oocytes at stage IV. The 
mature oocytes arrest in meiosis II after germinal vesicle break down (GVBD) and first polar body 
expulsion. BB=Balbiani body, YV= yolk vesicle, MP= micropyle, Y=yolk, GV=germinal vesicle. Figure A 
redrawn from (Kinoshita et al. 2009) and B from (Lubzens et al. 2010) 
1.7.2 Egfr signaling in oocyte-follicle interaction 
The complex interaction between the follicular layer and the oocyte itself is crucial for 
oocyte growth and maturation at all stages. The oocyte and the follicle have many gap 
junctions that allow chemical and electrical communication. It recently became 
apparent that oocyte-derived growth factors stimulate the activity of follicle cells and 
in turn, the follicle regulates all stages of oocyte development (Lubzens et al. 2010). 
The events triggered in the follicular layer as well as in the ooplasm are complex, and 
many signaling cascade, as G-proteins and cAMP changes, MAPK signaling, calcium 
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signaling, inositol triphosphate and protein kinase A and PKC signaling, are involved 
(summarized in (Lessman 2009)). Egfr activity stimulates some of these pathways. 
How the two Egfrs present in fish might fulfill this variety of duties of oocyte 
maturation and crosstalk between the oocyte, and the follicular layer remains to be 
elucidated. 
1.7.3 Formation of the chorion and the micropyle 
Since fish embryos develop externally, they have a protective layer, the chorion that 
develops around the maturing oocytes. The chorion does not only serve as a 
protective barrier for the embryos but also is the primary factor that guarantees that 
only one sperm fertilizes the oocyte. The only entry point for sperm is a small funnel-
like channel in the chorion of most teleosts, the micropyle (MP).  The animal pole of 
the maturing oocytes is characterized in the beginning by being opposite of the 
balbiani body (BB) and later by the presence of the MP. The MP if formed by a 
specialized granulosa cell in the early vitellogenic phase.  
The sequence of events of the formation of the MP was described in electron 
microscopic detail by Iwamatsu et al. (Nakashima, S; Iwamatsu 1989). During the 
previtellogenic phase, thecal and granulosa cells are minuscule. When the 
primordium of the chorion is formed in stage III, all follicular cells appear to be the 
same. As the yolk nucleus begins to swell during oocyte maturation, attaching 
filaments at the vegetal pole become visible and a micropylar cell (MC) can be 
distinguished from neighboring granulosa cells at the animal pole. While other 
granulosa cells are joined by desmosomes to which bundles of tonofilaments are 
attached, the MC has a large package of tonofilaments in the cytoplasm in contact 
with the cell nucleus. In Stage V the chorion develops into a two-layered structure 
with a thin inner and a thicker outer layer. Large bundles of tonofilaments become 
visible in the perinuclear cytoplasm of the MC on the site facing away from the 
oocyte. In stage VI of oocyte development, the yolk vesicles occupy a significant part 
of the cytoplasm.  The MC differentiates into a mushroom-shaped flat cell in which 
the nucleus is localized away from the chorion. The MC develops a long cytoplasmic 
process which protrudes through the chorion layers. 
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The MC also loses contact to surrounding connected granulosa cells (Nakashima, S; 
Iwamatsu 1989). Large bundles of tonofilaments occupy the cytoplasm between the 
nucleus and the cell process. Through rotation of the oocyte within the follicle the 
inner surface adapts its characteristic spiral surface as can be seen in figure 6.  
So far nothing is known about the event that leads to differentiation of a single MP 
cell and how the oocyte senses that an MP has formed. 
 
Figure 6: Appearance and function of the micropyle (MP) in the chorion of Oryzias 
latipes.  A. The appearance of the oocyte before and directly after fertilization. Upon sperm entry, 
though the MP the oocyte membrane becomes separated from the chorion and oil droplets move to 
the vegetal pole of the fertilized eggs. Pictures are taken from (Iwamatsu 2004). B. Electron microscopy 
pictures of the chorion B, and the MP before fertilization B' and after B'' C. Polyspermy block in teleost. 
As a sperm enters the MP channel and attaches to the oocyte membrane the membrane becomes 
depolarized and Ca2+ becomes released. The gamete fuses with the oocyte membrane and cortical 
alveoli (CA) are exocytosed which leads to separation of oocyte membrane and chorion. The 
perivitelline fluid flows up the MP channel and forms a plug which closes the MP. B and C are taken 
and redrawn from (Iwamatsu et al. 1991) Scale bar in B 100 µm, in B’ and B’’ 10 µm. 
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2. Aims 
In this study we looked at different aspects of Egfr signaling in the Japanese Killifish 
Medaka by using gene expression studies, clonal overexpression tools and reverse 
genetic approaches. Egfr signaling is a central pathway in in development and growth 
and therefore found deregulated in various diseases, yet in fish the pathway has so far 
not been studied to a great extend. Fish have gained increasing attention as models for 
human disease and it is therefore important to understand the physiological role of 
the Egfr in normal development. Growing throughout their live fish are ideal models 
to study growth signaling in physiology and disease. The retina of fish is a popular 
model to study neurogenesis in fish but so far the role of Egfr-signaling in CMZ has 
not been studied. 
The first objective was to investigate the function of Egfr signaling in the retinal stem 
cell niche. For that we first studied the expression patterns of receptors, ligands and 
signal transducers in the retina and compared these patterns to expression in the NSC 
niches in the brain. With this we intended to elucidate the role of the pathway in the 
development and growth of the CNS and more specifically of the retina. 
The second aim was to characterize the reaction of RSCs to the expression of Egfr-
related oncogenes. We addressed two main questions: does Egfr signaling play a role 
in maintenance and function of the retinal stem cell niche and can enhanced Egfr 
signaling change the behavior of RSCs. For this purpose we developed a genetic 
toolbox for transient and clonal expression of xmrk, K-Ras12V and myrAKT. 
As a third aim we tried to understand the specific role of Egfra in Medaka by 
generating and characterizing a CRISPR/Cas9 based egfra knockout fish and analysing 
the resulting phenotype. 
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3. Results and Discussion 
3.1 Expression study of components of the Egfr signaling 
pathway in the CNS of O.latipes 
To set a base for understanding the role of Egfr signaling in the growing retina and 
brain we performed a whole mount in situ hybridization (WISH) screen for Egfrs, 
Egfr-ligands and critical downstream targets of the receptor in the eye and brain of 
Medaka. Based on previous studies about Egf-receptors and -ligand expression in 
different tissues (Laisney et al. 2010), I designed probes against egfra, egfrb, as well as 
the receptor ligands egf, hb-egf and tgfa. These ligands were selected for their relative 
abundance in the eye and stem cell lines when compared to their expression in the 
brain (Laisney et al. 2010). Additionally, I designed in situ probes against key players 
of Egfr main downstream signaling pathways components, k-ras, AKT1 and AKT2, 
stat5a and b and stat3 to confirm the existence of these signal transducers in the CMZ 
and proliferative regions in the Medaka brain. 
In collaboration with Clara Baader, we investigated the expression patterns of Egfr 
signaling components during developmental stage 24 and 32 (critical stages in eye 
development) and in more detail in hatchlings, which have developed primary brain 
structures and the retina.  
3.1.1 Expression of Egfr signaling components in the retina 
The Egfr pathway is essential for maintaining the balance between proliferation and 
differentiation in various stem cell niches. In neural stem cells (NSCs) Egfr signaling is 
essential for proliferation and survival (Aguirre, Rubio, and Gallo 2010; Wagner et al. 
2006). In the post-embryonic retina of fish, Egfr signaling was not studied in depth.    
We found that both egfrs are actively transcribed in the CMZ (marked by dashed box 
in figure 7). Egfrb is expressed broader than egfra, also in early transiently amplifying 
zone next to the differentiated retina. Amacrine cells, the ciliary zone, and the cornea 
also express both receptors. The only investigated ligand that was found transcribed in 
the CMZ is hb-egf and also egf but at a lower level. The probes for all three ligands, 
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however, stain the ciliary zone and the cornea adjacent to the CMZ (figure 7B). The 
chorion surrounding the neural retina is strongly stained for all performed in situs 
and is therefore probably unspecific. Strong staining of the choroid layer makes in 
difficult to distinguish expression in the retinal pigmented epithelium 
 
Figure 7: Expression of mRNA of egfra  and b  and its l igands in the retina of Medaka 
larvae. WISH was performed using probes directed against egfra, egfrb, egf, hb-egf, and tgf-a. 
Stained WISH embryos were cut into 25 µm thick transversal vibratome sections. Sections of the retina 
displayed here were chosen at the level of the optic nerve to have a central picture of the CMZ. Egfra 
and b are expressed in the CMZ and the cornea. Egf and tgf-a are transcribed in the cornea but not the 
CMZ, whereas hb-egf is expressed in the cornea and the CMZ. The dashed boxes contain a detailed 
view of the CMZ, four times enlarged. Scale bar is 200 µm. 
 
egfra egfrb
egf tgf-ahb-egf
A
B
Scale bar is 100 µm and zoom ins are 4times enlarged
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The presence of both receptors transcripts in the CMZ indicates that Egfr signaling is 
functioning in the RSCs and reacts to paracrine signals from adjacent tissues. The hb-
egf ligand might also operate in an autocrine fashion in RSCs. In the cornea, Egfr has 
significant wound healing and homeostasis functions in mammals (Nakamura, 
Sotozono, and Kinoshita 2001; Zieske et al. 2000). 
Although not much is known about Egfr signaling in the vertebrate eye and RSCs, the 
Egfr was shown to be involved in the MC-mediated regeneration of the Zebrafish 
retina (Wan, Ramachandran, and Goldman 2012). Hb-egf is also expressed in MC in 
chicken and mouse and stimulates proliferation of MGCs upon injury by N-
Nitrosodimethylamie (NDMA) (Todd et al. 2015). The proliferation of MCs is 
induced most effectively by a combination of Egfr signaling and Insulin in NDMA 
treated retinae that upregulated egfr expression due to the treatment. The same way of 
induction works in the ciliary body of chicken retinae where human EGF (hEGF) or 
hFGF together with insulin induce strong proliferation and neurogenesis (Fischer and 
Reh 2003). It is thus probable that similar mechanisms are at work in the RSCs of 
Medaka. In other stainings, I could see dotted hb-egf expression in the INL 
implicating that it is expressed probably in MGCs in Medaka (data not shown). 
We looked at the expression of signal transducers of Egfr signaling and found that the 
mRNAs of most downstream signaling components (all but stat5a) are transcribed in 
cells of the undifferentiated region of the retina. Most restricted to the stem cell zone 
are the expression patterns of AKT1 and stat5b that were found exclusively in the 
outermost tip of the CMZ where Rx2-positive RSCs are located. The AKT2 gene, on 
the other hand, is strongly transcribed in the whole undifferentiated region of the 
CMZ as well as INL and GCL. Stat3 and k-ras display similar expression patterns in 
the CMZ and additionally k-ras is strongly expressed in the amacrine and the 
ganglion cell layer as well as in the ciliary body and the cornea while cells in this 
region only weakly express stat3. Stat5a is expressed obverse compared to its homolog 
stat5b; it is transcribed only in the differentiated part of the retina.  
  36 
 
Figure 8: Expression of mRNA of AKT, k-ras and Stat genes in the retina of Medaka .  
WHISH was performed using probes directed against AKT1, AKT2, k-ras, stat5a, stat5b and stat3. 
Stained WISH embryos were cut into 25 µm thick transversal vibratome sections. Sections of the retina 
displayed here were chosen at the level of the optic nerve to have a central picture of the CMZ. The 
dashed boxes contain a detailed view of the CMZ, four times enlarged. AKT1 and stat5 b are explicitly 
described in the outermost tip of the CMZ. The stat3 and AKT2 genes are transcribed in the entire 
CMZ, the ciliary body and the cornea. AKT2 is additionally transcribed in the ganglion and the inner 
nuclear layer, as is k-ras. Stat5a is transcribed in the cornea and only weakly in the differentiated part of 
the retina. Scale bar is 200 µm. 
Most of the investigated signal transducers are also downstream of RTK other than 
the Egfr, like insulin-like growth factor receptor (Igfr) or fibroblast growth factor 
receptor (Fgfr), with known function in retinal development and RSCs. Human 
derived insulin-related factors (insulin, insulin-like growth factor 1 and 2) but not 
EGF can stimulate proliferation of RPCs in the CMZ of goldfish retina cultures 
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(Boucher and Hitchcock 1998). RTKs other then Egfr might thus be the primary 
regulators of proliferation in the CMZ although both Egfrs are expressed in the region 
and phosphorylated Egfr is used to identify activated NSCs in the CNS (Codega et al. 
2014). The use of human ligands for Egfr to study the pathway might be misleading 
since ligand as well as the ligand-binding domain sequences are only partially 
conserved between teleosts and tetrapods (Laisney et al. 2010).  
Based on this result I took a closer look at the activity of one of the central pathways 
downstream of the Egfr, the Ras/Mapk/Erk pathway. I stained sections of hatchlings 
with a Phospho-p44/42 MAPK (Erk1/2) (pErk) antibody and found that it was 
activated in amacrine cells and photoreceptors but not in the CMZ (figure 9A). The 
brain shows a dynamic pattern with varying intensity of pErk in neural cells adjacent 
to, but never in the SVZ, where NSCs are located (figure 9 b). The expression zones of 
k-ras (GCL, INL) matches the pattern observed for its activated downstream target 
ERK, in photoreceptors k-ras was however not expressed. This ERK activation is 
probably Egfr independent following described mechanism in which the 
depolarization of neurons leads to Ca2+ influx which in turn activates the Ras/MAPK 
pathway and downstream transcription factors as CREB (cAMP response element-
binding protein)(Thomas and Huganir 2004). pErk patterns are very dynamic; it can 
be used to localize active neurons (Randlett et al. 2015). In this context, the 
Ras/MAPK pathway is probably not activated via the classical route (RTK dependent) 
but rather via membrane depolarization in a Ca2+ dependent manner as described in 
(Thomas and Huganir 2004). These pErk patterns are probably similarly active in 
neurons of the brain and amacrine cells. Amacrine cells depend on MAPK, PI3K and 
JAK/STAT for their survival and die if these pathways are inhibited (Kunzevitzky, 
Almeida, and Goldberg 2010). It is not clear how these pathways are activated, but 
Egfr has probably no relevance in Erk activity of retinal neurons. Egfrs might exert 
their possible function in the CMZ and the brain via the PI3K/AKT pathway and the 
STAT pathways which are more specifically expressed in the CMZ and the brain (see 
next chapter). In vivo as well as in vitro studies indicate that for proliferation in the 
CMZ different RTKs are likely to interact (Boucher and Hitchcock 1998; van der 
Veeken et al. 2009) and so they probably fulfill a partially redundant function. 
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Figure 9: Erk is phosphorylated in retinal neurons and brain but not the CMZ. Sections of 
Medaka hatchlings were stained for phosphorylated Erk (magenta) and DAPI (cyan). A. In the retina of a 
Medaka hatchling, Erk is activated in all three neuronal layers, the CMZ surrounded by a dashed line. B 
In the telencephalon pErk is present in many neurons but not in in the subventricular zone. The 
ventricle is indicated by a dashed line. CMZ= ciliary marginal zone, GCL= ganglion cell layer, INL= 
inner nuclear layer, ONL= outer nuclear layer, V= ventricle. The scale bars are 50 µm. 
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3.1.2 Expression of Egfr signaling components in the brain of 
Medaka larvae 
Just like the retina, the brain hosts neurogenic stem cell zones namely the 
subventricular zone (SVZ) along the lateral ventricle (Kuroyanagi et al. 2010) and the 
peripheral area of the optic tectum (OT) (Alunni et al. 2010; Nguyen et al. 1999). The 
OT grows in a similar way as the retina, temporally and spatially ordered populations 
of proliferative, postmitotic, and mature cells (Alunni et al. 2010; P. Raymond et al. 
2006).   
We compared the expression pattern of Egfr signaling components that we observed 
in the retina to the way in which they are transcribed in the brain. We especially 
looked for overlapping or adjacent expression of the receptors and the ligands in 
known proliferative regions of the brain and differences in patterns of downstream 
signaling components that might hint towards the main functional pathway in certain 
brain areas. We found that egfra and egfrb were expressed broadly in the brain and 
had some regions of higher expression in proliferative zones of the brain like the SVZ 
and the outer margin of the OT. Similar expression levels of both egfrs in the brain 
were also observed by Laisney et al. (Laisney et al. 2010). Egfra has a very distinctive 
area of high expression in the forebrain around the frontal starting point of the 
ventricle and slightly increased expression along the central ventricle and the 
uppermost central part of the OT (figure 10). Egfrb is expressed stronger than egfra 
along the central and lateral ventricles. 
The Egfr-ligands investigated in this screen show distinct patterns of expression. Egf 
has an articulate expression domain along the ventricles (central and lateral), this 
expression starts early and is clearly visible already at stage 32 (figure 12) and also in 
adult sections (data not shown). There is a weak expression of egf in the central part of 
the OT decreasing gradually towards the sides. For the other ligands (hb-egf and tgf-a) 
we observed rather broad and indistinct expression throughout the brain. Hb-egf is 
expressed strongly in the ear and also in the skin and connective tissue. Tgf-a has 
increased expression levels in the caudal part of the OT. Altogether these results fit the 
RT-PCR based expression study performed with adult Medaka tissues where egf 
expression in the brain is significantly higher than in the rest of the tissues and hb-egf 
and tgf-a are lower expressed than in other tissues (Laisney et al. 2010).   
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Figure 10: Expression pattern of egfrs  and its l igands in transverse brain sections of 
Medaka hatchlings. Medaka hatchlings of the Heino strain were used for WISH stainings with 
antisense probes against egfra, egfrb, egf, tgf-a and hb-egf. Stained hatchlings were cut transversally 
into 25 µm sections. A. Lateral view of a Medaka fish with the colored region for the approximate 
location of sections (a-d). B.  Sections of different brain regions (a-d) of WHIS embryos stained for egfrs 
and ligands. egfra and b are broadly expressed in the brain but slightly enhanced in the SVZ. Egfra is 
stronger directly surrounding the start of the ventricle (a) in the telencephalon and egfrb is higher 
expressed directly at the ventricles (b and c). Egf is very specifically transcribed next to the ventricle in 
the midbrain (b-d). Hb-Egf and tgf-a are broadly expressed in the brain, tgf-a slightly increased in the 
margin of the optic tectum (c). OT=optic tectum, Tel=telecephalon, Ht= hypothalamus, MO= medulla 
oblongata, E=ear, G=gills. Scale bar is 200 µm. 
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As mentioned before Egfr can be used as a marker for active stem cells in the SVZ of 
mammals (Codega et al. 2014). In the fish brain, the most probable candidate for the 
activation of Egfrs in the SVZ is egf. Tgf-α or one of the neglected egfr ligands (such as 
betacellulin, neuregulin and amphiregulin) might stimulate the Egfrs in the OT and 
the rest of the brain. Interestingly we could not find a similar strong expression of egf 
around the CMZ which hints towards a different ligand-receptor interaction pair in 
the CMZ and the OT compared to the SVZ. 
The expression of downstream pathways showed high similarities between retinal and 
brain patterns as can be seen in figure 11. Specifically expressed in proliferative zones 
are AKT1, stat3 and stat5a. K-ras is strongly expressed throughout the brain with 
slightly increased expression in proliferative zones; the same holds true for AKT2. 
This expression pattern indicates that both factors are activated Egfr-independently 
and rather fulfill survival and metabolic functions as described in (Wagner et al. 
2006). The two AKT kinase isoforms are expressed in different patterns in the Medaka 
brain, even though structurally very similar they are described to have specialized 
functions that might even advert each other (Heron-Milhavet et al. 2011).  
The most probable Egfr activated signal transducers that exert a proliferative function 
in the SVZ are AKT1, stat3 and stat5 since these genes are transcribed enhanced in 
NSC zones. Little is published on the natural role of Stat genes in the proliferative 
zones of the brain. However, tumors originating from the brain, so-called gliomas, 
often depend on hyperactive Stat3 and 5b to sustain their proliferation (Fan et al. 
2013; Gressot et al. 2015; Sherry et al. 2009; Xiong et al. 2009). Wagner et al. showed 
that Egfr signaling is essential for the survival of astrocytes but not neurons in the 
cortex; neurons, however, need astrocytes for their survival. While Egfr-/- midbrain 
astrocytes can sustain neuronal survival, cortical Egfr-/- astrocytes cannot but their 
survival can be rescued by RasV12 expression (Wagner et al. 2006). The broad 
expression of K-Ras observed here in the brain also implicates that K-Ras has an 
essential function in survival of neurons in Medaka.  
Based on the literature and our in situ data we assume that Egfr signaling plays a role 
in NSCs in the brain and the retina, there is, however, a difference in the stimulating 
ligand since egf is expressed very specifically in the SVZ but not in other stem cell 
zones of the CNS. Downstream effectors of Egfr signaling, probably stimulated in 
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concert with other signaling pathways, are the PI3K/AKT and Stat pathways in the 
stem cell zones rather than the broadly used Ras/MAPK pathway. 
 
Figure 11: Expression pattern of egfrs  related downstream signaling components in 
transverse brain sections of Medaka hatchlings. Medaka hatchlings of the Heino strain were 
used for WISH stainings with antisense probes against AKT1, AKT2, k-ras, stat3, stat5a and stat5b and 
sectioned 25 µM thick. A. Lateral view of a Medaka fish with the colored region for the approximate 
location of sections (a-d). B.  Sections of different brain regions (a-d) of WISH embryos stained for 
Results and Discussion 
 43 
different signal transducers in the egfr signaling cascade. AKT1 is expressed mainly in the dorsal and 
lateral margins of the OT (c) and slightly along the ventricles (b & c). AKT2 and k-ras are strongly 
transcribed throughout the brain with enhancing expression in the dorsal margin of the OT (c). Stat3 is 
expressed specifically in proliferative regions of the brain (SVZ and OT margin in a-c). Stat5a and b are 
weakly transcribed in the brain, stat5b shows enhance expression along the ventricles (b & c). OT=optic 
tectum, Tel=telecephalon, Ht= hypothalamus, MO= medulla oblongata, E=ear, G=gills. Scale bar is 
200 µm. 
3.1.3 Expression of Egfr signaling components during 
development 
We also looked at the expression of Egfr signaling components during development to 
uncover processes mediated by only one receptor, ligand or signal transducers. All 
tested genes of the Egfr signaling pathway are expressed throughout the head region 
of embryos at stage 24 when retina and lens are patterned, but the CMZ is not yet 
formed (figure 12 and 13). In stage 24 the expression of egfra is ubiquitous, egfrb, 
however, is expressed stronger in the forming lens and the central brain. Expression of 
the retina-specific transcription factor rx2 that was included as a positive control is 
strong throughout the retina since the CMZ has not yet formed (figure 12.A). At stage 
32 the expression patterns become more restricted, egfrb is mainly transcribed in the 
choroid layer, parts of the otic vesicle, along the optic nerve and distinct structures in 
the brain. Egfra is transcribed more broadly in the brain and somewhat enhanced in 
the ventricle region. In the newly formed CMZ in stage 32 embryos, we could not see 
the same increased expression observed in the CMZ in hatchlings  
The Egfr ligands show a broad expression pattern at developmental stage 24. The 
expression is slightly enhanced at the midbrain/hindbrain boundary as can be seen in 
figure 12B. Egf expression seems to be overall weak at early stages and only when 
brain ventricles are formed it starts to be transcribed in the SVZ (figure 12B). Tgf-α 
and hb-egf have similar expression patterns; rather ubiquitous at stage 24 and then 
mainly in the skin of stage 32 embryos. The retina at that stage shows some expression 
of the receptors but no obvious expression of ligands. Receptors and ligands are both 
expressed in the brain region (forebrain and midbrain/hindbrain boundary) and can 
contribute to development and growth. Egfrb is overall stronger expressed and 
becomes more restricted to certain areas in the brain suggesting a more distinct 
function of this receptor compared to egfra. 
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Figure 12: Broad expression of egfrs  and l igands at St.26 and more restricted 
expression at stage 32. Whole mount in situs (WISH) using antisense probes for detection of Egfra 
and b (A) as well as the receptor ligands egf, hb-egf and tgfa (B). The Rx2 antisense probe was used as 
a technical control. A. Egfra and b are broadly expressed at Stage 26. Egfrb is widely expressed Stage 
32 WISH were photographed in whole mount for egfrs and vibratome-sectioned in 25 µm thick 
sections for egfr-ligands. A central brain section has been chosen for display of Egfr-ligand expression 
at stage 32. Hb-egf and tgfa are expressed primarily in the skin and egf along the brain ventricle. Scale 
bar is 200 µm. 
 We also checked for the presence of mRNA of downstream components of the Egfr 
signaling pathway to understanding where and through which pathway Egfr signaling 
might function in CNS development. 
We detected strong expression of all investigated Egfr-related downstream genes 
throughout the head region of stage 24 embryos (figure 13) which is not surprising 
since at that stage most cells of the embryo are dividing and growth happens all over.  
Stats, AKT and K-ras are downstream of most growth signaling receptors like Fgfr 
and Igfr and might function in any of these.  
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The mRNA expression of most investigated downstream components becomes more 
restricted to proliferative brain regions or tissues at stage 32. AKT1 is mainly 
expressed in proliferative zones of the brain namely along ventricles (central and 
lateral) and the tectal plate while AKT2, on the other hand, is expressed more 
ubiquitously in the whole brain and retina. These differences in expression and also in 
function have been described before (Heron-Milhavet et al. 2011).  
 
Figure 13: Expression of downstream components of the Egfr signaling cascade, AKTs, 
Ras and STATs. Whole mount in situs (WISH) using antisense probes for detection of AKT1, AKT2, K-
Ras, STAT3, STAT5a and STAT5b were performed for stage 24 and 32 embryos. Stage 32 WHISH 
embryos were photographed after vibratome-sectioning (25 µm thick sections), and a central section 
was chosen for display. Scale bar is 200 µm. 
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K-ras is broadly expressed in the whole head but more enhanced along the border 
areas, like ventricles, around the eyes and in the area of the newly formed CMZ. Stat3 
mRNA could be found along the lateral ventricle at the margin of the OT and in more 
ventral brain regions of the stage 32 embryo. Both stat5 genes (a and b) show strong 
expression in the skin and proliferative zones in the brain and the forming CMZ.   
For all investigated components we could observe that during development most of 
the investigated growth-signaling components become gradually more restricted to 
proliferative zones in the brain of Medaka embryos. Co-expression of ligands hb-egf 
and tgf-α with the egfrb and all tested downstream components could be observed in 
the tectal plate. The indistinct expression of egfrs during development has been 
described before in other species (Gabay, Seger, and Shilo 1997; Threadgill et al. 1995;  
Zhang et al. 2010) and reflects the broad implication of the pathway in development, 
growth and maintenance of multicellular organisms. 
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3.2 Generation of an Egfr-signaling related toolbox for 
oncogene expression in O.latipes 
The Egfr signaling pathway is amongst the most commonly deregulated pathways in 
tumors. During my Ph.D. project, we created a genetic toolkit for the expression of 
oncogenes in the retina and other tissues of Medaka to investigate the effect of 
oncogene expression on retinal stem cells (RSCs). We raised various fish lines for 
inducible expression of the oncogenic Egf-receptor Xmrk, as well as for the human 
oncogenes K-RASV12 and myristoylated AKT (myrAKT). Xmrk has been identified as 
a very potent oncogene that can transform melanocytes into malignant melanomas 
and induce over-proliferation in hepatocytes (Li et al. 2012). So far Xmrk has only 
been used in a limited number of genetic settings mainly being expressed by tissue-
specific promoters (Patton and Nairn 2010; Schartl et al. 2010) or under control of 
transactivator response elements (Li et al. 2012; Zheng et al. 2014). We managed to 
clone the 3,5 kb open reading frame (ORF) of xmrk into various inducible genetic 
contexts in which its expression can be traced by a fluorescent tag. Additionally, we 
acquired published constructs containing human K-RASV12 and myrAKT from the lab 
of Marina Mione (Alghisi et al. 2013) and cloned them in the same construct setups. 
We tested the functionality of new Xmrk-variants with an assay based on strong heat-
shock inducible expression in injected embryos.  
3.2.1 Transient expression of oncogenes in Medaka hatchlings 
For a transient high expression of Xmrk, I cloned two constructs that were aimed for 
strong Tet-OFF-transactivator (tTA) based expression of the oncogene, as described 
in (Gossen et al. 1995). I generated a construct in which two TET-response elements 
(Knopf et al. 2010) are mirrored to drive expression of xmrk on one site and a stable 
GFP-tagged H2B variant on the other site. This construct was injected together with 
another construct expressing tTA after an HSP70 promoter. Constructs are 
schematically represented in figure 14A.   
I observed strong fluorescence of H2B-GFP in early embryos without applying heat 
treatment. Embryos that showed H2B-GFP expression in yolk cells often had a tumor-
like accumulation of cells and died (figure 14B) meaning that Xmrk can elicit a 
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proliferative response. Injected embryos with a mosaic expression of H2B-GFP soon 
developed irregularities in the tail muscle mass (figure 14C). Within one-week post 
hatch (wph) these H2B-GFP-postive irregularities grew out to easily visible bumps of 
somites (figure 14D). This outgrowth can only be due to Xmrk-activity since it was 
never observed in any other H2B-GFP expressing line in the lab. We realized that 
expression of xmrk and H2B-GFP is independent of the transactivator tTA since it 
proved to be dysfunctional by mRNA injection (experiment performed by Isable 
Krämer) data not shown. The two constructs displayed in figure 14A were co-injected 
and therefore likely co-integrated in a way that the hsp70 promoter element can drive 
expression of H2B-GFP and xmrk from the minimal promoter elements that are part 
of the DualTet RE, independent of the binding of tTA. 
 
Figure 14: Inducible and trans-activator independent expression of Xmrk and H2B-GFP 
lead to over proliferation in somites. A. Two constructs were co-injected in single cell stage 
embryos: DualTetRE driving H2B-GFP on one site and Xmrk on the other side and a Hsp70 promoter 
driving a tTA protein with a cmlc2-promoter driving GFP in the heart as insertion marker. Death rates of 
injected H2B-GFP expressing embryos were high. B. Surviving embryo that showed mosaic expression 
of H2B-GFP in the lens and somites one dph with irregularities in somite growth in tails. C. Five dph  
larvae show substantial overgrowth of muscle tissue at places where H2B-GFP is expressed 
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Fish with somitic tissue abnormalities never displayed any other obvious phenotypes 
even though a remaining H2B-GFP signal could be seen in many other tissues (retina, 
lens, brain and skin). Fish with muscle ver-growth retained a thicker tail when 
compared to wild type (WT) siblings but did not develop any further overgrowth. We, 
therefore, conclude that an initial pulse of Xmrk can induce muscle growth but the 
situation becomes stabilized as the fish grows into adulthood, thereby resembling 
human Embryonal rhabdomyosarcoma (ERMS) a disease originating from immature 
muscle-progenitors (Breitfeld and Meyer 2005). The injection of a K-RAS12D 
containing transgene in Zebrafish causes a similar phenotype with tumors forming in 
larvae with a mosaic expression of the transgene in satellite cells (muscle stem cells). 
Muscle overgrowth in Zebrafish becomes visible after 10dpf, which is comparable to 
the time frame that we observed here for Medaka. In the transgenic Rag2:: K-RAS12D 
ERMS model the expression of the oncogene is persisting in the satellite cells and 
tumors grow invasive and are fueled by satellite cancer stem cells (Langenau et al. 
2007). In our model, however, the over-proliferation seems to be due to an initial 
strong pulse after which muscle cells lose or adapt to enhanced growth signal, and no 
invasive growth takes place. The high expression from injected plasmids is probably 
due to a feedback loop of oncogenes with the stress-responsive hsp70 promoter 
element: Xmrk causes over-proliferation, which leads to stress, and more expression 
activity of the hsp70 promoter leading to more xmrk expression. 
Even though we did not use a muscle specific promoter the only tissue that showed a 
proliferative phenotype at this stage are the muscle cells. Hsp70 proteins have a 
known function in the muscle tissue reaction to exercise (Gomes Heck et al. 2012). A 
persisted stress response was also described for the somatic tissue of Xenopus laevis 
embryos after slight heat-shock (Lang et al. 2000). A baseline expression from the 
hsp70 promoter in fish under moderate stress conditions is thus not surprising.  
In the following generation, fish showed default expression of H2B-GFP in the lens 
due to the baseline activity of the promoter in this tissue that we observe in other 
hsp70- lines and which was reported in Zebrafish (Blechinger et al. 2002). When a 
heat treatment is applied to the F1 DualTetRE:: H2B-GFP/xmrk_ hsp70::tTA_ 
cmlc2::GFP (in the following named HSindX_H2B-GFP ) embryos always showed 
ubiquitous expression of H2B-GFP within less than 24 hours post heat shock (hpHS) 
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(figures 14E and 15). The cardiac myosin light chain 2 (cmlc2) promoter drives 
expression specifically in the heart and is used here as a screening marker. Fish heat-
shocked before hatching failed to do so and died, which might either be due to the 
Xmrk or the high H2B-GFP expression since in a control experiment where embryos 
only expressed H2B-GFP and no Xmrk some HS embryos also failed to hatch. In 
induced embryos, H2B-GFP expression can be found in all tissues and cell types as 
demonstrated in figure 15 for the brain (A' &B), eye (B'), skin (B'') muscles, gut, and 
neuromasts (B’’’).  
 
Figure 15: In vivo  imaging of DualTet::xmrk/H2B-GFP_Hsp70:.tTA_cmlc2::GFP l ine 
expressing H2B-GFP in every nuclei after heat shock treatment. A. In vivo imaging of head 
region. A’. Brain structures can be distinguished based on the density of nuclei. B. Central brain 
ventricle and surrounding neurons. B'. The eye is expressing H2B-GFP in choroid layer. B’’. Tail fin. B’’’. 
Somites, gut, and neuromast are expressing H2B-GFP. Scale bar is 100 µm. 
Xmrk expression in this context cannot be visually traced so that the impact of the 
oncogene can only be judged by looking at the tail appearance of hatchlings. Tails of 
HS fish grew thicker but stopped to grow any further. The HS-induced expression and 
translation of Xmrk protein are probably much slower than the H2B-GFP expression 
since the ORF of xmrk is three times the length. Hatchlings that were heat-shocked 
survived and did not display phenotypes, from that we conclude that short-term 
expression of Xmrk is insufficient to cause over-proliferation of cells.  
H2B-GFP in a very stable label of cells since it integrates into the chromatin and even 
when transcribed transiently persists for a long time, H2B-GFP can therefore also be 
used for label retention studies (Foudi et al. 2009) or to analyze chromatin dynamics 
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(Kanda, Sullivan, and Wahl 1998). Not much is known about the stability of Xmrk, 
cell culture experiments, however, show that ErbB1 receptors are endocytosed 
relatively quickly and degraded by ubiquitin ligase stimulated pathways (Levkowitz et 
al. 1998). Since a tight regulation of growth signaling is essential for proper 
development, growth, and maintenance, we assume that potent mechanisms act on 
the fast degradation of Xmrk similar to endogenous Egfrs.  
I also tested the induction of Xmrk and H2B-GFP expression in the HSindX_H2B-
GFP line by locally applied heat-shock with an IR-lego system as described in 
(Deguchi et al. 2009; Kamei et al. 2009). For this, we kept HSindX_H2B-GFP embryos 
in heat-stable conditions until hatch and then anesthetized and mounted them with 
methylcellulose (to prevent heat shock by warmed up agarose) on to an inverse 
spinning disc microscope coupled to an infrared (IR) laser (1480nm). Fish were 
mounted in a way that regions of interest were closest to the objective to reduce 
energy loss (figure 16A). The target area was then selected using the bright field 
channel and applied laser pulses with an energy of 60-100 mW for 1 to 3 seconds until 
we could see twitching of cells. We applied the IR-laser heat shock only to the eye 
(around the lens) and the tail (around the site where the spinal cord ends) of the left 
side of the fish to use the other as a control.  
One day after IR-laser treatment hatchlings were imaged under a regular fluorescent 
binocular. I observed H2B-GFP-positive cells around the lens of only the left eye of 
fish (N=3) and never in the right eye (figure 16B). Also, the tail fin showed a dispersed 
region of H2B-GFP positive cells. H2B-GFP was also expressed in the somites (figure 
16B), even though no direct HS was applied. The embryos subjected to IR-Lego 
treatment were fixed and sectioned to stain for the presence of nuclear GFP. In the left 
eye of the fish, we could see GFP-positive nuclei throughout different layers of the 
retina. The applied HS thus led to expression not only in the choroid layer but also 
within the retina itself. No GFP expression could be observed in the right eye except 
for the lens. 
Described pilot experiments for the transient expression of Xmrk together with H2B-
GFP of a mirrored HS-responsive element shows that the line can be used to test 
short-term effects of enhanced Egfr signaling. The use of the line is however limited 
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by the lack of a direct readout of Xmrk expression; we, therefore, worked on 
fluorescent tagging of the Xmrk gene, which will be described in the following. 
 
Figure 16: :  Local heat shock causes expression of H2B-GFP/Xmrk in the DualTETRE:: 
xmrk/h2b-fp_Hsp70::tTA  f ish l ine. A. The schematic graph is representing of the IR-lego setup. 
Medaka larvae are paralyzed and mounted on top of an inverted spinning disc confocal microscope, 
which is connected to an infrared laser to induce local heat-shocks. Red crosses indicate locations of 
induced heat-shocks. Heat-shocks were only induced on the left side of the fish; the right side was used 
as a control in larvae represented in B, N=3. B. Expression of H2B-GFP could be detected directly 
around the lens of only the left eye of the fish. The tail fin also showed activation of the constructs gene 
expression around the locations where local heat-shocks were induced at three positions. Somitic 
recombination could be observed independently in heat-shocked and no-HS fish. C. Cryosection of the 
retina of the fish shown in B. H2B-GFP transcription was induced in several layers of the retina, even 
though the heat shock was localized to the CMZ region close to the lens. The lens as the somites 
always showed expression of H2B-GFP independent of the heat-shock. 
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3.2.2 Tagging Xmrk with fluorescent proteins 
Xmrk expression cannot be detected in vivo or in fixed tissue since so far no FP-
tagged versions are available and commercial antibodies (Abcam) are only suited for 
Xmrk detection on western blots. Clara Becker and I collaborated in generating 
genetic constructs that allow a visual readout of Xmrk expression. For that, we C-
terminally tagged Xmrk with FPs using either a flexible linker (FL, GGGS)3 (Arai et al. 
2001; Trinh et al. 2004) or a T2A sequence (schematic representation in figure 17A). 
For testing the functionality of tagged Xmrk variants, we used the DualTetRE system 
again as described before in figure 14. We thus cloned plasmids with an H2B-GFP 
ORF on one side and the cyan fluorescent protein (CFP)-tagged versions of xmrk on 
the other side of a DualTetRE (HSindX-FL-CFP_H2B-GFP and HSindX-T2A-
CFP_H2B-GFP). These plasmids were then co-injected with the 
Hsp70::tTA_cmlc2::GFP plasmid into single cell WT embryos. As a control, we 
injected the same plasmids in which xmrk-CFP is replaced by an mCherry. We did not 
apply any HS but could observe the same mosaic expression as described for HSindX 
_H2B-GFP. When injected embryos hatched, we saw that in muscle cells the FP signal 
localized according to our expectation. Cells expressing H2B-GFP also showed 
membrane localized CFP in the case of the FL tagged version of Xmrk and 
cytoplasmic localization of CFP in the T2A variant (figure 17B, upper row). We 
confirmed the correct localization of CFP tagged to Xmrk with either T2A or FL in 
fixed tissue sections (figure17B, lower row).  
For all three dualTetRE constructs (Xmrk-FL-CFP, Xmrk-T2A-CFP, and mCherry) 
we found some embryos that showed expression of H2B-GFP and either CFP or 
mCherry and raised them until hatch. We discovered that T2A-tagged, as well as FL-
tagged Xmrk, was able to induce irregularities in muscle growth that were not present 
when embryos were injected with the mCherry control. The expression of CFP 
correlated with regions of somatic overgrowth indicating that C'-terminally tagged 
versions of Xmrk retain their functionality. Example results are depicted in figure 
17C. 
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Figure 17: C-terminal FP-tagged versions of Xmrk via T2A and FL are functional 
oncogenes. A. Representation of the tagged Xmrk proteins. The flexi-linker is a direct linker that stays 
connected to the receptor after its localization to the membrane. In the T2A tagged version of the 
Xmrk gene, GFP would be retained in the cytoplasm after translation since the T2A sequence causes 
ribosome-skipping. B. In vivo imaging of somites and sectioning both confirmed the expected 
localization of tagged receptor variants. C. Functionality test of tagged Xmrk. DualTETRE::Xmrk-(FL or 
T2A)-CFP/H2B-GFP or DualTETRE::mCherryH2B-GFP co-injected with Hsp70:tTA_cmlc2:GFP in single 
cell embryos. Ten dpf somatic overgrowth was only observed in Xmrk-linker-CFP expressing fish and 
not in DsRed expressing fish. A=anterior, P=posterior, D=dorsal, V=ventral. 
We also created DualTetRE based constructs for the HS-induced expression of eGfp-
K-RAS(V12) and eGfp-myrAKT and obtained the same results concerning overgrowth 
of tail tissue (not shown). To correlate the expression of oncogenes with DNA 
replication events, we incubated injected fish in BrdU. The experimental setup as 
depicted in figure 18A was as following: we co-injected fish with DualTet:tagged 
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oncogene/H2B-GFP (xmrk, myrAKT, and K-RASV12) and Hsp70::tTA _cmlc2::GFP 
constructs and let them grow until hatch. As a control, we injected the same plasmids 
with a mcherry gene instead of an oncogene. Since the phenotype occurred without 
any heat-treatment, we did not apply an HS. After hatching, larvae were incubated 
two days in BrdU and then fixed and stained against GFP/CFP and BrdU. All three 
oncogenes were localizing predominantly in the membrane of H2B-GFP positive cells. 
We also detected cells which expressed only H2B-GFP. This can be because H2B-GFP 
is significantly more stable than any of the oncogenes. We saw increased muscle mass 
co-localizing with high membrane or cytoplasmic GFP expression (data not shown). 
However, we could not directly correlate GFP-positive nuclei with the presence of 
BrdU-positive nuclei. BrdU-positive nuclei could be mainly detected in the skin, the 
spinal cord (along the ventricle) and regions between muscle sections (figure 18B-E).   
Even though we could see remarkable growth in muscle volume at sites of expression 
of the constructs we could not judge from this experiments whether the excess tissue 
mass is due to cell growth or proliferation. Due to the particular organization of 
somite tissue in multinucleated muscle fibers, it is hard to relate the nuclei to a specific 
fiber and sectioning of the fish does not allow judging proliferation dynamics based 
on BrdU-positive nuclei.  The two days BrdU-pulse might also have been to short 
since most of the proliferation likely happened during development before hatch. An 
actin staining performed to see thickness and number of muscle fibers did not show 
any distinct differences between oncogene-expressing and other muscle fibers (results 
not shown). 
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Figure 18: Expression of GFP-tagged oncogenes does not correlate with BrdU posit ive 
nuclei. A. schematic representation of the experimental setup, the DualTET::oncogene/H2B-GFP and 
Hsp70::tTA were co-injected, and embryos were raised until hatch. Hatchlings showing GFP expression 
were incubated for two days in BrdU and then stained for GFP and BrdU. Section through the tail of 
GFP positive embryos injected with Hsp70::tTA and DualTET::DsRed/H2B-GFP (B), DualTET::Xmrk-FL-
GFP/H2B-GFP (C), DualTET::eGFP-K-RAS(V12)/H2B-GFP (D) or DualTET::eGFP-myrAKT/H2B-GFP (E). 
18 µm sections were stained with a-GFP (green), a-BrdU (magenta) and DAPI (cyan). Scale bar is 50 µm. 
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3.2.3 Creation of a tool box for expression of oncogenes in single 
cells  
After confirmation of the functionality of tagged versions of Xmrk we (Clara Becker 
and me) generated a genetic toolkit for the inducible Cre-mediated expression of FP- 
tagged Xmrk, K-RAS12V, and myrAKT. For this, we used golden gateway cloning 
(Kirchmaier, Lust, and Wittbrodt 2013) to assemble plasmids containing a ubiquitin 
promoter (D. rerio), an mCherry STOP cassette flanked by loxP sites followed by the 
tagged versions of oncogenes and a triple polyA sequence. The construct design 
followed the example of published red-switch-green constructs by Lazaro Centanin 
(Centanin et al. 2014). As shown in figure 19A, the gene cassette is flanked by I-SceI 
restriction sites to allow optimal random integration into the Medaka genome 
(Thermes et al. 2002). The ubiquitous promoter was used to guarantee the versatile 
use of the transgenic fish lines in combination with tissue-specific Cre-drivers. 
mCherry expression was used as an insertion and ubiquitousness marker. Transgenic 
fish lines generated with defined constructs are named RS (red switch) followed by 
respective oncogene-FP fusions, being: Xmrk-T2A-GFP, Xmrk-FL-GFP, eGFP-K-
RAS12V, and eGFP-myrAKT. 
For expression of oncogenes from the RSOncogene constructs, the mcherry STOP-
cassette needs to be exist by Cre-mediated recombination of loxP sites. For temporal 
control, Cre is fused to an ERT2 promoter that is activated by binding tamoxifen 
(TMX). Another possibility of temporal control of Cre expression is to drive Cre fused 
to a nuclear localization signal (NLS) under an HS-protein activated promoter 
(Hsp70). We injected the RS-oncogene constructs in the Hsp70::Cre-NLS_cmlc2::GFP 
fish line to test the functional recombination after HS treatment of mCherry and 
cmlc2:: GFP positive embryos. In most cases, we could see broad recombination in 
somites of treated fish for RSXmrk-FL-GFP and RSXmrk-T2A-GFP as shown in figure 
19C. Membrane localization of Xmrk-FL-GFP was confirmed by staining sections of 
positively recombined fish (figure 19C lower right picture).  
  58 
 
Figure 19: Toolbox for expression of oncogenes in single cells after Cre-mediated 
recombination. A.  Constructs generated for the expression of Xmrk, Xmrk-FL-GFP, Xmrk-T2A-CFP, 
eGFP-K-Ras, eGFP-myrAKT after recombination of an mCherry stop cassette flanked by loxP sites 
under the control of a ubiquitin promoter and followed by a triple polyA site. B.  Examples of 
recombination by injection of oncogene plasmids into HSP70:: Cre line. Xmrk-T2A-GFP expressed in 
muscle cells, shown by in vivo imaging (upper row). Xmrk-FL-GFP localizes to the membrane of somitic 
cells here shown in vivo and on a transverse section through the tail of a hatchling stained with an a-
GFP antibody (green) and DAPI (white) SC=spinal cord, RS=red-switch. Scale bar is 100 µm. 
The ability of tagged oncogenes to induce proliferation transiently was confirmed by 
Narges Aghaallaei. She injected a combination of RSXmrk-FL-GFP and RSeGFPK-
RASV12 together with the Hsp70::Cre_cmlc2::GFP plasmid and imaged the fish at 10 
dpf (figure 20A). In mosaic embryos, she observed somatic over-proliferation as 
described before for the HSindOncogene _H2B-GFP constructs (figure 20B). Fish did 
not show over-proliferation in any other tissue either because they are not expressed 
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there, or other tissues need stronger and more prolonged exposure to oncogenic 
growth signaling to cause a visible proliferative response. 
 
Figure 20: Co-injection of RSXmrk and RSK-RAS12V with Hsp70:Cre plasmids cause 
over-proliferation in recombined muscle cells. A. Schematic representation of the 
experimental setup with co-injected constructs. Embryos were grown until hatch and imaged. B. Some 
co-injected fish showed over-proliferation in muscle cells that expressed GFP and mCherry at somatic 
bumps. Experiment and imaging performed by Narges Aghaallaei.  
A significant challenge in raising the RSOncogene lines was the screening for 
ubiquitousness of mCherry. The D. rerio ubiquitin promoter used for the expression 
of the oncogene cassette is only rarely integrated into the Medaka genome in a way 
that it is truly ubiquitously used. The expression in muscle fibers is always much 
higher than in the rest of the body and sometimes the only place of expression. This 
differential activity of the Ubi promoter in Medaka contrasts with the results found by 
Mosimann et al. who initially isolated the regulatory element. When integrated 
through Tol2 mediated transgenesis (Abe, Suster, and Kawakami 2011; Suster et al. 
2009) in Zebrafish the 3,5 kb Ubi regulatory element leads to high ubiquitous 
expression of transgenes throughout development and adulthood over several 
generations (Mosimann et al. 2011).  
For each construct (RSXmrk-T2A-GFP, RSXmrk-FL-GFP,RSeGFP-K-RAS12V and 
RSeGFP-myrAKT) we selected several founder fish based on the mCherry expression 
in tissues other than muscles (brain, retina, fins & heart). F0 fish were crossed to WT 
cabs and offspring with ubiquitous expression of all constructs were raised. Selected 
oncogene lines are summed up in table 1 with the respective stock numbers of their F1 
and F3 generation.  
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Figure 21: Heat-shock-induced recombination of RS-Xmrk-FL-GFP fish in the retina and 
somites. A. Experimental setup: Hsp70:Cre_cmlc2:GFP fish line was crossed to an F0 founder with a 
genomic insertion of Ubiq::RS-Xmrk-FL-GFP plasmid. Offspring was screened for ubiquitous mCherry 
expression and raised until hatch. A. Heat-shock was applied, and hatchlings were fixed, sectioned and 
stained with GFP and DAPI after that. B-D. Examples for recombination in the retina (B) and muscle 
cells of the tail (C). D. Section of recombined larvae in which head-muscle and retinal cells show 
different levels of GFP expression, D’ and D’’ are two times enlarged details of D. The dashed circle 
indicates the location of the lens. HS= heat shock SC= spinal cord, INL=inner nuclear layer, ONL=outer 
nuclear layer, MC= muscle cell. Scale bars are 50 µm. 
To test if the oncogene lines can recombine in tissues other than somites we tested the 
F1 offspring directly. The RSXmrk-FL-GFP Line #1 founder was crossed to 
Hsp70::Cre-NLS_cmlc2::GFP fish, an HS was applied after hatch and larvae were fixed 
two days post-HS (experimental procedures see figure 21A.). Several fish showed 
recombination in the somites (figure 21D) as well as in the central part of the retina 
(21B), GFP expression in the retina was much weaker than the expression in muscle 
cells. Figure 21D shows a section of a larva in which recombined cells were found in 
the head muscle cells and the retina, the GFP signal in muscle fibers is however much 
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brighter than in retinal neurons. This staining revealed a critical drawback of the 
oncogene lines: the expression of GFP in the retina is weak and even after 
immunostaining barely detectable. When compared to the GaudiRSG lines in which 
recombined cells express H2B-GFP (Centanin et al. 2014), the membrane-localized 
GFP in neurons is considerably less prominent. Other than GFP localization, 
differences in plasmid copy number, tandem repeats and loci of integration could 
attribute to this variation in readout visibility. Another possibility might be the active 
downregulation of transgenes by epigenetic mechanisms which has been reported 
previously in grafted and cultured cells (Lundberg et al. 1996; Wolff et al. 1989) and in 
vivo in Zebrafish (Goll et al. 2009). Also, the activity of the Hsp70 promoter driving 
Cre has differential activity in somites and neural tissue, and therefore recombination 
in somites is more frequent than in other tissues.  
 
Figure 22: Recombination in the CMZ of RSXmrk-fl-GFP_Tlx::Cre-ERT2  posit ive f ish two 
days after TMX induction. A. Experimental setup: Tlx::Cre-ERT2 fish were crossed to RS-Xmrk-FL-
GFP lines (F1) and raised until hatch. Upon hatch recombination in Tlx-positive cells was induced by 
TMX administration. Fish were fixed two days post induction and stained using antibodies directed 
against GFP. B. Examples of retinae derived from fish of two different RS-Xmrk-FL-GFP lines (L1 and L2) 
in which single recombined cells could be detected in the CMZ region of the retina. Expression of GFP 
was weak. Scale bars are 50 µm. 
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To investigate effects of Egfr-related oncogene expression specifically in the CMZ, I 
used Cre-driver lines that express the recombinase in specific cells in the CMZ. In a 
first short-term experiment, I wanted to know if shortly after recombination GFP-
positive cells are detectable in the RSC zone. I crossed two RSX-FL-Xmrk lines with a 
Tlx::Cre-ERT2_cmlc2::CFP line. The tailless (tlx) promoter drives gene expression in 
the CMZ as well as proliferative zones in the brain. Recombination was induced two 
days post hatch (dph) and embryos were fixed two days later as described in figure 
22A. In both lines, I could detect single, weakly GFP-positive, recombined cells in the 
CMZ where the Tlx promoter is active (figure 22B).  
Since the before mentioned result showed that recombination events could be 
achieved at desired location and time in the CMZ, I set up crosses of various oncogene 
lines with either Rx2::Cre-ERT2 cmlc2::CFP fish or Hsp70::Cre-NLS cmlc2::GFP fish to 
perform long-term ArCoS assays. With this experiment, I aimed to address the effects 
of oncogene expression on the behavior of RSCs and their progeny. For that, I crossed 
F1 fish of the different oncogene lines (RSXmrk-T2A-GFP, RSXmrk-FL-GFP,RSeGFP-
K-RAS12V and RSeGFP-myrAKT) to before mentioned Cre lines and either treated 
larvae with five µM TMX after hatch or applied an HS and grew fish for several weeks 
(experimental setup demonstrated in figure 23A).  
I could detect ArCoS formation only in the RSeGFP-K-RAS12V line, which showed 
eGFP-K-RAS12V expression in the retina (figure 23B) after heat-shock induced 
recombination. ArCoS were found in 2 out of 8 retinae starting at the induction ring, 
expressing GFP in the whole column of different retinal cell types and ending in the 
Rx2 expressing domain in the CMZ. The ArCoS therefore resembled WT ArCoS; an 
apparent effect of K-RAS12V expression on RSCs could not be detected.  
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Figure 23: ArCoS observed in the RS-eGFP-K-Ras_hsp70:Cre-NLS  l ine four weeks post 
heat-shock. A. Schematic setup for recombination experiment. F1 founders of RS-eGFP-K-Ras were 
crossed to Hsp70:Cre-NLS fish. After hatch fish were heat-shocked and raised for four weeks. Fish were 
then sacrificed, fixed and eyes were enucleated, bleached and stained for Rx2 and GFP. B. Example for 
one out of 4 retinae in which recombination could be detected as arched continuous stripes. ArCoS 
start in the Rx2 positive part of the CMZ along the lens and are marked here by yellow asterisks. The 
lower row shows an example ArCoS, a zoom-in from the retina represented in the upper row. Scale 
bars are 100 µm. 
In total, I tested five different lines for Xmrk, two for K-RAS12V and three for myrAKT 
(at least five hatchlings of each line) for the expression of the respective oncogene in 
single cells in the retina. Except for K-RAS12V, I could never detect any ArCoS or 
recombined cells in the retina even though HS-induced recombination of muscle cells 
showed the functionality of the recombination in these cell types. The lack of effect of 
oncogenic K-RAS12V expression is less surprising considering the survival function 
that the Ras/Mapk pathway has in neurons of the retina and the brain and the intense 
activity of the pathway in the INL and ONL as discussed in chapter 5.1.1. and 5.1.2. 
Although pErk was not detected in the Tlx expression zone (CMZ) (figure 9) k-ras is 
also expressed in the undifferentiated region of the retina (figure 8) but weaker than 
in amacrine cells.  
Several technical difficulties can explain the lack of ArCoS formation in other 
oncogene lines. The inefficiency of TMX and HS-induced recombination in 
hatchlings, low expression levels of the GFP-fused oncogenes or silencing of the 
constructs in neuronal tissue could be reasons for the outcome of the experiments.  
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In the  following generations of oncogene lines the intensity of GFP decreased even 
further so that in most lines even the somite expression of GFP after recombination 
became rather weak. For all oncogenes several lines were raised which are summed up 
in Table 1. To find out what happens to RSCs and RPCs directly after recombination, 
I performed several BrdU incorporation experiments and TUNEL stainings with 
TMX-induced RS-Oncogene hatchlings that I fixed two days post induction; I could 
however never detect any GFP signal in the retina. 
Red-Switch Oncogene lines 
Oncogene Stock # 
F1 
Recombinatio
n somites 
Recombination 
retina/brain 
ArCoS 
assay 
performed 
Outcome 
ArCoS 
assay 
Stock # F3 
Xmrk-fl-GFP L1 6603 Yes Yes Yes None 7310 
Xmrk-fl-GFP L2 6604 Yes Yes Yes None 7311 
Xmrk-fl-GFP L3 6610 Yes No Yes None 7307 
Xmrk-fl-GFP L4 6640 Yes No - - terminated 
Xmrk-fl-GFP L5 6694 Yes No - - terminated 
Xmrk-T2A-GFP 
L1 
6641 Yes No Yes None 7306 
K-RAS-GFP L1 6642 Yes No Yes None 7312 
K-RAS-GFP L2 6643 Yes Yes Yes ArCoS 7316 
myr-AKT L1 6677 Yes No Yes None 7314 
myr-AKT L2 6689 Yes No Yes None terminated 
myr-AKT L3 6755 Yes No - - terminated 
Table 1: Generated RS-oncogene l ines with previous and current stock numbers and 
summary of performed assays and findings.  
Apart from the technical problems the absence of Xmrk- or myrAKT-ArCoS could be 
explained by the effect of these oncogenes on RSCs and RPCs. In the SVZ of mice, 
Egfr signaling regulates the balance between NSCs and NPCs together with Notch 
signaling. Enhanced Egfr signaling shifts the balance between symmetric and 
asymmetric divisions and the NPC pool expands while the NSCs are reduced 
(Aguirre, Rubio, and Gallo 2010). If the same would also happen to RSCs, a single 
RSC would divide into two progenitor cells that would proliferate and differentiate. 
Phenotypically this could be detected as a footprint of green neuronal cells on the level 
of the induction ring that are not connected to the CMZ. Another possibility is that 
RSCs exposed to enhanced growth signaling undergo apoptosis. Even though Egfr 
signaling usually has an anti-apoptotic effect, RSCs might have sensitive mechanisms 
that detect if cells are exposed to enhanced growth signaling and activate programmed 
cell death. The accumulation of activated Egfr on endosomes in cell culture, for 
example, can induce apoptosis (Högnason et al. 2001; Rush et al. 2012). RSCs and 
RPCs with enhanced growth signaling might also be rapidly detected and removed by 
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the immune system; immune cells were found to patrol the retina and CMZ actively. 
In a transgenic interleukin1::GFP line, Il1-positive immune cells were seen to localize 
in or at least near the CMZ (Katharina Lust, personal communication). Furthermore, 
it has been shown in Zebrafish that oncogene-transformed cells are rapidly detected 
by the immune system via H2O2 signaling. Even though the immune system was 
shown to have a positive effect on the growth of the transformed cells it could be that 
in the retina the immune system functions as a quality control system (Y. Feng et al. 
2010). 
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3.3 Specific role of Egfra revealed by a CRISPR/Cas9 based 
knockout strategy 
Teleosts retained two functional copies of the egfr gene, egfr a and b (Gómez et al. 
2004), implicating that both receptors serve a vital function. The two receptors might 
be redundant for many functions since they show overlapping expression patterns in 
the CNS as demonstrated before. To unravel the particular role of Egfrs, I designed a 
CRISPR/Cas9 based knock-out (KO) strategy for egfra since it is more closely related 
to the mammalian egfr. 
3.3.1 Experimental design of Egfra knock-out 
A CRISPR/Cas9 based non-homologous end joining (NHEJ) approach was chosen to 
disrupt the ORF of the egfra gene by induction of double strand breaks (DSB). Three 
sgRNAs were designed using the CCTop prediction tool (Stemmer et al. 2015) to 
target the first exons of the egfra gene located on chromosome 17. I selected Exon #4 
and #7 since they had the lowest probability of off-targets as predicted by CCTop. By 
choosing two target sites, I aimed to disrupt the extracellular domain of the receptor 
(Domain I and II). 
Figure 24A shows a schematic representation of the Egfra-KO approach. Together 
with sgRNAs directed against the genomic locus I injected a plasmid coding for GFP 
lacking the start codon. An in-frame integration of the plasmid in exon 4 or 7 will 
result in a fusion protein of the Egfra N-terminus with GFP. The eGFPvar plasmid is 
linearized by co-injection of a sgRNA directed against the T1 site immediately 5' of 
the GFP sequence; the same strategy was used for tagging of the actin b locus in 
(Stemmer et al. 2015).    
First injections performed with all three Egfra-targeting sgRNAs (severe effects on 
injected embryos; more than 40 % died early after injection and several surviving 
embryos showed malformations or developmental delay (figure 24C). This 
observation is in line with the initial assumption that defective Egfr is lethal as it is the 
case in mammals. Genotyping pools of injected malformed embryos as well as 
phenotypically normal hatchlings showed high frequencies of Egfra mutations in exon 
4 but not in exon 7 (data not shown), suggesting that only the sgRNA targeting exon 4 
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is functional and efficiently inducing DBS in the desired region. The probability of in-
frame insertion of the GFP sequence is 1/6. GFP fluorescence could not be detected in 
the injected generation or any of the following, which is reported for several other 
cases of GFP insertion in first exons of an ORF in our lab.  
 
Figure 24: CRISPR/Cas9 based knockout strategy for NHEJ based insertion of an 
eGFPvar plasmid into the Egfra locus.  A. Schematic representation of the GFP donor plasmid, 
which is linearized in vivo upstream of the eGFPvar at the CR13 site, and the target locus on Chr. 17 
coding for the O. latipes Egfra gene. Two sgRNAs were designed to induce DSB in exon 4 and 7. B. 
Death rates after first injections with combined sgRNAs (Exon 4 and) were above 40%. One-third of 
surviving embryos showed severe malformations or growth delay four days post injection. C. An 
example of embryos injected with Egfra-targeting sgRNAs and Cas9 mRNA surviving until four days 
post injection. 
Since the sgRNA targeting exon 4 was proven functional, I raised injected fish to 
adulthood. I then crossed them to WT cabs, and the offspring was screened for 
insertion of GFP, excision of the locus between exon 4 and 7 and INDEL mutation at 
the sites where the DSBs occur. Figure 25 illustrates the PCR and sequencing-based 
screening procedure for Egfra mutant fish. The PCR strategy for screening of F1 
embryos and following generations is demonstrated in panel A. Most common were 
deletions of several base pairs. All identified mutations were deletions of triplets of 
bases ranging from 3 to 24, which do not cause a frame shift. Triplet deletions were 
observed for other cases of CRISPR/Cas9 mediated INDEL mutations in the lab. I 
identified two found fish and raised their offspring to adulthood. The first founder 
carried an insertion of the eGFPvar plasmid (EgfraGFPins/+) at the double strand break 
(DSB) site in exon 4. The second founder had a deletion of 12bp at the same location 
(Egfra12bpDEL/+)). The four amino acids  (glutamate (E), leucine (L), proline (P), and 
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methionine (M)) missing in the generated mutant version of Egfra are located in the 
extracellular domain 1 in which receptor-ligand binding takes place (Laisney et al. 
2010). This mutation can thus disturb the ligand binding by inducing a 
conformational change in the binding pocket.  
 
Figure 25: Experimental screening setup for detection of CRISPR/Cas9 mediated 
insertions and deletions in the egfra  locus. A. Representation of the WT locus and primers 
used for amplification of the WT locus between exon 3 and intron 7 and two identified mutations 
identified in F1 (forward insertion of eGFPvar plasmid/INDEL mutation in Ex4). B. Injected generation 
was outcrossed to WT Cab fish. Positive founders were identified by genotyping pools of F1 embryos. 
Offspring of positively identified founders (GFP insertion or INDELS) were grown to adulthood. Female 
F1 fish harboring a GFP plasmid insertion in one allele (EgfraGFPins/WT) were crossed to F1 males with a 
deletion in Exon 4. C. The F2 did not show any obvious phenotype and was grown to adulthood, fin-
clipped and genotyped by PCR (GFP insertion). Sequencing of Exon 4 revealed that Egfra-/- are viable. -
D. An example of sequencing results and assigned phenotypes of F2 fish, with responding genotype, 
please note that only the WT PCR bands (primers: JW5374/4354) were sequenced. The GFP plasmid 
containing alleles did not amplify with the used elongation time. Fish 1, 2, 5 amplified two different 
alleles (one with 12bp DEL and one WT), fish 3 and 7 only amplified a 12 bp DEL allele, the other allele 
must thus be GFP, since no two 12bp alleles can be present in the F2 (see crossing scheme in B).Fish 4 
and 6 amplified one or two WT alleles, and their genotype is either GFP/WT or WT/WT. 
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Since all EgfraGFPins/+ F1 fish were male and Egfra12bpDEL/+ were female both lines were 
crossed to obtain homozygous mutants in the next generation. Figure 25B illustrates 
the crossing scheme used to raise homozygous Egfra mutant lines. Screening of the 
offspring revealed that homozygous Egfra mutants (Egfra12bpDEL/GFPins) are viable and do 
not show distinct phenotypes as it is the case in knockout mice (Dackor, Caron, and 
Threadgill 2009; M Sibilia et al. 1998). This means that Egfra is either dispensable or 
the egfra transcripts deposited in the oocytes (Laisney et al. 2010) are sufficient to 
rescue its function in early development. 
3.3.2 Offspring of Egfra-/- females is not viable due to polyspermy 
Egfra knockout fish did not display a phenotype in the first two generations. However, 
offspring of homozygous Egfra12bpDEL/GFPins F2 females showed very early phenotypes. 
Oocytes and zygotes in one-cell-stage appear normal, but the first blastocyst cleavages 
are delayed and abnormal (see figure 26). In WT embryos the first cleavage furrow 
typically develops orthogonal to the axis of the micropyle (MP) and the second polar 
body (Iwamatsu 2004). In Egfra-/- however, multiple disoriented cleavage planes occur. 
Within the first two hpf, EgfraGFPins/+ derived embryos have developed until four cell 
stage; at the same time 85% Egfra-/- show severe blastocyst cleavage defects and die 
(figure 26, panel B). EgfraGFPins/12bpDEL cells continue dividing in disordered fashion for 
several hours until they fail to gastrulate normally (28hpf). The same and even more 
pronounced phenotype could be observed in oocytes derived from EgfraGFPins/GFPins 
females where 98% of embryos show early cleavage defects. Some zygotes of 
Egfra12bpDEL/GFPins females develop normally which might be due to some retained 
function of the Egfra12bpDEL variant. Both mutations thus lead to the same phenotype; 
therefore I assume that the insertion of the GFP plasmid or the 12bp DEL in exon 4 
leads to a defective receptor unable to bind ligands. It still needs to be demonstrated 
that both Egfra mutant alleles are non-functional or hypomorph. 
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Figure 26: Phenotype of embryos derived from homozygous Egfra mutant females in 
comparison with heterozygous and WT females. A. An example of cleavage events of embryos 
2 to 28 hpf (4-cell stage – end of gastrulation). WT embryos divide symmetrically in the first cleavages, 
4-cell stage to 16-cell stage and have reached gastrulation 28 hpf (25°C). Embryos derived from 
homozygous mutant females already show abnormal first cleavages two hpf, asymmetric growth of 
blastula (7 hpf) and typically fail to reach gastrulation. B. The ratio of embryos that reach hatchling 
stage is above 95% in homozygous WT and heterozygous Egfra mutants. Almost no embryos derived 
from homozygous Egfra GFP insertion females (EgfraGFPins/GFPins) manage to reach gastrulation. About 
12% of the offspring of homozygous mutants with EgfraGFPins/12bpDEL genotype reach gastrulation and 
manage to hatch. 
To determine the cause of the early cleavage phenotype and characterize the DNA 
replication dynamics I established a protocol that allows live imaging of chromatin 
dynamics in the forming zygote. The first striking feature that became evident in the 
time-lapse imaging (described later in figure 28) is the presence of multiple nuclei 
before the first cell division (30-40 mpf). 
To address whether excess pronuclei are of paternal or maternal origin I collected 
unfertilized mature oocytes as well as fertilized oocytes at 2 and 25 mpf from Egfra+/+ 
and Egfra-/-  females to address the question if excess pronuclei are of male or female 
origin. Oocytes were stained with DAPI and γ-tubulin and imaged in collaboration 
with Daigo Inoue to check determine for chromosomal abnormalities and presence of 
centrosomes that are naturally of male origin in most species (Schatten 1994). Results 
of this stainings are presented in figure 27A.  
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The chromosomal content of mature unfertilized oocytes does not differ between 
Egfra+/- and Egfra-/- and all supernumerary pro-nuclei observed in the live imaging 
experiment must thus be of male origin (figure 27 A).  
 
Figure 27: Oocytes derived from Egfra-/- females become ferti l ized by many sperms. A. 
Unfertilized oocytes of Egfra-/- show regular metaphase-arrested pronuclei, upon fertilization multiple 
male pronuclei enter the oocyte: male pronuclei are highly condensed at first (2 mpf). In WT embryos 
the female pronucleus migrates towards the decondensed male pronucleus, and both start fusing 20 
mpf. In multi-fertilized oocytes male pronuclei decondense and form aggregates. In fertilized embryos, 
the sperm brings one centrosome that divides before the first cell division (white arrows). In fertilized 
Egfra-/- oocytes multiple centrosomes are present (white arrows). B. Polyspermy only occurs in zygotes 
derived from homozygous Egfra mutant females, but not from heterozygous ones. The median number 
of pronuclei in fertilized mutant oocytes is 5 for Egfra12bpDEL/GFPins and 7 for EgfraGFPins/GFPins females. Scale 
bar is 25 µM for unfertilized oocytes and 50 µM for fertilized oocytes. mpf=minutes post fertilization, 
WT= wild type. 
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In WT embryos, male and female pro- nuclei can be distinguished by their size and 
dynamic. The male pronucleus is initially small (figure 27 A, 2mpf) but chromatin 
decondenses fast (figure 27 A, 25 mpf) and it becomes strikingly bigger than the 
female pronucleus. The female pronucleus remains in its metaphase confirmation and 
moves towards the male pronucleus along microtubules that are nucleated by the male 
centrosome (Schatten 1994).  
Egfra-/- oocyte pronuclei appear indistinguishable from WT nuclei. I counted the 
number of pronuclei present after fertilization in Egfra12bpDEL/GFPins, and EgfraGFPins/GFPins 
derived oocytes ranging between two (one male and one female) to 17 pro-nuclei that 
were visualized by DAPI staining of fertilized oocytes (2-15 mpf). The difference 
between Egfra12bpDEL/GFPins (median five pronuclei) and EgfraGFPins/GFPins (median is seven 
nuclei) might be due to the difference in the two mutant alleles where the 12bp DEL 
allele might be a hypomorph. 
3.3.3 Polyspermy leads to uncoupling of DNA-replication and cell cleavage 
To analyze the dynamics of polyspermy from, gamete fusion to later cleavages, I use 
fluorescent histone 1 (H1) to stain pro-nuclei before the first cell division. I imaged 
zygote formation and development in Egfra -/- female derived oocytes that were 
previously injected with H1 coupled to TexasRed under a confocal microscope as fast 
as possible ofter fertilization. Figure 28 shows several frames of two movies of a 
fertilized WT oocyte compared to a polyspermic Egfra-/- oocyte. The videos cover a 
time of about six hours in which the WT zygote manages to reach the 32-cell stage. 
The time frames shown in figure 28 represent the last moment in each cycle in which 
most condensed metaphase nuclei can be seen before chromosomes segregate and 
cells re-enter S-phase and lose H1-TexasRed signal.   
The first frame (0:00) shows localization of male and female pronuclei at the 
beginning of recorded period (approximately 40 mpf, on ice); in the Egfr-/- oocyte at 
least nine male pronuclei can be distinguished.  The second frame shows fused pro-
nuclei in metaphase before the first mitotic chromosome segregation. In mutant 
oocytes, most male pronuclei form aggregates with the female pronucleus. After the 
first chromosomal segregation and cell division, one large DNA-aggregate and two 
independent nuclei appear. The two separate nuclei keep dividing normally but the 
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chromatin aggregate, formed by excess chromatin, replicates and is segregated 
incompletely. This is likely because the presence of several centrosomes brought along 
with each sperm and the formation of several sperm asters (Snook, Hosken, and Karr 
2011). 
 
Figure 28: Time-lapse imaging of chromatin dynamics in early Egfra WT and 
homozygous Egfra mutant embryos reveal polyspermy as the cause for defective f irst 
cleavages. One-cell stage embryos were injected with H1-Texas red early after fertilization and 
imaged from about 40 mpf to 6hpf. Frames were chosen at time points of the highest number of 
metaphase nuclei. In Egfra WT-derived embryos male and female nuclei could be distinguished (frame 
00:00) based on size and behavior. Egfra -/- derived embryos clearly have multiple male nuclei that 
aggregate, aggregates are highlighted by white arrows. Images are false colored, and the scale bar is 
200 µm. mpf=minutes post fertilization. 
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Blastomeric cleavage seems to happen independently from proper chromatin 
segregation leading to the formation of multiple incompletely and non-nucleated 
subdivisions. The independence of blastomeric cleavage from DNA replication has 
been described before by Dekens et al. in the Zebrafish futile cycle (fue) mutant where 
cells cleave in the normal stereotypic way even though they are anucleate due to a 
chromosome segregation defects (Dekens et al. 2003). In the Egfra-/- these cleavages 
are not stereotypic probably due to microtubule organizing centers created around 
excess centrosomes. 
Incompletely separated chromatin re-aggregates after each replication (Egfra-/-, frame 
2:08 and 3:08). The observed phenotype of Egfra-/- derived oocytes, and their failure to 
properly gastrulate is solely due to polyspermy since mutant embryos that are 
fertilized by only one sperm develop normally. In teleost oocytes, polyspermy does 
not occur naturally and cannot be compensated in most cases. Different cases of 
pathological polyspermy have been described, and species differ in how male and 
female nuclei interact. In sea urchin, two or more pronuclei can fuse with the female 
pronucleus while other male pronuclei do not interact. The multinuclear fusion leads 
to the occurrence of multipolar spindles and chromatin fragmentation (Laubichler 
and Davidson 2008). In Xenopus, all sperms that enter the oocyte form bipolar 
spindles and the number of cleavages corresponds to the number of sperm pronuclei 
(Snook, Hosken, and Karr 2011; E. B. Wilson 1897). Xenopus, sea urchin and also fish 
are thus unable to deal with excess centrosomes independent of how many male 
pronuclei fuse with the egg pronucleus.  
In some species, as birds and newts, polyspermy occurs naturally and is necessary for 
proper oocyte activation and development of the oocyte (Snook, Hosken, and Karr 
2011). In physiological polyspermy only one bipolar spindle forms around the egg 
pronucleus and one male pronucleus, the rest of the male pronuclei degenerate. In 
many bird species, it is necessary for proper karyogenesis that many sperms enter the 
egg. (Elinson and R P 1986; Rothschild 1954; Tarin and Cano 2000). For several 
species, it was reported that multiple sperms fertilize otherwise monospermic oocytes 
without having any adverse developmental effects (Rothschild 1954), this type of 
polyspermy is described as ‘compensable' polyspermy by Snook et al. (Snook, Hosken, 
and Karr 2011). Compensable polyspermy was observed in multiple taxa as insects, 
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newts and salamanders, reptiles, birds and cartilaginous fishes in all of these cases 
yolky eggs are externally fertilized, and no fast block of polyspermy exists.  
3.3.4 Embryos have a rescue strategy for polyspermy 
In Medaka polyspermy is pathogenic and in most cases leads to failure of gastrulation. 
While in other species polyspermy leads to developmental arrest when midblastula 
stage is reached Egfra-/- derived embryos develop until gastrulation in most cases and 
sometimes even manage to regain the normal developmental program and survive. 
Figure 29 shows a time-lapse series of pictures of three embryos collected from the 
same Egfra12bpDEL/GFPins female.  
 
Figure 29: Survivors of polyspermy induced early cell  division defect. Three examples of 
Egfra12bpDEL/GFPins derived zygotes with early cleavage defect due to polysemy. Polyspermic embryo A 
and B survived and formed viable embryos despite polyspermy. Embryos were followed for 30 hpf 
when embryos reach St 21, which is comparable to WT embryos. 
In all three cases, one hpf embryos look similar to WT embryos of the same age. At 3,5 
hpf (32-cell stage) all three zygotes had atypical cleavage patterns. Example A had 
approximately 15 large cells; Example B shows some separation between cells dividing 
in a contained space (dashed line) and cells that begin to migrate away from the 
animal pole. At 4,5 h the zygote A also showed a contained area which looked 
comparable to a WT embryo at stage 7-8 (32-64 cells) (Iwamatsu 2004). In embryo C 
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a comparably bigger area of the oocyte surface is covered by cells, and fewer cells are 
excluded from the conglomerate, suggesting that after 4,5 hpf the zygote is unable to 
form the dome-shaped blastoderm in early morula stages which typically comprises of 
three layers (Iwamatsu 2004). Embryo C finally failed to gastrulate and died at 30 hpf. 
 
Figure 30: Appearance of chromatin in Egfra +/- and -/- embryos in early (stage 8) and 
late (stage 9) morula stage. Single nuclei are enlarged and depicted in colored frames. WT nuclei 
in stage 8 are mostly synchronous (here prophase) while in Stage 9 cells become increasingly 
asynchronous and chromatin can be found in different cell cycle stages (here anaphase along with 
prometaphase nuclei, yellow frame). In Egfra -/- embryos, cells divide asynchronously, and nuclei are 
mostly odd shaped due to aneuploidy (blue frame). Spindle separation is often imperfect with 
chromosomes leaking behind (green frame). Scale bar is 100 µm, color framed pictures are four times 
enlarged. 
The described findings indicate that early O.latipes embryos have the ability to survive 
supernumerary pronuclei in rare cases. In polyspermic shark embryos (compensable 
polyspermy) supernumerary male nuclei undergo mitotic divisions synchronously 
with the synkaryon (fused male and female pronuclei) derived from one male and one 
female (the same can be observed here, figure 28). Supposable cells from the 
synkaryon occupy the central part of the germinal disc and push the supernumerary 
sperm containing cells to the periphery. The male pronuclei even display superficial 
cleavage sites (Ginzburg 1968). Similar mechanisms seem to operate in example A 
Results and Discussion 
 77 
and B indicating that in some circumstances polyspermic embryos manage to rescue 
themselves if the synkaryon derived cells manage to displace supernumerary 
pronuclei.  
To obtain insights into the reactions of embryos to an abnormal DNA content I 
performed DAPI stainings of Egfra -/- and WT embryos in early and late morula stage 
(figure 30). In the early morula stages of WT embryos, the cell cycle is still 
synchronized, and all nuclei can be found in a similar stage of cell cycle. In Egfra-/- 
embryos nuclei with abnormal shapes can be seen (figure 30, blue frame), and the cells 
cycle asynchronously (condensed metaphase and decondensed S-phase 
chromosomes). Furthermore, most polyspermic embryos did not manage to separate 
male pronuclei from the synkaryon and become aneupleudic (chromatin aggregated, 
blue frame). In late morula stage WT cells start to cycle increasingly asynchronous, 
nuclei show typical rounded shapes and mitotic figures are symmetric (figure 30, 
yellow frame). Metaphase chromosomes of Egfra-/- embryos often look abnormal and 
fail to segregate (figure 30, green frame) which leads to less but bigger, uneven shaped 
nuclei with high chromatin content when compared to a WT embryo of the same 
stage. Interestingly, cells continue to divide even after midblastula transition, and the 
zygote manages to develop into a mostly irregular cell mass and in most cases only 
fails at gastrulation stage and dies (figure 26).  
To check for the presence and appearance of metaphase chromatin and mitotic 
spindles, we (together with Daigo Inoue) performed phospho-Histone 3 (pH3) and α-
tubulin and stainings of embryos at four hpf. The results revealed additional 
abnormalities in polyspermic Egfra-/- embryos demonstrated in three examples in 
figure 31 (B-D). 
In heterozygous Egfra mutant as in WT embryos, all spindles, visualized by α-tubulin 
staining, are symmetric and always exist in two fold (fig. 31.A''). Metaphase 
chromosomes as revealed by pH3 staining are always located along a line between two 
spindles (dashed line in A’’’). In Egfra-/- embryos division defects resulting from the 
presence of multiple spindles becomes apparent. Differently shaped chromosomal 
aggregates stain positive for the metaphase marker pH3 (B'') and are connected to at 
least two, but often more, spindles. The large chromatin aggregates are clear 
indications for aneuploidy (B'), which is a standard feature in polyspermic embryos 
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resembling phenotypes that can be found in cancer cells (Snook, Hosken, and Karr 
2011). 
 
Figure 31: Phenotypes of early cell  cleavage and cell  division in polyspermy embryos 
(offspring Egfra -/-)  in comparison with heterozygous embryos (Egfra +/-).  Embryos were 
fixed four hpf and stained for a-tubulin (green), phosphorylated H3 (magenta) and DAPI (cyan). A. In 
normally fertilized embryos, metaphase chromosomes (division plain indicated by dashed line in A''') 
are always pulled by two spindles and chromosomes are divided evenly (A'') with each cleavage. B-D. 
Examples of unusual events caused by abnormal chromosome content of polyspermy embryos derived 
from Egfra -/- females. B. Mitotic figures (pH3 associated chromatin) have irregular shapes (arrow B'''), 
and chromatin is divided unequally between cells. C. Up to six spindles (C'', arrow) were found to be 
associated with one metaphase (C''') chromatin aggregate (arrow in C'''). D. Cell division (cleavage) can 
take place independently of DNA replication. Some blastomeres defined by tubulin distribution 
(approximate location of cell borders marked by dashed lines) (D'') lack chromosome content, large 
chromatin aggregates appear (D’, arrow). Scale bar is 50 µm. 
In one extreme example, we saw up to six spindles pulling on one chromosomal set 
(C'') that fails to organize itself properly along one axis  (C'''). Even chromosomes only 
pulled by two spindles often fail to organize themselves along the equatorial axis 
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between spindles (figure B, arrow in B'''). Furthermore, polyspermic O.latipes embryos 
have the ability to cleave and form newly separated cell space, independent of DNA 
replication (fig. 31D), which I observed in the live imaging as well (figure 28).  
No cases of naturally occurring polyspermy in teleost species have been reported so 
far thus the polyspermic block, which in fish is mainly mediated by the egg shell 
works very efficient. The only describe cases of polyspermy in teleosts are described 
for denuded eggs of various species (Ginzburg 1968; Sakai 1961). 
3.3.5 Polyspermy in Egfra-/- embryos is due to multiple and 
abnormal shaped micropyles 
Polyspermy in teleost fish is prevented by a mechanical blockage of sperm entry 
through the protective eggshell (chorion) (Ginzburg 1968; Murata 2003). In this 
chorion only one point of sperm entry, the micropyle (MP), is present.  
In Egfra heterozygous and WT embryos only a single MP channel was found (figure 
32A). The chorions of Egfra12bpDEL/GFPins and EgfraGFPins/GFPins female derived zygotes 
displayed multiple MP channels (indicated by violet asterisks in fig. 32A). The Egfr-/- 
MPs are distributed around the animal pole of the chorion, which can be identified as 
the site opposite of the long attaching filaments on the vegetal pole of the egg. Besides 
the multiple MPs and the more “curly” filaments around the MP area the chorion of 
Egfra-/- mutants look normal. 
The shape of the micropyle is essential for the described way of polyspermy block in 
Medaka. WT MPs always displayed a characteristic funnel shape, becoming narrower 
from the surface towards the oocyte (Iwamatsu et al. 1991; Nakashima, S; Iwamatsu 
1989) (Fig. A, lower picture). In Egfra -/- mutants the micropyles are often odd-shaped 
and do not have the characteristic funnel shape of WT MPs (fig. 32A, lower picture). 
Mutant micropyles display straight channel walls probably allowing access to multiple 
sperms.   
Egfra12bpDEL/GFPins mutants had a broader range of MP numbers compared to 
EgfraGFPins/GFPins mutants and in average have more MPs per oocyte even though 
EgfraGFPins/GFPins oocytes in average have more pronuclei after fertilization (Figure 32 B). 
The variance of MP numbers in Egfra12bpDEL/GFPins oocytes is bigger, indicating a less 
predictable outcome in which sometimes only very few MPs are found accounting for 
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the percentage of monospermic fertilizations. Monospermy was never observed in 
EgfraGFPins/GFPins derived oocytes. The higher number of MPs in Egfra12bpDEL/GFPins oocytes 
might be related to the age of the females, which were bigger and older at times of 
oocyte collection. The MP numbers of both Egfra mutant genotypes together with the 
data acquired for survival rates of offspring imply that there is some residual function 
of the Egfra12bpDEL variant which leads to a broader range of phenotypes.  
In the following, I also correlated the number of MPs and pro-nuclei by counting both 
in the same embryo (Egfra12bpDEL/GFPins and EgfraGFPins/GFPins taken together). No direct 
correlation could be identified (R2=0.064) between the two factors as shown in figure 
32 panel C, indicating that besides the number of MPs also the shape of the channels 
contributes to the failure of the polyspermy block in Egfra mutant oocytes. 
 
Figure 32: Egfra mutant females produce oocytes with multiple micropylar channels. A. 
The surface of a Cab and an Egfra-mutant chorion. Egfra -/- derived oocytes have many MPs at the 
animal pole of the oocytes. MP are marked by asterisks. Micropyles in mature oocytes (yellow arrows) 
differ in number and shape. B. Box plot for numbers of MP channels found in Egfra mutants. Only one 
MP channel was present in 48 observed Cab oocytes. Egfra mutants always had many MPs with an 
average of 15 MPs for EgfraGFPins/12bpDEL and 8 for EgfraGFPins/GFPins genotype. C. No correlation could exist 
between the number of micropyles and the number of male pronuclei in Egfra mutants (R=0,064).   
The occurrence of multiple micropyles was so far not described for teleost; they 
typically have one micropyle. In acipenserid fish (primitive sturgeon species), which 
are not considered teleosts, the occurrence of multiple micropyles was described and 
visualized by electron microscopy (Clark 1982). The perforation of the white sturgeon 
complex egg-envelop by multiple channels (around 10) is thought to increase the 
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probability of fertilization in spawning grounds of low sperm density (Clark 1982; 
Ginsburg 1961). It is possible that the block to polyspermy that consists of the 
blocking of MP channels with vitelline fluid to generate a fertilization cone takes place 
faster in sturgeon eggs. Since fertilization in Medaka takes place very localized with 
high sperm density, the existence of multiple MPs inevitably leads to polyspermy. 
3.3.6 Egfrs and ligand expression in mature ovaries 
Egfrs are key players of interaction between the follicle cells and the 
oocytes(FregosoLomas et al. 2013; Hsieh, Thao, and Conti 2011; Jamnongjit, Gill, and 
Hammes 2005; Park 2004). The before mentioned results show that in Medaka, the 
Egfra is important in guaranteeing that only one MP is formed through which the 
sperm can penetrate the mature oocyte. To gain insights into the role of Egfr-signaling 
and expression of both receptors in the oocytes, we (with the help of Narges 
Aghaallaei) performed in situ hybridization (ISH) on sections of adult ovaries. Figure 
33 shows the expression of egfra and b (fig 33A) as well as of three Egfr ligands: egf, 
hb-egf, and tgf-a at different stages of oogenesis as well is an example of a vitellogenic 
oocyte (150-300 µm). Due to the enormous size of the gametes compared to 
surrounding follicle cells and the signal that becomes trapped in the hairs surrounding 
the vitellogenic oocytes, expression profiles are hard to interpret. Also, no difference 
between expression in granulosa and follicular cell layer can be seen because of lack of 
resolution.  
Egfra and egfrb are expressed in previtellogenic oocytes as well as in follicle cells 
around vitellogenic oocytes. At least egfra appears to be expressed to a higher extend 
in follicle cells at the animal pole. The egfr ligand egf and tgf-a are expressed in some 
previtellogenic and egf also in vitellogenic oocytes of medium size. Hb-egf seems to be 
transcribed in some cells of the follicles are interspersed support tissue as well as in 
the epithelial layer surrounding the ovary. 
Egfrs, as well as the ligands tgf-a and egf, are also present in the ovaries of birds and 
mammals (Fukumatsu, Katabuchi, and Okamura 1995; Göritz, Jewgenowyer, and 
Meyer 1996; Maruo et al. 1993; Scurry et al. 1994). Both cell types of the follicle layer, 
granulosa, and thecal cells express tgf-a (Kudlow et al. 1987; Yeh, Lee, and Aanderson 
1993) and the production of this ligand is stimulated by FSH  (Kudlow et al. 1987). 
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Egf has an activating effect on oocyte maturation in mammals (Brucker et al. 1991; S 
Coskun and Lin 1995; Serdar Coskun and Lin 1994; Dekel and Sherizly 1985) and  
Zebrafish and Goldfish in which Tgf-a has the same effect (Pang and Ge 2002; Pati et 
al. 1996). Although follicle cells have been identified as the most probable site for egf 
activity (Procházka et al. 2000), it might also act directly on the oocytes since it was 
shown that it also exerts and effect on denuded bovine oocytes (Lonergan et al. 1996). 
 
Figure 33: Expression pattern of egfra  and egfrb ,  egfr l igands egf ,  hb-egf ,  and tgf-a  in 
adult ovaries. Two pictures are displayed for each staining; one is showing different stages of 
previtellogenic oocytes (no filaments and no yolk vesicles) and the other displaying a vitellogenic 
oocyte (surrounded by chorion with attached filaments) in which a follicular layer can be distinguished. 
Filaments stain with trapped signal. Both Egfrs are expressed in previtellogenic oocytes and follicle 
cells surrounding vitellogenic oocytes. Expression patterns of ligands are difficult to discern. Hb-egf 
and tgf-a seem to be expressed by single follicular cells and epithelial lining of the ovary as well as in 
individual previtellogenic oocytes as is egf. If identifiable the vegetal pole of vitellogenic oocytes is 
marked with V and the animal pole with A. Scale bar is 100 µm. 
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There is plenty of egfr-dependent crosstalk between follicles and oocytes reported in 
various species (Park 2004; Pati et al. 1996; Wayne et al. 2007). The formation of a 
micropyle is an essential step in oocyte maturation in the teleost, and it is therefore 
not surprising that Egfr-signaling functions in the communication of the granulosa 
cell layer with the oocyte about the existence of one channel. Since all steps of 
oogenesis except for the formation of the micropyle seem to be normal in Egfra-/-the 
only defect lies in the induction of several granulosa cells to differentiate into 
micropyle cells (MCs) in which signaling through Egfra appears to be specific. The 
ISH studies of WT ovaries shows that both receptors are expressed in the ovary in 
primary oocytes and the follicle layer and might be redundant for most of their 
functions. 
3.3.7 Activity of Ras/MAPK/Erk pathways in WT and Egfra 
mutant ovaries 
As previously described the MP is formed by a single granulosa cell (GC) that 
gradually adapts a particular cell shape and forms a channel by pushing of 
microtubule and tonofilament bundles through the chorion towards the oocyte. The 
micropylar cell (MC) loses contact to surrounding GCs and stays connected to the 
oocyte to the moment of follicular rupture (Nakashima, S; Iwamatsu 1989). I first 
addressed the question if the multiple MPs observed in Egfra -/-oocytes are due to the 
occurrence of multiple MC or to the fact that one MC forms several channels. For 
this, I stained whole mount or sectioned ovaries of adult reproducing Egfra WT and 
mutant females for DAPI, α-tubulin and phospho- p42/44 Erk (pErk) (figure 34). 
Although the Erk/MAPK signaling pathways are widely used by other growth related 
receptors (e.g. the IGF-receptors) the comparison between WT and Egfra mutant 
allowed to narrow down the site of egfr-signaling deregulation.  
Active pErk was detected in primary oocytes of WT and Egfra -/-, in levels decreasing 
with oocyte growth, and in GC directly adjacent to the MC. In mutant oocytes, 
multiple MCs are among the GCs around the animal pole of vitellogenic mutant 
oocytes all of which are surrounded by pErk-positive GCs (figure 34 A, B, D & E).  
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Figure 34: Active Erk signaling in WT and Egfra-/-ovaries. A-C WT ovaries: A. Section of the 
MP region of a vitellogenic WT oocyte. A yellow arrow indicates the location of the micropylar channel 
where it meets the oocyte cytoplasm. Follicular cells immediately adjacent to the micropylar cell are 
positive for phospho-Erk (p-Erk) (A’’). B. Whole mount staining of a vitellogenic WT oocyte with a 
region of cells positive for p-Erk on the animal pole (B’’). C. Oocytes of different stages, primary 
oocytes stain positive for p-Erk (white arrows). D-F Egfra-/- ovaries: D. Section through an MP region of 
an Egfra -/- oocyte. Multiple MP channels, deriving from different MC in a thickened part of the chorion 
(dashed line), can be distinguished by a tubulin staining (D’’’). Nuclei of micropylar cells are located 
below nuclei of the follicular layer (D’, indicated by red arrows). Follicular cells are surrounding the MP 
region stain positive for pErk (D’’). E. Whole mount staining of the follicular layer at the animal pole of a 
vitellogenic oocyte. Multiple pErk-positive areas can be distinguished (red errors in E & E'') around the 
MPs (holes in y-tub staining E'''). F. PO in Egfra-/- stain positive for pErk (white arrows). Scale bar is 50 
µm. Ch=Chorion, fl=follicular layer, y=yolk, PO= primary oocyte. 
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An example of an MP region in WT (MP marked by yellow arrows) and 
EgfraGFPins/GFPins mutant can be seen in figure 34. In the chosen section plane of the 
Egfra mutant oocyte, three MP channels are visible in the a-tubulin channel (D’’’), all 
three nuclei can be distinguished from the GC nuclei and are marked with red arrows 
in the DAPI channel (D’). The MC nucleus can be distinguished from nuclei of 
surrounding GCs by its flat shape. GC nuclei usually have nuclei that are elongated on 
the axis perpendicular to the oocyte (see in figure 34, D'). The MC is considerably 
bigger than other GCs, judging from the space that is formed around the MP nucleus. 
Around the MC, GC nuclei appear less elongated, and the whole MP area is 
protruding (fig. 34A). In the Egfra12bpDEL/GFPins oocytes the granulosa layer is more 
disorganized in the MP region (fig 34D). In whole mount stainings, it becomes 
evident that each MC forms a focus point around which pErk-positive GCs and 
microtubules organize (E’’’). 
These results indicate that Ras/Mapk/Erk signaling is not active in the MC itself since 
it never stains positive for pErk. So far nothing has been reported about the 
mechanisms through which a GCs differentiates into an MC and how this is 
maintained. Whether the differentiation of a single GC into an MC is a result of the 
localized upregulation of pErk or if the cells around the MC upregulate Erk signaling 
as a response to the MC still needs to be elucidated. However, there seems to be more 
to a micropyle than a single cell. 
Egfra mutant embryos apparently fail to signal the animal pole surrounding GC that 
an MC has successfully formed an MP and that no more are needed. Instead, more 
than one MC differentiates. Cells in the MP domain appear very disorganized 
whenever many MPs are present within close proximity as depicted in figure 35B’. 
Figure 35 shows false colored sections of micropylar and non-MP regions of WT 
(fig.35A) and Egfra mutant (fig.35B) oocytes. Nuclei positive for pERK are colored 
violet in the DAPI channel, and the nucleus of the MC is colored yellow. No 
difference can be seen in the appearance of GCs (gray) and follicle cells (green) in any 
other region of the oocytes of WT and Egfra mutant oocytes. pErk-positive nuclei 
around the MC are organized to fit around the MC. In the broad pErk-positive 
"mutipyle" region of Egfra mutant oocytes, granulosa and follicular layer are 
thickened (B') and nuclei have a rounder shape. If an MC in an Egfra-/- follicle is not 
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near another MC (Fig.35B''), the surrounding GC layer looks comparable to WT. 
Follicle irregularities originate thus from the presence of densely placed MCs that 
have difficulties to gather supporting pErk-positive granulosa cells and therefore 
hinder themselves which could cause the occurrence of odd-shaped MP channels in 
Egfra-/- mutants. The Ras/Mapk/Erk was found to be critical for the differentiation of 
rat granulosa cells and is stimulated by FSH in Egfr dependent manner (Buratini and 
Caixeta 2012; Wayne et al. 2007). 
 
Figure 35: The appearance of the foll icular layer outside of the micropyle region is 
indistinguishable between WT and Egfra mutant oocytes. False-colored images of sections of 
WT and Egfra mutant ovaries stained for p-Erk. A. Appearance nuclei of the follicular layer around 
chorions (dashed lines) of different oocytes at non-micropylar (A) and micropylar region (A’). Oocytes 
are surrounded by the granulosa layer (gray nuclei) and a follicular layer (green flattened nuclei). Nuclei 
of cells positively stained for pErk are indicated in purple and appear elongated. The nuclei of 
micropylar cells are colored in green. B. On the vegetal side Egfra-/- follicles are indistinguishable from 
WT follicles. In the animal region several micropylar cells can be found (B’) and surrounding granulosa 
cells form a cluster of pErk-positive cells B.' The thickness of the chorion varies between non-micropylar 
and micropylar region. Whenever there is only one micropylar cell present, the follicular layer appears 
indistinguishable from the WT follicle. Scale bar is 50 µm. Y=yolk. 
The only other reported case of multiple micropyles in teleosts is the Zebrafish 
mutant bucky ball (buc). Buc is essential for the assembly of the balbiani body and the 
localization of animal and vegetal transcripts in primary oocytes. The failure to 
establish the animal-vegetal axis in buc mutants also leads to the formation of 
micropyles all around the chorion (Marlow and Mullins 2008). In the Egfra mutant, 
however, all micropyles are concentrated around the animal pole, and the animal-
vegetal axis is not disturbed. In mammals, follicle formation is initially similar to 
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teleosts, but then follicle cells divide faster to form multiple follicular layers. In the 
secondary follicle (antral follicle) an asymmetric cavity forms and upon oocyte-
derived stimuli, a distinct population of follicle cells is generated, the mural and 
cumulus cells (Diaz, Wigglesworth, and Eppig 2007; Eppig 2001). It remains to be 
determined if there is any relationship between differentiation of the MP cell in 
teleosts and the formation of the granulosa cell types in the antral cavity of mammals. 
With Egfra we identified another important player in the crosstalk between follicle 
and oocytes that lead to the differentiation of specialized GCs. 
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4. Conclusion 
Fish are an ideal model to study the role of growth factor receptors since they increase 
in size throughout their lives and develop externally. The characterization of Egfr 
signaling in the CNS of Medaka embryos and hatchlings showed that both Egfrs are 
expressed overlapping. The difference between stem cell zones of the retina and the 
brain lies in the expression of different ligands. Especially Egf is strongly upregulated 
only in the SVZ of fish but not of mammals (Novak, Walker, and Kaye 2001) (Vaughn 
et al. 1991) and might form a gradient to regulate proliferation of NSCs and their 
progenitors.  
Only very few studies address Egfr-signaling in the teleost, and it is still unclear why 
fish retained two copies of the receptor  (Laisney et al. 2010). The results of the Egfra 
knockout indicate that most functions of Egfra can be rescued by Egfrb. If Egfra can 
compensate the loss of Egfrb needs to be shown by another KO line which is being 
generated at the moment. The injection of sgRNAs against Egfrb did not cause 
lethality in the injected generation supporting the hypothesis of a general redundancy 
of the receptors. If the loss of one receptor leads to the upregulation of the other can 
be demonstrated by WISH on mutant embryos.  
The specification of a single micropyle at the animal pole of oocytes seems to be the 
only function that cannot be rescued by Egfrb. We identified a connection of Egfr 
signaling with the MC by showing Ras/MAPK/Erk signaling activity in MC 
surrounding cells at several spots at the animal pole of mutant oocytes. The lack of 
one Egfra might lead to an over-compensation by Egfrb that fails to restrict the signal 
to one particular MC. Based on the literature we assume that GCs, as well as the 
oocytes, express Egfr. To confirm that, more ISH studies are necessary to differentiate 
the expression between follicular layers and oocyte. Another possibility is that Egfra 
expressed in follicular cells is required to prevent several GC from differentiating into 
an MC in response an Egfr ligand send by the oocyte. The oocyte itself could also need 
Egfrs signaling to sense the presence of the MP. The two Egfrs have a different 
binding affinity for the ligands (Gómez et al. 2004), and it is possible that the 
specification of the MC is dependent on the interaction of Egfra with a particular 
ligand that does not bind Egfrb. 
Conclusion 
 89 
So far this is the only report showing that not only the MC specifies the animal pole of 
the follicle but also MC-surrounding granulosa cells. 
It is probably the oocyte that provides the signal for differentiation of the MC since 
this process is particular to the animal pole which is specified by the oocyte (Marlow 
and Mullins 2008), it is thus the oocyte that has to initiate the formation of animal 
pole specific structures. It would also be interesting to compare the process and the 
genetics of MC formation between Medaka, as an example of single MP, and the 
multiple MPs in Sturgeons. The sturgeon micropyles look very similar concerning 
number and localization (Clark 1982)  when compared to the Egfra mutant, but 
sturgeons have a large polyploid genome that might have even more copies for the 
egfr.   
The single micropyle strategy as a block for polyspermy is so effective that no cases of 
naturally occurring polyspermy are reported in teleosts (Ginzburg 1968; Snook, 
Hosken, and Karr 2011) except for the buc Zebrafish mutant that fails to develop the 
animal-vegetal axis (Marlow and Mullins 2008). The Egfra mutant generated in this 
work provides a new and so far the only genetic model for polyspermy in teleost fish. 
Using this mutant will allow studying fertilization and zygote formation without 
disturbing animal development by denuding or injecting fragile unfertilized oocytes. 
Polyspermic embryos share some characteristic with fast dividing cancer cells as 
aneuploidy, the presence of multiple centrosomes and fast replication and division 
cycle. Therefore, the easy-to-image polyspermic embryo can also serve as a disease 
model to study centrosome and chromatin dynamics in degenerated cells.  
In contrast to Chondrichthyes (cartilaginous fish) where polyspermy occurs frequently 
and can be compensated (Ginzburg 1968; Snook, Hosken, and Karr 2011), it is 
pathogenic in teleosts and zygotes usually die. Here we report several instances in 
which Medaka zygotes can survive with supernumerary sperm. The way in which this 
is achieved resembles the mechanism in which shark zygotes dispose of excess male 
pronuclei (Rothschild 1954). The Egfra-/- mutant is, therefore, interesting to study 
from an evolutionary point of view. By fertilizing embryos with  
By creating the toolbox for the expression of Xmrk, oncogenic K-Ras, and myrAKT in 
single cells or cell types we observed that cell types react differently to the expression 
of oncogenes. Xmrk, very potent in stimulating melanomas also caused over-
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proliferation of somites but so far did not show a noticeable effect on neural cells. 
Even though many lines were tested for the ubiquitous expression and induction of 
oncogenes, it was rare to find oncogene-expressing cells in neural tissues. The shape 
and growth of the retina in teleost fish is very robust, and the growth of a tumor 
derived from an adult retina has so far not been observed. For studying the effect of 
oncogenes in the CMZ, detailed proliferation and apoptosis assays have to be 
performed. It is probable that RSCs have efficient regulatory mechanisms to avoid 
excess growth that act early to keep cells with enhanced growth signaling under 
control. One of the biggest obstacles encountered when creating the oncogene lines 
was the lack of a defined locus that allows high and ubiquitous expression of 
oncogenes as the Rosa-26 locus in mice (Zambrowicz et al. 1997). It would thus be of 
great importance to invest in the identification of this ubiquitously accessible locus in 
Medaka. This could be done by sequencing of existing ubiquitous lines and 
subsequent targeting locus by CRISPR/Cas9 approaches. Creating a genetic toolbox 
with stable expression of different oncogenes would highly improve the application of 
Medaka as a model for cancer. 
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5. Appendix 
5.1 Transparent QuiH fish are suitable for in vivo imaging 
One of the major advantages of fish model systems compared to mammalian models 
is the extra-uterine development that allows following development of embryos from 
the first cell division on. In later stages of development the appearance of 
autofluorescent pigments interferes with the imaging of deeper or highly pigmented 
tissues as the brain or the eye. A possible solution for this problem is the use of 
pigment-free fish lines. The QuiH fish line has several mutations in pigmentation-
related genes (up to seven). The line originates from a cross of the albino line Heino 
(Loosli et al. 2000) with the Quintet line mentioned in (Kuroyanagi et al. 2010). In line 
was inbred for at least 15 generations and has some important features. Figure 36 
shows bright field pictures of a QuiH larva (A) compared to a WT hatchling at ten 
dpf. QuiH fish are completely transparent and have no pigmentation and are 
therefore free of autofluorescence (A’’). These features make the line optimal for in 
vivo imaging in fluorescence microscopy.  
There is, however, a shiny layer around the eyes that becomes more pronounced with 
the age of the fish. The intensity of this layer is strongly enhanced when fish are grown 
in Hatch medium containing methylene blue and can vary between offspring of 
different females. We (together with Katharina Lust) compared hatchlings of two lines 
with retinal GFP expression for the feasibility of in vivo imaging using a two-photon 
laser in a Leica SP5 confocal microscope. These lines were:  the Fu_mitfb::GFP QuiH 
line (C) and the Tlx::GFP Cab (C') line. Cab embryos were treated with 5xPTU to 
suppress pigmentation and observed considerable differences in image quality. In Cab 
fish, the autofluorescent choroid layer hampered the imaging of a big part of the 
retina while in QuiH we could discern different retinal layers easily. 
The lack of pigmentation and therefore autofluorescence in QuiH fish is not caused 
by the absence of pigment cells as was shown by injecting a plasmid leading to 
melanocyte-specific GFP expression (Ol_mitf::GFP) as shown in transient in figure 
36D.  
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When crossing different QuiH females to Cab based WT and transgenic lines, I 
observed that every once in a while some fish in the F1 lacked pigmentation in the 
eyes and had reduced auto-fluorescence. Several crosses were set up to fathom this 
phenomenon, and three successful cases are reported so far.  
 
Figure 36: The pigment-free QuiH l ine allows in vivo  imaging undisturbed by auto-
fluorescence. A. The appearance of QuiH hatchling under a bright field microscope, lateral (A) and 
ventral (A') view and dorsal view under filtered red light to show auto-fluorescence (A''). B. The 
appearance of WT hatchling under a bright field microscope, lateral (B) and ventral (B’) view and dorsal 
view under filtered red light to show auto-fluorescence (A''). C. Comparison of the imaging conditions 
under confocal imaging of hatchling eyes expressing GFP in the retina. C. QuiH line is expressing GFP 
under the Fu_Mitfb promoter in neurons. C’. Cab expressing GFP under the tlx promoter in neural 
proliferative zones. D. Expression of GFP in pigment-free melanocytes in hatchlings injected with the 
Ol_Mitf::GFP plasmid. 
The direct generation of pigment-free fish only worked when female QuiHs were 
crossed out, it worked only with some females and also only with some lines. From 
this crosses, we were unable to devise a theory. The findings hint towards a dominant 
Qui H hatched lavea lateral view
QuiH: transient Ol_Mitf::GFP 
QuiH: Fu_Mitfb::GFP iCab: Ol_Tlx::GFP
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factor suppressing pigmentation that is present only present in some females and 
dependent on the genetic background as well as environmental factors. 
A transgenic fish line that was created by injecting a plasmid containing the promoter 
element of the microphthalmia-associated transcription factor B (mitf) of fugu and a 
GFP sequence illustrates the image-advantages of QuiH fish. Against expectations, the 
fu_mitfb element did not drive expression of GFP in the pigment cells but in most 
neurons of the fish. Figure 37A shows an embryo of the fu_mitfb::GFP QUiH line 
were all neuronal tissues (brain, retina and spinal cord) are clearly visible without 
being disturbed by pigments. We used hatchlings of the line for live imaging with the 
two-photon laser and were able to distinguish single cells in the optic tectum and the 
retina (B) and the spinal cord (C). Neuromasts (C), as well as skin innervating 
neurons and single axons in the spinal cord, are nicely visible in this line. In the retina, 
the expression pattern of GFP was analyzed in more detail. Almost all neurons express 
GFP but with varying intensity, MGCs, RPCs and RSCs do not show any expression 
indicating that in Medaka the promoter is activated only in differentiated neurons. A 
sharp border marked by GFP expressing cells can be observed between the CMZ and 
the differentiated part of the retina. 
 
Figure 37: A Fugu mitfB promoter element is activated in most neurons of the CNS in 
Medaka. A stable transgenic QuiH line with an integration of the Fu_mitfb::GFP plasmid displays GFP 
expression in most neurons of the central nervous system. A. An embryo of the Fu_mitfb::GFP QuiH 
lines showing expression in neuronal tissue without auto-fluorescence, the chorion is represented by a 
dashed line. B & C. Live imaging in a Fu_mitfb::GFP hatchling in optic tectum and retina (B) and spinal 
cord (C). D expression of GFP in the retina of the Fu_mitfb::GFP, GFP is expressed in most 
differentiated neurons of the retina but not in the CMZ. The GS staining of MGCs (magenta) shows that 
GFP is not expressed in these cells. The scale bars are 100 µm.  
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1.1.3 Endogenous Tlx translational reporter  
In the course of my PhD, I also worked on a strategy for endogenous tagging of 
factors specifically expressed in the CMZ with fluorescent proteins and transactivators 
to analyse the effect of oncogene expression in this specific cell types. One fish line 
that was generated in the course of these experiments is a Tlx-T2A-GFP fusion line. In 
this line, the endogenous Tlx (tailles) locus was tagged on its 3'end by a CRISPR/Cas9 
mediated homology-directed repair strategy demonstrated in figure 38A. For the 
induction of a DSB two sgRNA were chosen next to the Stop codon using CCTop 
(Stemmer et al. 2015). 
  
Figure 38: CRISPR/Cas9 based endogenous 3'tagging of the tlx locus by homology-
directed repair. A. Schematic representation of the plasmid containing a CR13 site for linearization, 
5' and 3'HF consisting of the sequences upstream and downstream of the stop codon and a T2A-GFP 
sequence between HFs. B. in silico assembled plasmid used for endogenous tagging. C. Alignment of 
sequencing result showing successful integration by homology-directed repair on the 5'end. 
A plasmid was cloned in which two homology flanks (HFs) 440 bp upstream (5’HF) 
and 760 bp downstream (3’HF) of the stop codon are placed left and right of a T2A-
GFP sequence lacking a start codon (figure 38B). The 3’HF contained the entire 3’ end 
untranslated region (3’UTR). The plasmid was injected with sgRNAs, and Cas9 
mRNA and one founder was selected that displayed distinct GFP expression in the 
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brain and early retina. The proper fusion of T2A-GFP with the ORF of endogenous 
Tlx was confirmed by sequencing of GFP positive offspring (figure 38C). We only 
confirmed the in frame integration on the 5’end and did not check for tandem 
integrations.  
Since we included the entire 3’UTR and the expression pattern is similar to what was 
observed in the Tlx::GFP line we are confident that multiple integrations do not 
influence the expression pattern of the endogenous gene significantly. 
By tagging of the endogenous locus, we created a translational reporter for the Tlx 
transcription factor. Figure 39 shows the expression pattern of the line in the brain 
and the retina, Tlx-T2A-GFP is expressed in the proliferative zones in the brain (A) as 
well as in the CMZ (B) in the retina. The expression observed here is consistend with 
the transcriptional reporter line published by Robert Reinhardt et al. (Reinhardt et al. 
2015). Additionally, Tlx protein is present in glial cells which was confirmed by GS 
staining (A''' and B'''). The staining reveals that GFP is localized in the cytoplasm 
rather than in the nucleus, indicating that the T2A linker is efficiently causing 
separation of the two peptides.  
 
Figure 39: Localization of GFP in an endogenously tagged Tlx-T2A-GFP translational 
reporter l ine. A. In the brain, Tlx is translated in the subventricular zone ( ventricle marked by dashed 
line) and glia cells around the telencephalon, GS (A’’’) staining overlaps with GFP staining (A''). B. In the 
retina Tlx-T2A-GFP is RSCs and progenitor cells in the CMZ (marked by dahsed outline) (B’’) and 
MGCss (B’’’). Scale bars are 100 µm. 
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6. Materials & Methods 
6.1 Materials 
6.1.1 Fish lines  
• Cab F61-F65: Inbred strain was used as wild type (wt) Medaka (Oryzias 
latipes). 
• QuiH2 F12-F15: Pigment free inbred strain, cross of Heino and Quintet 
pigment mutant lines 
• Heino F26-F27: Albino Medaka line used for ISH experiments with hatchlings 
and later developmental stages. 
• Ubi::loxPmCherryloxP_Xmrk-FL-GFP F0-F2: Lines expressing Xmrk tagged 
to eGFP after Cre-mediated recombination. Several lines were raised (see table 
1 in results) Stock numbers: F0:  
• Ubi::loxPmCherryloxP_Xmrk-T2A-GFP F0-F2: line expressing Xmrk tagged 
with GFP via T2A linker 
• Ubi::loxPmCherryloxP_GFP-K-RAS12V F0-F2: Line expressing EGFP tagged 
K-RAS after Cre-mediated excision of stop cassette 
• Ubi::loxPDsRedloxP_GFP-myrAKT F0-F2: Line expressing EGFP tagged 
myrAKT after Cre-mediated excision of stop cassette 
• Dual Tet::Xmrk/H2B-GFP_Hsp70::tTA_cmlc2::GFP) F0 (#5956)-F2 (#6365) 
• DualTetRE::H2BGFP/mCherry_ Hsp70::tTA_cmlc2)F0-F1: bidirectional heat-
shock inducible expression of H2B-GFP and mCherry  
• DualTetRE::H2BGFP/Xmrk-FL-CFP_ Hsp70::tTA_cmlc2)F0: bidirectional 
heat-shock inducible expression of H2B-GFP and Xmrk-FL- CFP  
• DualRTetRE::H2BGFP/Xmrk-T2A-CFP _ Hsp70::tTA_cmlc2)F0: 
bidirectional heat-shock inducible expression of H2B-GFP and Xmrk-T2A- 
CFP 
• DualRTetRE::H2BGFP/ GFP-K-Ras12V _ Hsp70::tTA_cmlc2 F0: bidirectional 
heat-shock inducible expression of H2B-GFP and GFP-K-Ras12V 
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• DualRTetRE::H2BGFP/ GFP-myrAKT _ Hsp70::tTA_cmlc2 F0: bidirectional 
heat-shock inducible expression of H2B-GFP and myrAKT 
• Fu_Mitf::eGFP F0-F5: fugu promoter driving GFP, expression in Neurons 
• Tlx-T2A-GFP F0- F3: endogenous Tlx locus fused 3’ to GFP via T2A 
expressing GFP in CMZ, SVZ and glia cells 
• Egfra -/- F0: injected fish for CRISPR/Cas9 based induction of DSB in Exon4 
and 7, 3 sgRNAS injected 
• Egfra 12bpDEL/WT F1: Female founders having a 12bp deletion in Exon four of one 
Egfra allele 
• Egfra GFPins/WT F1: Male founders having a GFP plasmid insertion in one Egfra 
allele  
• Egfra 12bpDEL/GFPins F1-F2: Homozygous Egfra mutants with one 12bp deletion 
and one GFP plasmid insertion allele 
• Egfra GFPins/GFPins : F1 Homozygous Egfra mutants with two GFP plasmid 
insertion alleles 
6.1.2 Plasmids 
Table 2: pGEM-T easy vectors 
Plasmid 
Primers used (JW) Stock 
number 
Cloned 
by 
pGEM-T_egfra insitu probe (770 bp) 4215/4140 4415 EH 
pGEM-T_egfrb insitu probe (650 bp) 4295/4139 4593 EH 
pGEM-T_hb-egf insitu probe (690 bp) 3652/4144 4417 CEPB/EH 
pGEM-T_stat5b_insituprobe (700 bp) 5516/5517 4710 CEPB/EH 
pGEM-T_akt1_insituprobe (700 bp) 5506/5507 4730 CEPB/EH 
pGEM-T_akt2_insituprobe (700 bp) 5504/5505 4732 CEPB/EH 
pGEM-T_stat5a_insituprobe (790 bp) 5514/5515 4740 CEPB/EH 
pGEM-T_egf_insituprobe (678 bp) 3560/4145 4741 CEPB/EH 
pGEM-T_tgfa_insituprobe (433 bp) 5508/5509 4742 CEPB/EH 
pGEM-T_K-RAS_insituprobe (500 bp) 5510/5511 4743 CEPB/EH 
pGEM-T_stat3_insituprobe (770 bp) 5518/5519 4798 CEPB/EH 
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Table 3: sgRNA oligos cloned into DR274 sgRNA expression vector 
Plasmid  Stock number Oligos (JW) Cloned by 
DR274_Tlx_stop_sgRNA_T1 4597 3525/3526 EH 
DR274_Tlx_stop_sgRNA_T4 4598 3527/3528 EH 
DR274_Egfra_Ex4_sgRNA 4599 4345/4346 EH 
DR274_Egfra_Ex4_sgRNA 4600 4347/4348 EH 
DR274_Egfrb_Ex2_sgRNA_T3 4684 4326/4328 EH 
DR274_Egfrb_Ex2_sgRNA_T6 4685 5330/5331 EH 
DR274_Egfrb_Ex5_sgRNA_T2 4686 5332/5333 EH 
 
Table 4: Entry vectors used for Golden Gate Assemblies described in this work 
Name entry vector Internal stock 
number 
Cloned 
by 
pGGEV_6_Linker 2818 KL 
pGGEV_3_loxP 2829 KL 
pGGEV_5_loxP 2832 KL 
pGGEV_7_linker 2849 KL 
pGGEV2_+(H2B-EGfpinv)+_-1_PCR 3789 LC 
pGGEV_8_-(ISCeI_3')-_+/-1_PCR 3793 LC 
pGGEV_1_-(ISCeI_5')-_+/-1_PCR 3794 LC 
pGGEV_5_-(3xpolyA)-_+1_BK 3901 MS 
pGGEV2_-(ubi_3.4kb)-_+1_PCR 4018 TTT 
pGGEV4(dsRed_3xpolyA)+_+1_BK 4019 TTT 
pGGEV6_(cmlc2 promoter)-_-1_BK 4023 EH 
pGGEV7(H2A mCherry_3xpolyA)+_+1_BK 4027 EH 
pGGEV7_-(3xpolyA)-_+1_BK 4120 TTT 
pGGEV2_(Tlx3'end tagging 5'HF (416bp))-_+1_PCR 4319 EH 
pGGEV8_(Tlx3'end tagging 3'HF (763bp))-_+1_PCR 4321 EH 
pGGEV6(old)_+(CFPwCR13_3pA)+_+1_BK 4329 EH 
pGGEV6_-(Xmrk)_+1_GG 4334 CB 
pGGEV5_(flexilinker)-_+1_OA 4353 EH/CB 
pGGEV6_(eGFPmyrAKT)+_+1_BK 4419 CB/EH 
pGGEV4_(eGFP-myrAKT)+_+1_BK 4420 CB/EH 
pGGEV6_+(CFPwCR13_3pA)+_+1_BK 4422 CB/EH 
pGGEV4_(eGFP-K-RAS12V)+_+1_BK 4424 CB/EH 
pGGEV6_(eGFP-K-RAS12V)+_+1_BK 4425 CB/EH 
pGGEV2_(Egfrb_Ex2_5'HF)-_+1_PCR 4687 EH 
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Table 5: GG Assemblies performed in course of this work. All assemblies were 
performed in pre-digested DV #3900. 
Assembly  Stock 
numbe
r 
Entry vectors used in DV 
#3900 
SC(DualTet::Xmrk/H2B-GFP) 3944 3794, 3789, 3191, 3901,2818, 
3192, 3793 and Xmrk PCR 
product 
SC(DualTet::Xmrk-fl-CFP/H2B-GFP) 4437 3794, 3789, 3791, 4317, 
4353, 4422, 4120, 3793 
SC(DualTet::Xmrk-T2A-CFP/H2B-
GFP) 
4434 3794, 3789, 3791, 4317, 
4122, 4422, 4120, 3793 
SC(DualTet::DsRed/H2B-GFP) 4433 3794, 3789, 3791, 4019, 3901, 
4023, 4028, 3793 
SC(DualTet::eGFP-myrAKT/H2B-
GFP_cmlc2:DsRed) 
4440 3794, 3789, 3791, 4420, 3901, 
4023, 4028, 3793 
SC(DualTet::eGFP-K-RAS/H2B-
GFP_cmlc2:DsRed) 
4441 3794, 3789, 3791, 4424, 3901, 
4023, 4028, 3793 
Sc(Ubiq::loxPDsRedloxPXmrk) 4335 3794, 4018, 2829, 4019, 2832, 
4334, 4120, 3793 
Sc(Ubiq::loxPDsRedloxPXmrk-fl-GFP) 4405 4335 mutated with JW4079/4080 
primers and assembled with 3885 
and 3961 
Sc(Ubiq::loxPDsRedloxPXmrk-T2A-
GFP) 
4390 4335 mutated with JW4079/4080 
primers and assembled with 3885 
and 4121 
Sc(Ubiq::loxPDsRedloxPeGFP-K-RAS) 4443 3794, 4018, 2829, 4019, 2832, 
4425, 4120, 3793 
Sc(Ubiq::loxPDsRedloxPeGFP-
myrAKT) 
4442 3794, 4018, 2829, 4019, 2832, 
4419, 4120, 3793 
CR13_tlx3’end-T2A-GFP tagging 4418 3776, 4315, 4373, 2801, 3885, 
2822, 2849, 4321 
pGGDestSC_Cr13_egfrb_ex2_5'HF_-
GFP+_3xpolyA 
4688 3776, 4687, 4681, 4044, 3190 
 
Table 6: Other plasmids 
Plasmid Stock 
number 
Cloning 
strategy 
Cloned by 
SC(Fu_Mitf::GFP) 1120 PCR/ Restriction 
digest 
Martinez 
Morales 
SC(Ol_Mitfa::eGFP) 3352 unknown Schartle Lab 
pDest_SC(hsp70::tTA_cmlc2::GFP) 4007 Gateway cloning EH 
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6.1.3 Primer and other oligonucleotides 
Table 7: Primer used for PCRs and sequencing of plasmids 
Number Name Sequence 
JW2352 Ev4overhangXmrkfor CAGGGTCTCGACTAATGGAGTTTCTGCGCGGA
GGAG 
JW2353 Ev4 overhang Xmrk rev CAGGGTCTCGGCAGCTAGCGGACAGGAGTGT
ACAGTGC 
JW2848 XmrkEv6 new OH for CAGGGTCTCGAACTCTAGCGGACAGGAGTGTA
CAGTGC 
JW3415 EGFRa in situ f GCAACCGTTTAAACCTGCTAGG 
JW3416 EGFR a in situ rev T7 CCAAGCTTCTAATACGACTCACTATAGGGAGA
GCAGTTCTTTACACAGGTGGC 
JW3417 EGFRb in situ f ATCTGTGTGTGTTTCAGTATGCC 
JW3418 EGFR b in situ r T7 CCAAGCTTCTAATACGACTCACTATAGGGAGA
CCTGCTGGCTTTTGTGGTTA 
JW3444 TlxC_5’HF f GCCGGATCCTTGTTAAAAAGTAATGTGTGTTTT
GCA 
JW3445 TlxC_5’HF_KpnI GCCGGTACCTATATCGCTCGACTTGTACATGTC
CGAGAGGAG 
JW3446 TlxC_3’HF_BamHI_f GCCGGATCCACCCTTTCCCAAACCGTCCG 
JW3447 TlxC_3’HF_KpnI_r GCCGGTACCCCAGATAATGTGACAGCTGGATT
T 
JW3448 TlxC_seq_f TTGAGGAAACAGGAGGAGAAATGT 
JW3449 TlxC_seq_r CAAGGTTGCTCAAGGAGAAAACAA 
JW3560 EGF in situ_f GAAGGGGGAGGTACGGAGAA 
JW3561 EGF_in situ_Rev_T7 CCAAGCTTCTAATACGACTCACTATAGGGAGA
ACCGAGAGAGCAGCCGT 
JW3562 hbegfa in situ_f AAGAGGAATATGACGATGAAGCCT 
JW3563 hbegfa_rev_T7 CCAAGCTTCTAATACGACTCACTATAGGGAGA
GGACAGGCCGGTCTTCTTC 
JW3848 Xmrk4H-Stop rev CAGGGTCTCGGCAGGCGGACAGGAGTGTACA
GTGC  
JW3922 MCS Xmrk II CCAAGGCCGTTTAAACTAGTTAATTAAGGCGC
GCCGC 
JW3923 MCS Xmrk II rev GGCCGGTTCCGGCAAATTTGATCAATTAATTCC
GCGCGGCGCCGG 
JW4139 egfrb in situ rev CCTGCTGGCTTTTGTGGTTA 
JW4140 egfra in situ rev CAGTTCTTTACACAGGTGGC 
JW4142 egfrb in situ rev  GCTTGCATTTTCGTCCACATTGG 
JW4143 egfrb in situ f new GGCCTCATGCGCTACGATC 
JW4144 Hbegfa in situ rev  GGACAGGCCGGTCTTCTTC 
JW4145 EGF in situ rev ACCGAGAGAGCAGCCGTg 
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JW4295 egfrb in situ fwd CGTACACTCTGGAAAACCAGG 
JW4353 egfra f 1 TGAGAGCAAACAGGCATGTGTGG 
JW4354 egfr rev 1 CCCAACACTGTCATTGTCAAACAGT 
JW4355 egfra seq f 2 TGTTACCCGAAGTCATCAACTGTT 
JW4356 egfra seq r 2 AAAGTCCATTCAGTCGGTGACA 
JW4357 egfra seq f 3 TCCTGGAGGGGTAAAAGCCATCC 
JW4479 Xmrktag_mut PCR for ggtctcatcagAGTTGCGGATCCACCATC 
JW4480 Xmrktag_mutPCR rev ggtctcttagtGCGGACAGGAGTGTACAG 
JW5335 egfrb ex2 5’HF rev kpnI GACTGGTACCATTGACCAGCGGGACGGTC 
JW5336 egfrb ex2 5’HF for BglII AGTCAGATCTCTGCTGAAGTCAGACTCTTTC 
JW5355 egfraa simp KO seq fwd AGACCTGCCACTCCCTGCTG 
JW5356 egfra simp KO seq rev GCAAGTCAGCCTCCATCAGCA 
JW5374 egfra ex4 KO seq fwd ATCTGCGCATCATCCGGGGT 
JW5375 egfrb ex4 KO rev CGACAGGCCTGCAGCACAAA 
JW5376 egfrb seq ex2 rev CAACGATGTCCCACCACTG 
JW5377 egfrb Ex5 seq fwd ACTCCTTCCCCATGAGCGCA 
JW5378 egfrb Ex5 seq AACAGCTGCGTGCCTCACAG 
JW5379 egfrb 5’HF rev wob ATTGACCAGCGGGACTGTCG 
JW5440 egfrb seq primers 5’of ex2 GCCACCCTTCCCCTTCTC 
JW5504 akt2 fwd AGACAGGGCGCGGTTTTACG 
JW5505 akt2 rev TCATTCCCGAATGCTGGCGC 
JW5506 akt1 fwd CCACGTGGAGACCCCTGAGG 
JW5507 akt1 rev GCGGCCGTAGTCGTTGTCTT 
JW5508 tgf-a fwd GTGGCTGCAGCTGTTCGGTC 
JW5509 tgf-a rev CAAAGGTTTGTGGGCCACAC 
JW5510 k-ras fwd TTGGCAAGAGCGCGCTTACC 
JW5511 k-ras  rev AGGTTGACACAGCGTGGAGTCT 
JW5514 Stat5a CAACTGGCAGGCAATGGGGG 
JW5515 Stat5a rev CGGTTGCTCTGCACCTCTGC 
JW5516 Stat5b fwd AAGTTTGCAGCCACGGTCCG 
JW5517 Stat5b rev GCTCCACCACGCCATCGAAC 
JW5518 Stat3 fwd TGGTTCAGCAGCCCATCCCA 
JW5519 Stat3 rev TGACCCTCGAATGGCAGCCA 
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6.1.4 sgRNA oligos 
Table 8: Oligonucleotides used for the generation of sgRNAs, annealed and cloned in 
DR274 plasmid. 
Number Name Sequence 
JW3525 Tlx sgRNA T1 f TAGGAAAGGGTTCATATATCGC 
JW3526 Tlx sgRNA T1 r AAACGCGATATATGAACCCTTT 
JW3527 Tlx sgRNA T4 f TAggCGCTGGACTTGTACATGT 
JW3528 Tlx sgRNA T4 r AAACACATGTACAAGTCCAGCG 
JW4343 egfra ex5 sgRNA T1 f  TAgGCCAAAGATGGAGCTCCCGA 
JW4344 egfra ex5 sgRNA T1 rev AAACTCGGGAGCTCCATCTTTGG 
JW4345 egfraa ex4 sgRNA T6 f TAgGTTAATTCTGATAAAGGAAC 
JW4346 egfr ex4 sgRNA T6 rev AAACGTTCCTTTATCAGAATTAA 
JW4347 egfra ex7 sgRNA T1 f TAggCCTTACACACCCCGTCGTCT 
JW4348 egfra ex7 sgRNA T1 r AAACAGACGACGGGGTGTGTAAGG 
JW5326 egfrb sgRNA Ex2  T3 fwd TAggCCGTCCCGCTGGTCAATCTA 
JW5328 egfrb sgRNA ex2 T3 rev AAACTAGATTGACCAGCGGGACGG 
JW5330 egfrb sgRNA Ex2 T6 for TAgGTCAATCTAAGGCTGATCCG 
JW5331 egfrb sgRNA Ex2 T6 rev AAACCGGATCAGCCTTAGATTGA 
JW5332 Egfrb sgRNA Ex5 T2 fwd  TAggCTGCTCAGCACACACTAGCT 
JW5333 egfrb sgRNA Ex5 T2 rev AAACAGCTAGTGTGTGCTGAGCAG 
 
6.1.5 Antibodies 
Primary antibodies 
Antibody directed against Specie
s 
Producer/Catalog 
number 
Dilutions 
a-Tubulin mouse Sigma Aldrich / T9026 1:200 
Phospho-p44/42 MAPK (Erk1/2) Rabbit NEB cellsignaling / 
4370 
1:200 
PhosphoH3(Ser10) rabbit Millipore/ 06-570 1:200 
y-Tubulin mouse Sigma / T6557 1:200 
anti EGFP IgY Chicken life technologies / 
A10262 
1:200 whole mounts, 
1:500 sections 
Rx2 Rabbit Lab made 
(Reinhardt et al. 2015) 
1:200 whole mounts, 
1:500 sections 
BrdU BU1/75 (ICR1) Rat AbD Serotec / 
OBT0030G  
1:750 
Glutamine Synthetase (GS) mouse  Chemicon / MAB302 1:500 sections 
Anti-Digoxigenin-AP, Fab 
fragments 
sheep Roche 1:2000 WISH, 1:1000 
section ISH 
 
Materials and Methods 
 103 
Secondary Antibodies 
Alexa Fluor® 647 anti-Rabbit 
IgG (H+L) *2 mg/mL* 
Goat Life Technologies / A21245 1:500 
Alexa Fluor 488  anti-mouse 
IgG (H+L) 2mg/ml 
Goat Life Technologies / A11029 1:500 
AlexaFluor 633 anti-rat IgG 
(H+L) 
Goat Life Technologies  1:500 
DyLight549 anti Rat IgG ML Goat Jackson 1:500 
AlexaFluor 633 phalloidin  Life Technologies 1:200 / 1:50 
Alexa Fluor 488-AffiniPure Anti-
Chicken IgY (IgG) (H+L)  
Donkey  Jackson / 703-545-155 1:500 
 
6.1.6 Chemicals, reagents and bacteria 
Chemical/Reagent Supplier 
4',6-Diamidino-2-phenylindole (DAPI) Roth 
10% Sodium dodecyl sulfate (SDS) Roth 
10xPBS (section ISH)  
20 % Sodium dodecyl sulfate (SDS) Roth 
5-Bromo-4-chloro-3-indoxylphosphate (BCIP) Roche 
6x DNA loading dye, blue Thermo Scientific 
Adenosine triphosphate (ATP) Thermo Scientific 
Agar Sigma 
Agarose Sigma 
Ampicillin Roche 
Blocking reagent Roche 
Blocking reagent  
BM purple  Sigma Aldrich 
Bovine Serum Albumin (BSA) Sigma 
Deoxyadenosine triphosphate (dATP) Thermo Scientific 
Deoxynucleotide Triphosphates Set (dNTPs) Life Technologies 
Digoxigenin-dUTP (10 mM) Roche 
Dimethyl sulfoxide (DMSO) Roth 
Dithiothreitol (DTT) Sigma 
dNTP Mix (10mM) Sigma 
Ethanol Sigma 
Ethidium Bromide (EtBr) Sigma 
Ethylene-diamine-tetra-acetic acid (EDTA) AppliChem 
Ethylenediaminetetraacetic acid (EDTA) Roth 
Ficoll  
Formamide Sigma 
Formamide Sigma 
Gelatine Sigma 
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GeneRuler DNA Ladder Mix Thermo Scientific 
Glacial acetic acid Merck 
Glutaraldehyde Solution Fluka 
Glycerol Merck 
Glycine Sigma 
Heparin Sigma 
HEPES Roth 
Hydrochlorid acid Merck 
Isopropanol Sigma 
Kanamycin Roth 
Mach1TM T1 phage resistant chemically competent E. coli Lab made 
Magnesium chloride Merck 
Magnesium sulphate heptahydrate Gru ̈ssing 
Methanol Roth 
Methylene blue Sigma 
Mowiol 4-88 Roth 
Nitro blue tetrazolium (NBT) Roche 
Normal goat Serum (NGS) Gibco 
Paraformaldehyde (PFA) Sigma 
Phenol:Chlorophorm:Isoamyl (25:24:1) Roth 
Potassium acetate Sigma 
Potassium chloride (KCl) Applichem 
Potassium dihydrogen phosphate (KH2PO4) Merck 
Proteinase K Merck 
Ribolock Thermo Scientific 
Ribonucleoside Triphosphate Set Roche 
Roti Aqua-P/C/I  Roth 
Sheep Serum Sigma 
Sodium chlorid dihydrate Sigma 
Sodium chloride (NaCl) Sigma 
Sodium citrate Merck 
Sodium hydrogen phosphate (Na2HPO4) Applichem 
Sodium hydroxide (NaOH) Merck 
Sucrose Sigma 
Torula RNA Sigma 
Tricaine mesylate Sigma 
TRIS-Hydrochloride (TRIS-HCl) Sigma 
Triton X100 Sigma 
Tryptone Sigma 
Tween20 Sigma 
Water (H2O) Sigma 
X-gal (5-Bromo-4-Chloro-3-Indolyl-β-D-Galactopyranoside) Roth 
Yeast Extract Roth 
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6.1.7 Buffers and media 
Buffer/medium Composit ion 
100x Denhardts 
solution 
5 g Ficoll, 5 g BSA 5g Polyvinylpyrrolidone in 250 ml RNAse free 
water 
10x Blocking 
reagent 
Blocking reagent powder (10%) was diluted in MAB buffer under 
heating.  
10x PBS pH 7,3  1,2 M Sodium chloride, 0,35M Sodium hydrogen phosphate, 25mM 
Potassium dihydrogen phosphate 
10x Yamamoto 171 mM Sodium Chloride, 4 mM potassium chloride, 2.7 mM calcium 
chloride dihydrate, 4.9 mM magnesium chloride hexahydrate,24 mM 
sodium hydrogen carbonate, pH 7.3 
1x Medaka hatch 
solution 
0,1 % (w/v) Sodium chloride, 0,003% (w/v) Potassium chloride,0,004% 
Sodium chloride dihydrate(w/v), 0,016% (w/v) Magnesium sulphate,  
heptahydrate,0.00002% (w/v) Methylene blue 
1xPTW 1x PBS, 0,4% tween20 
20xSSC 3 M Sodium chloride, 0,3 M Trisodium citrate dihydrate adjusted to 
pH 7 
4xSSCT 2x SSC, 0,1 % Tween20 
Annealing buffer 10mM Tris pH 7.5 - 8, 30mM NaCl 
ERM 17 mM NaCl, 0.4 mM KCl, 0.27 mM CaCl2, 0.66 mM Magnesium 
Sulphate Heptahydrate, pH7 
Fin-Clip buffer 2 M Tris pH8, 0.5 EDTA pH8, 15 M NaCl, 20% SDS 
Gelatine/Albumin 0,49 g gelatine disssolved in 100 ml 1xPBS upon heating, 30 gBSA , 
20 g Sucrose added after cooled down, store at -20°C 
Hybridization Mix 50% Formamide, 5x SS, 50 µg/ml Heparin, 0,1% Tween20, 5mg/µl 
Torula RNA 
LB 10 g/l bacto-tryptone, 5 g/l yeast extract, 10 g/l sodium chloride 
LB-plates 10 g/l bacto-tryptone, 5 g/l yeast extract, 10 g/l sodium chloride, 
18g/l Agar-Agar 
MAB 100 nN Maleinsäure, 150 mM NaCl, 2mM Levamisol, 0,1% Tween 20, 
PH adjusted to 7,5 with NaOH pellets 
NTMT 100 mM Tris pH 9,5, 50 mM MgCl2, 100 mM NaCl, 2mM levamisol 
0,1% Tween20 in RNAse free H2O 
P1 50 mM glucose, 25 mM Tris-HCl, 10mM EDTA, 100 µg/ml RNAse A, 
pH8 
P2 0.2 N NaOH, 1% SDS 
P3 5 M Potassium acetate 
TAE 242 g/l Tris-base, 5.71% glacial acetic acid, 50 mM EDTA, pH8,5 
TB Medium 12 g/l bacto-tryptone, 24 g/l yeast extract, 0.4% glycerol,2.13 g/l 
potassium hydrogen phosphatepotassium dihydrogen phosphate, 
12.54 g/l 
TE Buffer 10 mM Tris-HCl, 1mM EDTA pH 8.0 
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6.1.8 Antibiotics 
Kit Name Stock 
concentration 
Working concentration Producer 
Ampiciline 50 mg/ml 50 µg/ml  Sigma 
Kanamycine 100mg/ml  100 µg/ml Roth 
 
6.1.9 Enzymes and Buffers 
Enzyme Buffer 
BamHI HF Cutsmart NEB 
KpnI HF Cutsmart NEB 
BsaI/Eco31I FD Fast digest Thermo Scientific 
PmeI  Cutsmart NEB 
HpaI Cutsmart NEB 
SpeI HF Cutsmart NEB 
NcoI Fast digest Fast Digest Green Thermo Scientific 
EcoRI HF Cutsmart NEB 
Sac II Buffer B Thermo Scientific 
DraI HF Cutsmart NEB 
T4 Ligase Ligase Buffer Promega 
Taq Roboklon Buffer B Promega 
Proteinase K  Roche 
20 U/µl Sp6 RNA polyerase 10x Transcription Buffer Roche 
20 U/µl T7 RNA polyerase 10x Transcription Buffer Roche 
 
6.1.10 Kits 
Kit Name Company Used for 
RNeasy MinElute Cleanup Kit  Quiagen RNA cleanup used for sgRNA 
production 
innPREPPCR pure Kit  Analytic Jena PCR clean up 
innuPREPGel Extraction Kit  Analytic Jena DNA cleanup after gel electrophoresis 
Plasmid Midi Kit  Quiagen Plasmid preparation 
QIAquick PCR Purification Kit  Quiagen Cleanup of DNA fragments 
Q5 site directed 
mutagenesis 
NEB Xmrk tagging in oncogene plasmids 
pGEM®-T Easy Vector 
System  
Promega TA-cloning of in situ probes 
MEGAshortscriptTM T7 
Transcription Kit 
Applied 
Biosystems/ 
sgRNA transcription 
Gateway cloning Kit Invitrogen/Thermo Gateway assembly of  
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6.1.11 Miscellaneous material 
Material Source 
6xDNA loading dye, purple NEB 
6x DNA loading dye, blue Thermo Scientific 
Borosilicate glass capillaries GC 100T ClarcElectromedical Instruments 
GeneRuler DNA Ladder Mix Thermo Scientific 
Jung Tissue Freezing Medium Leica 
Glass bottom dishes MatTEC 
Slides and coverslips Roth 
Slides for cryosetions: Superfrost Plus Thermos Scientific 
6.1.12 Software  
Geneious R8: Planning and testing of cloning strategies In silico assembly of 
constructs. Alignments and plasmid database  
CCTop: Online tool for target and off-target prediction of sgRNAs 
http://crispr.cos.uni-heidelberg.de/ 
Fiji Image J: Image processing, quantification 
Adobe Illustrator: Graphs and Figures 
Adobe Photoshop: Image processing 
Statistics: BoxPlotR: http://shiny.chemgrid.org/boxplotr/ 
Pearson Correlation: http://www.socscistatistics.com/tests/pearson/ 
NEB TM calculator: http://tmcalculator.neb.com/#!/ 
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6.1.13 Equipment 
Equipment Source 
“Insitu Pro” robot intravis AG bioanalytical Instruments 
Axio Imager M1 microscope Zeiss 
Bacterial Shaker INNOVA 44 New Brunswick scientific 
Centrifuge 5417C Eppendorf 
Centrifuge 5430 R Eppendorf 
Centrifuge 5810 R Eppendorf 
Cryostat CM 3050S Leica 
Digital sight DS-U3 Nikon 
Embryo incubators Heraeus instruments and RuMed 
FemtoYet express or Microinjector 5242 Eppendorf 
InjectMan NI2 Eppendorf 
Leica TCS SPE Leica 
Leica TCS SP5 Leica 
Microwave Sharp 
Mini-centrifuge Starstedt 
Multipette Eppendorf 
NanoDrop 2000C Spectrophotometer  Thermo Scientific 
Needle puller P-30 Sutter Instrument Co USA 
Pipettes 10 µl & 200 µl Eppendorf 
Pipettes 20 µl, 1 mL Gilson 
Power supply Power-PAC Basic Bio RAD 
Shaker Innova44 Eppendorf 
SMZ18 stereomicroscope Nikon 
Stereomicroscope Olympus SZX7 Olympus 
Stereomicroscope Zeiss Stemi 2000 Zeiss 
Thermocycler Bio RAD 
Thermomixer 5436 UV-Gel-cutting Table 
Vibratom VT1000S Leica 
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6.2 Methods 
6.2.1 Fish maintenance and embryo collection 
All used fish used in this work were of the species Oryzias latipes. The WT strain from 
which most lines were generated is Cab. Fish were maintained under standard 
aquaculture conditions with water recirculation. The day/night cycle was 14/10 h. For 
embryo collection the fertilized eggs were carefully removed from the ventral part of 
the female using a net and a metal hook. Embryos were freed from sticky filaments by 
rolling or forceps and placed in plastic dishes containing 1xERM or 1xHatch solution. 
Embryos were incubated at either 18°C, RT of 28°C dependent on desired rate of 
development. Embryos that need to be screened were kept in 1xERM to prevent 
autofluorescence caused by methylene blue in hatch solution. 
6.2.2 Mating and microinjection 
For mating of fish males were separated from females over night and placed back to 
female tanks the next day. 15 to 25 min after spawning fertilized oocytes were 
collected from each female and placed in RT or ice cold 1x ERM. Embryos were freed 
of filaments and either placed in pre-cooled injection molds (1,5% agarose/dH2O in a 
petri dish) or fixed at desired stage. 
For injection, embryos in one cell stage were sorted in molds and orientated in a way 
that they could be injected using a fine glass needle attached to an automatic injection 
device. Glass needle were made of borsilicate glass capillaries pulled with a P-30 
needle puller. The needle was loaded with injection mix from the back using Micro-
loader tips. Approximately 10% of the visually estimated zygote volume was injected 
using a Microinjector and InjectMan N12. For details see (Porazinski, Wang, and 
Furutani-Seiki 2010). After injection embryos were taken out of the molds and placed 
in dishes with 1xERM at 28°C or RT. 
For generation of transgenic lines by random genome insertion using a meganuclease 
based approach as described in (Thermes et al. 2002) was used. Injection mix 
contained 10 ng/µl Plasmid, 1xYamamoto buffer, 1xI-SceI buffer, 1 µl I-SceI 
meganuclease in dH2O.  
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For CRISPR/Cas9 based genetic manipulation I used 150 ng/µl Cas9 mRNA, 15 
ng/µl of each sgRNA and 10 ng/µl of plasmid. 
Cre-mRNA mRNA was injected in a concentration of 10 ng/µl.  
H1-Texas red protein eluate kindly provided by the Lemke Lab was injected 
undiluted. 
6.2.3 PCR 
PCRs for amplification of genomic loci, cDNA sequences (in situ probes), and 
sequences form plasmid and genotyping of CRISPR/Cas9 manipulated lines were 
performed using Q5 polymerase with following conditions.  
Component 50 µl mix 25 µm mix 15 µm mix 
5x Q5 Reaction buffer  10 µl  5 µl 3 
10 mM dNTPs 1 µl 0,5 µl 0,3 
10 µm fwd primer 2,5/1 µl 1, 25 µl 0,4 
10 µm rev primer 2,5/1µl 1, 25 µl 0,4 
gDNA/cDNA/plasmid 2 µl/1µl/<10 ng 1µl/0,5µl/- 1 µl 
Q5 High-Fidelity DNA polymerase  0,5/0,3 µl 0,2 µl 0,05 µl 
Nuclease-free H2O Ad 50 µl Ad 25 µl Ad 15 µl 
 
We decreased the amount of Q5 polymerase recommended by the manufacturer. 
Desalted primers were ordered at MWG. PCRs were run in thermo cyclers using 
following conditions adapted to melting temperature of primers and length of 
amplified fragment.  
Step: Temperature Time 
1  98 °C 2 min 
2  98 °C 20 sec 
3  TM 20 sec 
4  72°C 30 sec/kb 
5  go to 2. 30-35 times 
6  72°C 5 min 
7  10 °C 10 min 
 
PCR fragments were purified either from the gel or directly using the innuPREP DNA 
purification kit.  
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6.2.4 Agarose gel electrophoresis DNA 
Gel electrophoresis was carried out for PCR amplificates and restriction digests. 
Usually 1% Agarose/TAE gels were used in TAE filled champers. DNA samples were 
mixed with 6x purple loading dye and loaded on gels together with a Generuler 1kb 
ladder (thermo scientific). A voltage between 120 and 140 V was applied for 30 to 50 
minutes. Gels were stained in a TAE bath containing 2 µg/µl ethidiumbromide (10-20 
min). EtBr stained DNA was detected using a UV-based gel documentation system. 
6.2.5 Agarose gel electrophoresis RNA 
For RNA gels, chambers, combs and ridges were cleaned by incubating in 0,1 M 
NaOH for 20 min. 1x TAE was diluted from the stock using Millipore water and 1%- 
1,5% agarose gels were prepared freshly. 2 µl RNA aliquots were mixed with 3 µl 
RNAse free water and 5 µl 2x RNA loading dye. RNA was denatured by heating to 80 
°C for 10 min and the gel was pre-run at 120 V for 10 min. EtBr bath was prepared 
freshly and gels were stained for 10 min. Filter tips and gloves were used at all times. 
Detection was done as for DNA gels. 
6.2.6 Gel extraction of DNA fragments 
DNA fragments as PCR products and or restriction digests that were used for 
subsequent cloning or send for sequencing were run on 1% agraose gels. PCR 
fragments were cut out from stained gels using a fresh scalpel and cleaned up with the 
innuPREP Gel Extraction Kit from Analytic Jena according to the manufacturers 
instructions. Instead of elution buffer we used pure water to elute DNA fragments 
from the column.  
6.2.7 Finclipping 
For genotyping we use finclips of juvenile and adult fish. For that fish were 
anaesthetized in 1x Tricane and placed in a plastic spoon. The tailfin was placed in a 
way that it hung over the edge of the spoon. The tip of the fin was cut of with a sharp 
scissor and placed in a 1,5 ml tube containg 100 µl finclip-buffer and 5 µl Proteinase 
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K. Finclipped fish were placed in individual numbered tanks containing 1/3 hatch 
medium and 2/3 fish water. 
6.2.8 Genomic DNA extraction 
Genomic DNA (gDNA) was extracted either from clipped fins or single or pools of 
embryos. Finclips and embryos were placed in 100µl finclip-buffer containing 5 µl 
proteinase K. Embryos were homogenized using a pestle. Emerged tissue and 
homogenized embryos were incubated at 60 °C over night. The next day 200 µl of H2O 
were added and proteinase K was deactivated by boiling for 10 min at 95°C. gDNA 
dilutions were then centrifuged for 20 min at 10.000 rpm, 4°C. 2 µl of gDNA dilution 
was used in 50 µl PCR mix. 
6.2.9 A-tailing  and TA-cloning in pGEM-T easy vector 
PCR fragments that were amplified with Q5 proofreading-polymerase were A-tailed 
for TA cloning into pGEM-T-easy vector. For that cleaned up PCR product was 
incubated with 3 U Taq polymerase (Robokon) and 2 mM dATP, 1x standard 
polymerase buffer B for 25 min at 72°C. 
Cloning into pGEM-T easy vector (Promega) was done with half the amount of vector 
as recommended by manufacturer. 3,5 µl of A-tailed PCR or Taq PCR product was 
used for a ligation with 0,5 µl pGEM-T easy vector in 2x ligation Buffer, using either 
the T4 DNA ligase provided by the kit or the common lab T4 DNA ligase (5U). the 
ligation-mix was incubated for at least 1 hour at RT. Transformation was performed 
after standard protocol in 50 µl of chemically competent DH5α cells. For blue-white 
selection ampicillin plates were coated with 50 µl X-Gal using glass beads prior to 
plating of transformed bacteria. 
6.2.10 Design and Cloning of sgRNAs 
Target sites for sgRNAs were identified using the CCTop online tool (Stemmer et al. 
2015). Sequences of first exons of egfra and egfrb were entered and sequences with 
least off-targets were selected as target. For tagging of the tlx locus I selected the 
region 20 bp upstream and downstream of the stop codon and selected target 
sequence with least off-targets.  
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Oligo Annealing 
Two complement DNA oligonucleotides were ordered at MWG, oligos were diluted 
to 100 µM. 1 µl of each oligo was mixed with 18 µl H2O and 20 µl annealing buffer and 
incubated in thermal cycler: 5 min at 95°C, ramped down (0,1°C/s) to 70 °C, hold for 
10 min and ramped down to 65 °C (0,1°C/s) hold for 10 min, ramped down (0.1°C/s) 
to 60°C, hold for 10 min, ramped down (0.1°C/s) to 10°C. The oligo-solution was 
diluted 1:3 and ligated with 0,025 pmol BsaI predigested sgRNA vector (DR273; 
addgene #42250).  
sgRNA plasmid generation 
Bacterial transformation was performed after standard protocol and plated on 
ampicillin-plates. Up to five colonies were prepared for test-digest with BsaI. Non-
digested plasmids were confirmed for oligo-insertion by sequencing and Midipreps 
were performed to amplify correct sgRNA containing plasmids. 
6.2.11 Generation of plasmids 
Constructs listed in 6.1.2 were assembled as described in chapter 6.2.12 (GG 
assembly). Plasmids with internal stock numbers 4405 and 4390 (see table 5) were 
cloned via Q5 site directed mutagenesis PCR (NEB Kit) from plasmid 4335 with 
primers JW4079 and JW4080 (Table 5). The mutagenesis PCR removed the Xmrk 
Stop-codon and inserted an Eco31I restriction site that upon digest will generate EV4 
and EV5 overhangs. The mutated plasmids was thus used in a GG Assembly together 
with plasmids #4121 and 3885 for generation of plasmid 4390 and vectors 3961 and 
3885 for plasmid #4405. 
6.2.12 Cloning of entry vectors 
Inserts for entry vectors were either sub-cloned from other entry vectors or amplified 
from the genome (homology flanks, HF) or other plasmids (Xmrk, HRAS, myrAKT) 
via PCR. Most entry vectors were cloned into the BamHI/KpnI digested site of Entry 
vectors, PCR products were amplified using BamHI/BglII and KpnI restriction site 
containing primers. Some inserts were cloned into other restriction sites in multiple 
cloning site (MCS) containing entry vectors. Entry vectors 4419 and 4420 were cloned 
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via BamHi/KpnI release of insert from vector 4414 and ligated in EVs 4 and 6 (3240 
and 4274) at same restriction sites. Entry vector 
6.2.13 GG-Assemblies of oncogene constructs  
Assembly of oncogene containing plasmids (except entry vectors) was based on 
(Kirchmaier, Lust, and Wittbrodt 2013). 20 fmol of each entry vector (1-8) and 50 ng 
BsaI pre-digested destination vector were mixed with 1 µl FD Buffer, 1 µl T4 Ligation 
buffer, 1µl 10 mM ATP, 0.6 µl Eco31I FD enzyme and 0,6 µl 30U/µl T4 ligase. The 
volume was added up with dH20 to 20 µl. The reactions were incubated in the thermo 
cycler for 10 repeats of 30 min at 37°C (digest) and 20 min at 15 °C (ligation). 
Enzymes were inactivated by 10 min incubation an 85°C and then cooled down to 10 
°C. Since in most assemblies there was at least one insert with internal BsaI restriction 
sites another 30-60 min ligation step was performed adding 1 µl of ligase and 1 µl 
10mM dATP and incubating at RT. 3-5 µl of the assembly were transformed in 50 µl 
bacteria after standard transformation protocol and bacteria were plated on Kan-LB-
plates previously treated with X-Gal. In case of plasmid 3944 (DualTet::Xmrk/H2B-
GFP) Xmrk was amplified by PCR using primers JW2352 and JW2353, that generated 
EV4 overhangs upon digestion,  cleaned up after gel electrophoresis and used directly 
in the assembly with other EVs and DV as indicated in table 5 (chapter 6.1.2.). NOTE: 
GG assembly of Xmrk did not work when internal Eco21I sites were mutated; the 
cloning of Xmrk is extremely facilitated when cloned in a multi-factor ligation. 
Whenever an insert did not fill a space in the assembly we used EVs containing 
linkers. When the assembly was shorter we used STOP EVs that upon Eco31I digest 
have DV compatible overhangs. 
6.2.14 Standard transformation procedure 
Ligations were transformed in chemically competent DH5α bacterial cells (prepared 
by the lab). For that 3 to 5 µl of ligation were incubated for 15-45 min with 50 µl 
competent cells that were thawed on ice in a 1,5 ml tube. A 42 °C 45s heat shock was 
then applied and cells were stored on ice for 2-3 min. Cells were then provided with 
250 µl TB and incubated for 1 hour at 37°C in the shacking incubator (200 rpm). 
Using glass beads bacteria were then plated on agar plates with desired antibiotic 
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(ampicillin for standard ligations and pGEM-T easy TA cloning and kanamycin for 
golden gate assemblies). We usually plated 100 µl of transformed cells. Plates with 
transformed bacteria were incubated over night at 37°C. 
6.2.15 Bacterial cultures and plasmid preparation 
Mini prep 
For small-scale plasmid preparations (Mini prep) 2-5 ml LB medium containing the 
respective antibiotic were inoculated with a single colony (white colonies when blue-
white selection was applied) from the overnight plate using an autoclaved toothpick. 2 
ml cultures were grown for 4-5 h at 37°C and 200 rpm, 5 ml cultures were grown o/n. 
2 ml of cultures were transferred in 2 ml tubes and spun down for 1 min at 14000 
rpm. Supernatant was discarded and the pellet resuspended in 250 μl P1 (10°C). Lysis 
was done by adding 250 μl P2 at room temperature and mixing by inverting the tube. 
Immediately afterwards, 250 μl P3 were added for neutralization. The tube was mixed 
by inverting and the mix then centrifuged for 10 min at 14000 rpm at 10°C. The 
supernatant was transferred to a fresh 1,5 ml tube and plasmid DNA was precipitated 
by adding 500 μl isopropanol and shacking. Precipitated plasmid were pelleted by 
centrifugation (15 min, 4°C and 14000 rpm). The supernatant was discarded and the 
pellet washed with 500 μl 70% ethanol. After centrifugation (5 min at 14000 rpm) 
ethanol was removed and the pellet dried at 60°C. Subsequently the DNA-pellet was 
resuspended in 30 μl H2O. Plasmids were then tested for proper ligation by restriction 
digest and successful cloning was confirmed by sequencing. 
Midi prep 
For large-scale clean plasmid preparation of cloned constructs 80-100 ml LB medium 
containing either amp or kan were inoculated by adding a drop of positively identified 
mini-culture. Midi-cultures were grown o/n in 37°C shacking incubator and filled in 
50 ml the next day. Cells were pelleted by centrifugation (4000 rpm, 1h at 4°C). 
Plasmid purification was performed with the QIAGEN Plasmid Midi Kit widely 
according to the manufacturers instructions. Following changes have been made to the 
protocol due to equipment limitation. After P3 buffer was added the solution was filtered 
using QBT equilibrated filter paper that was installed in a funnel on the column directly. 
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Following centrifugation steps (pelleting plasmid DNA and washing pellet) were 
performed at 4000 rpm for 45 min each at 4°C. After pellet was dried the plasmid DNA 
was resuspended in 80 µl TE and DNA concentration was measured using the NanoDrop. 
DNA was diluted to a concentration of 1 µg/µl with TE whenever possible and stored at -
20 °C.  
6.2.16 Restriction digest 
Restriction digests were performed to test for linearization of plasmids, excise DNA 
fragments from plasmids for subsequent cloning and to check for successful ligations 
of inserts in plasmids.  
Screening for positive ligation 
Whenever possible restriction digests were set up with either FastDigest enzymes 
(Thermo Scientific) or High Fildelity (HF, NEB) enzymes. For digestion of 5 µl mini-
prep 0,1 µl enzyme and 1 µl FD or CutSmart buffer were used in 10 µl volume. The 
digest was incubated at 37°C for 20 min up to several hours. 
6.2.17 Linearizing plasmids for mRNA  
For in situ probe generation we digested 10 µg of clean plasmid with 1-2 µl of 
restriction enzyme in 50 µl volume o/n at 37 °C. Following enzymes and buffers were 
used: 
Template Enzyme Enzyme 
volume  
Buffer Promoter 
for 
transcription 
ISH probe pGEMT easy SpeI HF (NEB) 1 CutSmart  T7 
ISH probe pGEMT easy NcoI (NEB) 1 CutSmart SP6 
ISH probe pGEMT easy SacII (Thermo 2 Buffer B (thermo) Sp6 
 
An aliquot of linearized plasmids were then run on gel, cleaned with the InnuPREP 
Kit (Analytic Jena) and used for mRNA transcription.  
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6.2.18 In Situ RNA probe transcription 
10 µg of digested plasmid were cleaned up with InnuprepPCRpure Kit or the 
QIAquick PCR Purification Kit according to the instructions. Elution was carried out 
with 22 μl RNase free H2O. The concentration of purified plasmid was determined 
and 1 μg used for in vitro transcription. Following transcription mix was pipetted on 
ice, using filter tips:  
Component  Volume  Final concentation 
Linearized Plasmid 1 µg 50 ng/µl 
100 mM DTT 2 µl 10 mM 
NTP-Mix 1,3 µl 0,77 mM ATP, CTP, GTP 0,5 mM UTP 
10 mM Dig-UTP 0,3 µl 0,35 mM 
RiboLock (40 U/µl) 0,5 µl 1 U/µl 
10x Transcription Buffer 2 µl 1x 
RNase free H2O Ad 18 µl - 
RNA-Polymerase (SP6/T7) 2µl 2/U µl 
 
Polymerase was added last, after the rest of the transcription mix was mixed gently. Sp6 
polymerase was used for NcoI and SacII digested template vectors and T7 polymerase was 
used for transcription from SpeI digested plasmids. The reaction mix was incubated fir 3 
h at 37°C and then placed on ice. 1 µl TurboDNas (2U/µl) was added and the mix was 
incubated again at 37°C for 15 minutes. mRNA was then immediately purified using the 
RNeasy MiniElute Cleanup Kit according to the instructions. RNA was eluted by applying 
25 µl H2O two times. A 2 µl aliquot was used on a RNA gel to test mRNA quality and 
relative quantity. 150 µm of Hybridization-Mix was added to the rest of the mRNA ISH-
probe which was then stored at -80°C. 
6.2.19 SgRNA production 
Transcription 
For production of sgRNAs 12 µg of sgRNA sequence containing DR274 plasmids 
were digested with 2µl FD-DraI (Thermo Scientific) in 50 µl o/n at 37°C. The digest of 
was run on a freshly prepared RNAse free agarose gel and the 300 bp band was cut out 
and purified using the InnuPrep gel purification Kit or the MinElute Kit from 
Quiagen. 15 µl of H2O were used for elution and concentration has been measured. 
300 ng of DNA were then used for the transcription reaction when possible otherwise 
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the maximum amount that could be obtained in 6,5 µl. Transcriptions of sgRNAs was 
done with the MEGAshortscriptTM T7 Transcription Kit from Life Technologies 
according to the manufacturers instructions. After minimum 3 h of incubation at 
37°C the, 1 µl of TurboDNase was added to the transcription reaction and incubated 
for another 15 min at 37°C. The reaction was placed on ice and the clean up was 
started immediately. 
Chloroform extraction and alcohol precipitation 
The 20 µl of Megashort-sample were mixed thoroughly with 250 µl of H2O and 
Ammonium Acetate Stop (provided with the MEGAshortscriptTM T7 Transcription 
Kit) to stop DNAse digest.  
Under the fumehood 300 µl of Roti Aqua-P/C/I (Phenol-Chloroform-Isoamylalkohol 
25:24:1, pH 4,5-5) was added, mixed thoroughly and incubated for 5 min at RT. 
Phases were separated by centrifugation (13.000 rpm at 4°C for 5 min). The upper 
aqueous phase was transferred to a new tube and same volume of chloroform was 
added. After thorough mixing and 5 min incubation at RT the mix was centrifuged 
again at 13.000 rpm and 4°C for 5 min. After centrifugation the upper aqueous phase 
was transferred to a new tube, 2 vol 100 % EtOH was added and well mixed. For 
optimal precipitation EtOH RNA mix was incubated at -20 °C for one hour and then 
centrifuged at 14.000 rpm for 8 min. Supernatant was removed carefully and 500 µl of 
ice-cold 75% EtOh were added to wash DNA pellet by another 8 min centrifugation at 
14.000 rpm and 4°C. The wash step was repeated one time after which the supernatant 
was removed and the pellet dried for maximum 5 minutes. The pellets were typically 
diluted in 50 µl of RNAse free H2O. The RNA concentration was measured and the 
sgRNA was diluted to 150 ng/µl. The working concentration for all sgRNAs used was 
15 ng/µl. The quality of produced sgRNAs (ca. 200 bs) was confirmed by gel-
electrophoresis. 
6.2.20 Induction of recombination by heat shock 
Embryos younger than stage 36 were heat shocked by 1h incubation at 39°C (heating 
block in tubes) after which they were transferred back to 28°C. Older Embryos and 
hatchlings were heat shocked by replacing the RT ERM to 42°C warm ERM and 
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incubating the dish for 2 hours at 37°C. Afterwards hatchlings were kept at RT on the 
bench until screened the next day. 
6.2.21 Induction of recombination by tamoxifen 
Hatched embryos of the oncogenes lines crossed to Cre-ERT2 lines were treated with 
tamoxifen in order to induce recombination. For that hatchlings were placed in six-
well plates and fed with arthemia prior to o/n treatment. Tamoxifen was diluted to a 
concentration of 5 µM in ERM and hatchlings were incubated o/n in the dark. 
Hatchlings were washed several times the next day and screened for recombination in 
muscle cells and/or retina. Positive fish were fixed after 2-3 days or placed in the fish 
room for ArCoS assays. 
6.2.22 Cryo-sectioning 
For sectioning of hatchlings, adult fish and organs (ovaries, brain) fixed tissue was 
dehydrated by incubating in 30 % Sucrose at least o/n on 4°C. 30 % Sucrose was then 
replaced by a 1:1 mix of 30% sucrose and tissue freezing medium and tissues/fish were 
incubated for several days (minimum 3). Prior to sectioning, fish or tissues were 
placed in cryomolds, covered with tissue freeze medium, oriented and deep-frozen in 
liquid nitrogen. When the block was frozen thoroughly it was either placed in the 
cryostat directly or stored at -80°C. After mounting and orientating the frozen block, 
sections were cut 16-25 µm thick and collected on specifically coated clean glass slides. 
Sections were then dried either at RT for at least 4 h or o/n up to three days at 4°C. 
6.2.23 Immuno-stainings of cryosections 
For staining of sections from 16 to 25 µm the slides were placed in tight plastic 
containers. Dry sections were rehydrated for 20 min with 1xPTW and blocked for 2 h 
with 10% NGS/PTW. After rinsing 2x with PTW the 1.AB in 1%NGS/PTW was 
applied and slides were covered with parafilm, incubation was o/n at 4°C. The next 
day the slides were washed 3x 10 min with PTW and the 2.AB in 1%NGS/PTW with 
1:1000 diluted DAPI was applied and slides were covered with parafilm. The 2.AB was 
incubated for 2h at 37°C and then washed off 3x 10 min. After washing slides were 
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dried using a tissue. 60 µl of 60% glycerol was pipetted on stained section and a cover 
slip was put and sealed with nail polish. 
6.2.24 BrdU staining of tissue-cryoscetions 
For BrdU stained sections a special treatment was applied on sections previously 
stained with other antibodies as described in 6.2.23. After 2.AB incubation and wash 
steps the sections were fixed in 4%PFA for 30 min at RT and washed again 3x10 min 
with 1xPTW. Sections were then treated for 60 min at 37°C with 2N HCl 0,5%/ 
TritonX in PTW for antigen retrieval and washed again 3x 10min with PTW. The pH 
was recovered by applying a 2:3 dilution of saturated Borax in PTW for 15 min. Slides 
were washed again, blocked for 2 h with 10% NGS /PTW, rinsed with PTW and 
incubated o/n at 4°C with 1.AB (1:750 a-BrdU (rat) in 1% NGS/PTW). After six 10 
min washes with PTW the 2. AB was applied 1:750 in 1%NGS/PTW for 2 h at 37°C. 
After final washing steps (3x10 min with PTW) the slides were mounted as described 
in 6.2.23. 
6.2.25 Whole mount immunostainings (no heating) 
The whole mount staining was used to stain young embryos and hatchlings as well as 
adult ovaries and brains. Fixed embryos were washed in PTW at least 3x 5min and 
dechorionated using two forceps. PTW was then removed and replaced by pre-chilled 
acetone (-20°C). Samples were incubated for 20 min at -20°C. Acetone was removed 
and samples washed 3x 5 min with PTW. Samples were blocked for 2-3 h with 
blocking buffer (10% SS or NGS, 1% BSA and 0,8% TritonX100 in PTW). 1. ABs were 
diluted 1:200 in (1% SS/NGS, 0,8% TritonX100, 1%BSA)/PTW and samples were 
incubated with 1.AB for two days on turning wheel at 4°C. Samples where then 
washed 2x 30 min with PBS-TS (1% TritonX100, 1% SS/NGS in 1x PBS) and then 1h 
with PBST (1%TritonX100 in PBS). After washing secondary AB was diluted in the 
same way together with 1:500 DAPI and samples were incubated again for 2 days at 
4°C in the dark on a turning wheel. Washing steps after 2.AB were the same as for the 
first AB. Samples were then mounted for imaging in methyl-cellulose or 1% low 
melting agarose/dH2O. 
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6.2.26 Whole mount immuo-staining (heating method) 
The whole mount immuno-stainings with the heating method were performed for 
embryos and hatchlings and organs when the phospho-pErk1/2 antibody was used. 
The staining protocol was similar as in 6.2.25 except for the heating step before 
acetone treatment. Samples were placed in 100 mM Tris-HCl (pH 8.0) for 15 min at 
70°C (in 1,5 ml tubes on heat block). Samples were then allowed to cool down and 
washed with PTW 3x 5 min before proceeding to Acetone treatment. 
6.2.27 DAPI staining of fertilized oocytes 
The staining of fertilized oocytes, which were fixed 2 min to 40 mpf, was performed 
after fixing for several days with 4%PFA. The oocytes were first dechorionated and 
then stained o/n in 1:500 DAPI/PTW.  
6.2.28 Fixation, dissection and staining of adult retinae 
Adult fish were sacrificed by 20x tricane treatment and fixed in 4%PFA/2XPTW for at 
least one week. Fish were washed for several hours with PTW replacing it at least five 
times. Heads of fish were cut using a scalpel and bleached in 3%H2O2, 0,5% KOH in 
H2O in six-well plates shacking. After 1-2 hours fish-heads were washed with PTW 
and retinae were dissected carefully using two sharp forceps, the lens was removed. 
Retinae were bleached again in described ways until all pigmentation disapeared. The 
retinae were rinsed in PTW two times and incubated in pre-cooled acetone at -20°C 
for 15 min. Retinae were again rinsed with PTW, then washed 2x 5 min in PTW on 
the shaker and blocked in 1 ml blocking buffer (4% SS, 1% BSA, 1% DMSO in 
1xPTW) o/n rotating at 4°C. A 1:200 dilution of the 1. AB in blocking buffer was 
prepared the next day and retinae were incubated for at least two o/n at 4°C on a 
rotor. After 1.AB incubation retinae were washed in 10 cm petri dishes on shaker at 
least 5 times for 30 min. The 2.AB was diluted 1:200 in blocking buffer together with 
1:500 DAPI and retinae were incubated in it o/n rotating at 4°C in the dark. 
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6.2.29 Fixation, dissection of adult ovaries 
For dissection of ovaries and other organs from WT and Egfra mutants, fish were 
treated with 20x tricane. When fish were dead the tail was removed with a razor blade 
and the belly was opened with a forceps to extract ovaries and other organs. Ovaries 
and other organs were then fixed separately in 4%PFA/PTW for several days or frozen 
in liquid nitrogen for protein and mRNA extraction. 
Adult ovaries were stained as described in chapter 6.2.25 and 6.2.26 for 
phosphorylated-pErk1/2 and a-tubulin. 
6.2.30 Preparation of hatchlings for in vivo imaging 
Hatchlings were anaesthetized in 1x tricane and mounted in 1% low melting agarose 
(LMA) in ERM in a glass bottom dish (MaTEC-dish). For that hatchlings were 
transferred to the agarose tube and from there pipetted onto the glass bottom of the 
dish with 160 µl of LMA. Fish were oriented for imaging and agarose was allowed to 
solidify before overlaying the agarose with 1xtricane/ERM. In vivo imaging was 
mostly carried out under the Leica TCS SPE and in some cases (fu_Mitf::GFP line) 
under the Leica TCS SP5 using the two-photon setup. 
Embryos injected with H1-texasred were mounted the same way (but no tricane) and 
embryos were imaged under the Leica TCS SPE for several hours. 
6.2.31 Preparation of fixed tissue for imaging 
Fixed tissue or whole mount embryos were mounted with 3% methyl-cellulose in 
MaTeC glass bottom dishes in order to be able to reorient the specimen faster.  
6.2.32 Screening and imaging 
General screening for phenotypes of FP expression was performed using the Nikon 
AZ100 Multizoom macrofluorescence binocular. Hatched fish were anaesthetized in 
1xTricane/ERM before screening. 
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6.2.33 Whole mount in situ hybridization (WISH) 
Embryo preparation 
Embryos for ISH were collected for stage 18 and 24 from Cab and for later stages and 
hatchlings from Heinos. Embryos were grown until desired stage and fixed with 4% 
PFA for several days at 4°C. Hatchlings were grown until hatch, euthanized with 20x 
tricane and fixed in 4% PFA at least o/n. 
After fixation all embryos and hatchlings were washed at least 5 times for 5 min with 
PTW and embryos were dechorionized using two forceps. Embryos were then stored 
in 100% MeOH at -20 °C for at least one week.  
Proteinase digestion and postfixation 
All steps were performed in a 6 well culture dish with a standard volume of 5 ml.  
Embryos were rehydrated by incubation in a serial section of 75, 50 and 25 
MeOH/PTW for five minutes each on a shaker. Embryos were then rinsed two times 
five minutes in PTW (on shaker) and digested with 1 µg/ml proteinase K dependent 
on the developmental stage of the embryo:  
Embryonic 
stage 
Time of proteinase 
digest 
18 5 min 
24 7 min 
32 45 min 
Hatchling 2 hours 
 
After proteinase K digest embryos were rinsed two times shortly with freshly prepared 
2 mg/ml glycine/PTW after which they were fixed in 4% PFA/PTW for 20 min. 
Fixation was followed by five times washing for five min with PTW. 
Hybridization 
Hybridization mix was defrosted and warmed up to RT. Embryos were transferred to 
2 ml tubes and 1 ml of RT warm Hyb-mix was added. After embryos sank to the 
bottom of the tube it was placed in a 65°C water bath for pre-hybridization (2 hours). 
RNA ISH probes were natured in 200 µl Hyb mix by heating for 10 min to 80°C. We 
used between 2-5 µl probe per 100 µl Hyb-Mix. When probe was denatured, Hyb-mix 
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was taken off the embryos and probe-mix was applied. Embryos were incubated for 
hyrbridization o/n at 65°C. 
Washes 
The next day washing solutions were all pre heated to 65°C and wash steps were 
performed at the same temperature. Embryos were washed two times for 30 min with 
2 ml 50%Formamide/4xSSCT, then two times for 15 min with 2 ml 2xSSCT and 
finally two times 30 min with 2ml 0,2xSSCT. After the last wash step embryos were 
brought back to RT. 
Detection  
Embryos were blocked for 1-2 h with 5% SS/PTW at RT on a turning wheel. Embryos 
were then incubated with anti-Dig-AP Fab Fragments (1:2000) in 400 µl PTW/5%SS 
o/n at 4°C on a turning wheel.  
The next day staining buffer (SB) was prepared freshly. Embryos were transferred to 
6-well plates and washed 6x for 10 min while shaking in PTW at RT. Embryos were 
equilibrated in SB 2x for 5 minutes while shaking. 4,5 µl NBT (finale concentration: 
337,5 µg/ml) and 3,5 µl BCIP (final 175 µg/ml) per 1 ml SB were dissolved and applied 
to embryos in 12-well plates. Embryos were stained up to 24 hrs and then washed 3x 
5min in PTW and destained using a serial dilution series of EtOH (50, 75, 100 % 
EtOH) and incubating for 1 hour shacking. Embryos were then rehydrated and fixed 
for 20 min in 4%PFA/PTW.  For imaging of embryos they were then stored in 87% 
glycerol for several day before they were mounted and imaged with the Zeiss 
microscope.  
For preparation of vibratome sections from hatchlings and embryos they were stored 
in PTW after fixation until they were mounted in gelatin. 
6.2.34 WHISH of Medaka embryos using the in situ robot 
For developmental stage 24, 28 and 32 WISH where performed with the in situ robot. 
Rehydration, Proteinase K treatment and post fixation where done as described in 
previous chapter. Per stage and probe a minimum of five embryos were transferred 
from 1xPTW in small nets that where then mounted in the device. The bufferes A, B, 
C, D, E, F, G, L and M were prepared in assigned tubes and placed in the machine. 
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The machine can hold up to 30 samples and all volumes given in the table are based 
on the maximum number of samples. 
 
Buffer Component Volume 
A 1xPTW 
20% Tween 20 
150 ml 
750 µl 
B Hybridization mix 15 ml 
C 4xSSCT 
100% Formamide 
15 ml 
15 ml 
D 2x SSCT 30 ml 
E 0,2xSSCT 30 ml 
F TRIS-HCL pH 7,5 
NaCl 
20%Tween20 
water 
2,5 ml 
500 µl 
125 µl 
ad 25 ml 
L 2x Malate-Buffer pH 7,5 
10%Blocking Reagent  
20% Tween20 
Water 
10 ml 
4 ml 
100 µl 
ad 20 ml 
M Blocking Buffer L 
Anti-Dig AB Fab-Fragment  
9 ml 
4,5 µl 
 
The Blocking solution L was allowed to settle and only the supernatant was used to 
not block the robots pump device. 
All probes were repared in 0,5 ml tubes by diluting them 1/50 to 1/20 in hybridization 
mix. The probes were denatured by heating for 10 minutes at 80 °C and placed in the 
machine according to pre-determined order. When everything but buffer G (staining 
buffer, as previously described) was placed in the machine the machines program was 
started. The next day buffer G was freshly prepared (see protocol staining buffer in 
WISH protocol) and placed in the robot. The robot then finished the protocol and 
samples were removed from the nets and placed in 24-wellplates to start the staining 
procedure. Staining was performed as described before for 3-5 h in the dark. Embryos 
were then washed, destained with EtOH and post-fixed in 4%PFA. Embryos were 
placed in 87% glycerol for imaging of kept in PTW at 4°C for vibratome sectioning. 
Sections and whole embryos were imaged using an Axio Imager ZEISS upright 
microscope with DIC filters. 
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6.2.35 Vibratome sectioning of WISH embryos and mounting 
For vibratome sectioning of hatchlings and stage 32 embryos, 3 cm wide plastic dishes 
were filled with 2,5 ml gelatin/albumnin and 1-3 embryos were oriented in the gelatin. 
For polymerization 200 µl of glutaraldehyde solution was added and mixed by 
pipetting with blue tips.  Embryos were re-oriented quickly before polymerization was 
completed. A small gelatin block, around the embryo to be sectioned, was cut out 
using a scalpel and glued on a metal block that was mounted in the vibratome. The 
gelatin was then submerged in a water-bath and cut in 25 µm thick sections. Single 
sections were collected using two fine brushes and placed in 64 well plates filled with 
water. The single sections were then moved to a glass slide and water was removed as 
good as possible. 60 µl moviol was used to mount the sections under a cover slip. 
6.2.36 In situ hybridizationon paraffin sections 
For the detection of mRNA of egfrs and ligand in ovaries together with Narges 
Aghaallaei we performed ISH on paraffin sections of adult WT IdU treated fish 
(kindly provided by Narges Aghaallaei). Slides with paraffin sections were kept at 4°C 
and dried in the incubator at 37°C for 20 minutes after being placed in an RNAse free 
Coblin jar. Sections were dewaxed by 15 min incubation in Xylol and washed 
afterwards with 100% EtOH for 5 min. Sections were then rehydrated by incubating 
for 2 min each in 95%, 90%, 70% and 30 % EtOH. After washing 5 min with PBS 
sections were fixed in 4% PFA/PBS for 20 min and washed again 2x for 5 min with 
PBS. Sectioned tissue was then digested with 10 µg/ml Proteinase K/0,1M Tris pH7,5 
for 10 min at 37°C. The digest was stopped by incubating slides for 10 min in 0,2% 
Glycine/PBS (freshly prepared). After a 2x 5 min wash with PBS sections were washed 
with 0,2 N HCl for 15 min and again 2x 5 min with PBS. Then sections were 
incubated in 0,1 M Triethanolamin pH 8,0/0,25% Acetic-anhydride (freshly prepared) 
under strong stirring. This step was followed by a 5 min wash in PBS and 5 min wash 
in H2O.  
Pre-hybridization was performed after an 5 min incubation in RNAse free water 
(MilliQ). 150 ml of Pre-hybridization buffer were prepared as following. 
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Pre-hybridization 
Buffer 
Component  
 
Volume for 150 
ml 
100 % Formamide 75 ml 
20 SSC pH7,5 37,5 ml 
100x Denhardt’s solution 1,5 ml 
20x Tween20 0,75 ml 
H2O 35, 25 ml 
 
Slides were incubated in pre-hybridization buffer for 2 hours at 70°C.  
5 µl of each probe placed in one PCR (100 µl) tube and heated up to 70°C for 10 min. 
In parallel 1:200 tRNA was heated up to 70°C and 5 µl were added to 1 ml pre-
hybridization buffer to make the hybridization buffer. 60 µl of hybridization buffer 
was added to each probe and incubated for another couple of minutes at 70°C. Probe 
was then applied to the sections and a cover slip was placed atop. The hybridizing 
slides were then placed in an air-proof humid container at 65°C o/n.  
The next day following solutions were prepared: 
Solutio
n 
Component Volume for 200 
ml 
1 Formamide 
20xSSC pH 4,5 
20% SDS 
Water 
100 ml 
50 ml 
10 ml 
30 ml 
2 Formamide 
20xSSC pH 4,5 
20% SDS 
Water 
100 ml 
20 ml 
4 ml 
76 ml 
 
Solution 1 and 2 were warmed up to 65°C before cover slides were removed from 
hybridized section. Slides were then placed in a Coblin jar containing pre-warmed 
solution 1 in which they were incubated 3x 30 min at 65°C. Solution 1 was then 
replaced with solution 2 and incubated 2x 30 min at 60°C. Slides were then washed 3x 
5 min in MAB at RT and blocked for 3 h in MAB/1%Blocking Reagent. The slides 
where then covered with 100 µl AB-solution (1:4000 anti-Dig fab Fragment AB in 
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MAB/1%Blocking Reagent) and a cover slip and incubated o/n at 4°C in a humid 
chamber. 
The next day cover slips were removed and slides were rinsed with MAB. Then slides 
were washed 3x 10 min and 3x 30 min with MAB and 3x 10 min with NTNT. Sections 
were then stained with BM Purple/2mM Levamisol in plastic containers by placing 
the sections upside down on the staining solution. Sections were then stained in the 
dark for three days at 4°C. The plastic container was kept from drying by closing 
container with parafilm. Since no obvious staining could be detected after three days 
the AB incubation was repeated. Sections where thus washed in water, blocked again, 
then and incubated o/n with 1:1000 anti-Dig fab fragments AB. From then on all steps 
were repeated as described before. After staining the straining solution was washed 
with pure water and sections were left to dry a bit and mounted with moviol.  
6.2.37 IR-lego 
For the local induction of heat-responsive elements in vivo we used an laser-evoked 
gene operator system as published in (Deguchi et al. 2009; Kamei et al. 2009). 
HSindX_H2B-GFP embryos were kept in heat-stable conditions until hatch and then 
anesthetized and mounted with methylcellulose (to prevent heat shock by warmed up 
agaraose) in glass bottom dishes. The dishes were mounted onto an inverse spinning 
disc microscope coupled to an infrared (IR) later (1480nm). Fish were mounted in a 
way that regions of interest were closest to the objective to reduce energy loss (figure 
16A). The target region was then selected using the bright field channel and applied 
laser pulses with an energy of 60-100 mw for 1 to 3 seconds until we could see 
twitching of cells. The region of IR-Lego activity was determined before by testing the 
bleaching of Flourescin by laser exposure. This experiment was conducted with the 
help of Jan-Felix Evers and Franz Kuchling. 
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III. Contributions 
Clara Baader clones several in situ probes and most of the bench work for the WISH 
screen for Egfr-signaling components during her Bachelor thesis. She also helped with 
screening the F2 of Egfra mutant fish. 
Clara Becker did most of the cloning work for the oncogene lines (mostly Golden 
Gate assemblies of final constructs) and injected and performed initial tests of the 
Oncogene lines (Figures 17-19) during her Master Thesis. 
Dr. Narges Aghaallaei did the injections and took the picture for double clonal 
expression of oncogenes in figure 20 and helped with the ISHs on ovary sections for 
which she also provided the material. 
Daigo Ioune did the staining of unfertilized oocytes and the a-tub, pH3 stainings of 
Egfra-/-embryos 4hpf (figure 31). 
Katharina Lust did the immuno-stainings of the Fu_Mitf::GFP line in figure 37 D. 
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IV. Abbreviation list 
A Anterior 
AB Antibody 
ADAM A disintegrin And metalloprotease 
AKT (PKB) Protein Kinase B 
AP Alkaline Phosphatase 
ArCoS Arched COntinuous Stripe 
AREG Amphiregulin 
ath5 Atonal bHLH transcription factor 7 
BCIP 5-Bromo-4-chloro-3-indolyl phosphate 
bp base pair 
BSA Bovine Serum Albumin 
BTC Betacellulin 
cDNA Complementary DNA 
CFP Cyan fluorescent protein 
CMZ Ciliary Marginal Zone 
CNS Central Nervous System 
Cre Cyclization recombinase 
CTP Cytidine triphosphate 
D Dorsal 
DNA Deoxyribonucleic Acid 
DAPI 4',6-diamidino-2-phenylindole 
DIG Digoxigenin 
DMSO Dimethyl sulfoxide 
dNTP 2'deoxy-nucleotide-tri-phosphate 
dpf Days post fertilization 
DTT Dithiothreitol 
E.coli Escherichia coli 
eCFP Enhanced cyan fluorescent protein 
EDTA Ethylenediamine-tetraacetic acid 
EGF Epidermal growth factor 
eGFP Enhanced green fluorescent protein 
EGFR Epidermal growth factor receptor 
egfra Epidermal growth factor receptor a 
egfrb Epidermal growth factor receptor b 
EPGN Epigen 
ErbB Erb-B receptor tyrosine kinase 
EREG Epiregulin 
Erk Extracellular signal-regulated kinase 
ERM Embryo rearing medium 
EtBr Ethidium bromide 
EtOH Ethanol 
FGF Fibroblast growth factor 
FGFR Fibroblast growth factor receptor 
FL Flexible linker 
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FP Fluorescent protein 
fwd Forward 
GCL Ganglion cell layer 
gDNA Genomic deoxyribonucleic acid 
GFP Green fluorescent protein 
Grb2 Growth factor receptor-bound protein 2 
GTP Guanosine triphosphate 
h Hour 
H2O Water 
H2O2 Hydrogen peroxide 
Hb-egf Heparin-binding EGF-like growth factor 
hpf Hour post fertilization 
IGF Insulin-like growth factor 
IGFR Insulin-like growth factor receptor 
INL Inner nuclear layer 
ISH In situ hybridisation 
K-RAS Kirsten rat sarcoma viral oncogene homolog 
LB Lisogeny broth 
MAPK Mitogen-activated protein kinase 
MC Micropylear cell 
MeOH Methanol 
MGC Müller glia cell 
MP Micropyle 
MCS Multiple cloning site 
MEK Mitogen-activated protein kinase kinase 
min Minute 
mpf Minutes post fertilization 
mRNA Messenger ribonucleic acid 
myrAKT Myristoylated protein kinase B 
NaCl Sodium chloride 
NaOH Sodium hydroxide 
NBT Sodium bismuth titanate 
NFκB Nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
NGS Normal goat serum 
NLS Nuclear localization signal 
NPC Neural progenitor cell 
NR Neural retina 
NSC Neural stem cell 
ONL Outer nuclear layer	
ORF Open reading frame 
OT Optic tectum 
P Posterior 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
pErk Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) 
PFA Paraformaldehyde 
PI3K Phosphoinositide-3 kinase 
PKB Protein kinase B 
PKC Protein kinase C 
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PLCγ Phosoholipase Cγ 
PTW Phosphate buffered saline + tween-20 
qRT-PCR Quantitative reverse transcription PCR 
RAS Rat sarcoma 
rev Reverse 
RNA Ribonucleic acid 
RPC Retinal progenitor cell 
RPE Retinal pigment epithelium 
RSAKT Red switch myrAKT 
RSC Retinal stem cell 
RSG Red switch green 
RSK-RAS Red switch K-RAS 
RSX Red switch Xmrk 
RSXFLGFP Red switch Xmrk flexible linker GFP 
RSXT2AGFP Red switch Xmrk T2A GFP 
RT Room temperature 
RT-PCR Reverse transcripase-PCR 
RTK Receptor tyrosine kinase 
Rx2 Retinal homeobox gene 2 
SB Staining buffer 
SC Rtem cell 
SDS Sodium dodecyl sulfate 
sgRNA Single guide RNA 
SOS Son of Sevenless 
SS Sheep serum 
STAT Signal transducer and activator of transcription 
SVZ Sub ventricular zone 
TAE Tris-acetate EDTA buffer 
TGF-β transforming growth factor β 
TGFα transforming growth factor α 
tlx T-cell leukemia 
Tris 2-amino-2-hydroxymethylpropane-1,3-diol 
tTA Tetracycline transactivator 
ubi Ubiquitin promoter 
UTP Uridine triphosphate 
V Ventral 
wa-2 Waved-2 
WISH Whole mount in situ hybridization 
wpf Weeks post fertilization 
WT Wild type 
X-gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
Xmrk Xiphophorus Melanoma Receptor Kinase 
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